hg_137141.1

Basic information about the TSS

---

TSS ID: hg_137141.1 Species: human Chr: chr13		Start: 46003279 End: 46003308 Strand: -
TSS cluster detected*

  * The number of TSS cluster called studies (maximum 16)

Gene and protein annotation

---

Transcript_name: BC032425 Distance: -4 GeneID: 23091 HGNC/MGI_ID: HGNC:20368 UniProt_ID: A0PJJ2

Gene_name: zinc finger CCCH-type containing 13 Gene_symbol: ZC3H13 Gene_synonyms: DKFZp434D1812 Xio Gene_source: HGNC:20368

TATA-Box annotation

---

Distance to TSS:	49452
Nearest PromoterID:	NM_001330564
Entrez ID:	23091
Nearest Unigene:	Hs.136102
Nearest Refseq:	NM_015070
Nearest Ensembl:	ENSG00000123200
Gene Name:	zinc finger CCCH-type containing 13
Gene Alias:	KIAA0853|Xio
Gene Description:	zinc finger CCCH-type containing 13
Gene Type:	protein-coding
CpG%:	0.01
GC%:	0.338308
TATA-Box(TBP)/Promoter/Homer Distance From TSS(sequence,strand,conservation):

TSS expression

Sample Category  All in vivo cell sample cell line sample tissue sample human bronchial epithelial cell sample CD19-positive B cell sample CD8-positive T cell sample CD4-positive T cell sample common myeloid progenitor sample human monocyte immature derived dendritic cell sample human endothelial cell of the aorta sample human cardiac fibroblast sample human dermal fibroblast sample human fibroblast of gingiva sample human fibroblast of periodontium sample granulocyte macrophage progenitor cell sample human hepatocyte sample human mesenchymal stem cell of umbilical cord-Sciencell sample human mesenchymal stem cell of adipose sample human mesenchymal stem cell of bone marrow sample mouse sample mouse granule cell sample mouse hepatocyte sample human neutrophil sample human osteoblast-Sciencell sample human osteoblast-Cell applications sample human renal glomerular endothelial cell sample human retinal pigment epithelial cell sample human skeletal muscle cell sample human aortic smooth muscle cell sample human smooth muscle cell of umbilical artery sample human urothelial cell sample cerebellar granule cell sample human sample mast cell- heparinase treated sample human mature adipocyte sample human cardiac mesenchymal precursor cell sample human mesenchymal precursor cell- ovarian cancer-left ovary sample human mesenchymal precursor cell- ovarian cancer-metastasis sample human mesenchymal precursor cell- ovarian cancer-right ovary sample human whole blood sample control treatment sample human adipose tissue - adult sample human brain - adult sample human parietal lobe - adult sample hippocampus - adult sample human CD14-CD16-positive Monocytes sample mouse cerebellum- embryo E13 sample mouse cerebellum- embryo E15 sample mouse cerebellum- embryo E18 sample human Monocyte-derived macrophages 0h after mock infection sample human Monocyte-derived macrophages 0h after udorn influenza infection sample human Monocyte-derived macrophages 2h after udorn influenza infection sample human Monocyte-derived macrophages 7h after udorn influenza infection sample human Monocyte-derived macrophages 24h after udorn influenza infection sample human Monocyte-derived macrophages 24h after mock infection sample mouse whole body- embryo E17.5 sample adenocarcinoma cell line sample small cell lung cancer cell sample carcinoma cell line sample teratocarcinoma cell line sample sarcoma cell line sample K-562 cell sample embryonic cell line sample epithelial cell line sample THP-1 cell sample gastrointestinal cancer cell sample acute myeloid leukemia cell line sample cervical cancer cell line sample squamous cell carcinoma cell line sample mesothelioma cell line sample NCI cell sample human nasal epithelial cell sample macrophage, TB infection sample iPS differentiation to neuron, control sample iPS differentiation to neuron, down-syndrome donor sample myoblast differentiation to myotubes, control sample H1 embryonic stem cells differentiation to CD34+ HSC sample 293SLAM rinderpest infection sample COBL-a rinderpest infection sample partial hepatectomy sample sham operation sample ES-OS25 embryonic stem cells sample ES-OS25 embryonic stem cells, untreated sample ES-46C embryonic stem cells, neuronal differentiation sample ES-OS25 embryonic stem cells, KD for exosomal component EXOSC3, biol_rep1 sample ARPE-19 EMT induced with TGF-beta and TNF-alpha sample hIPS sample

		Promoter select All p1@ZC3H13 p2@ZC3H13 p3@ZC3H13 p4@ZC3H13 p5@ZC3H13 p6@ZC3H13 p8@ZC3H13 p9@ZC3H13 p10@ZC3H13
Sample		p1@ZC3H13	p2@ZC3H13	p3@ZC3H13	p4@ZC3H13	p5@ZC3H13	p6@ZC3H13	p8@ZC3H13	p9@ZC3H13	p10@ZC3H13
293SLAM rinderpest infection, 00hr, biol_rep1	13541-145H4	36.04	4.29	0.39	0.39	0.78	0.19	0.19	0.97	1.95
293SLAM rinderpest infection, 00hr, biol_rep2	13542-145H5	32.17	5.46	0.00	0.40	0.00	0.20	0.00	1.21	1.82
293SLAM rinderpest infection, 00hr, biol_rep3	13543-145H6	39.16	3.86	0.39	0.39	0.19	0.58	0.58	0.77	1.54
293SLAM rinderpest infection, 06hr, biol_rep1	13544-145H7	35.34	2.49	0.00	0.21	0.00	0.42	0.00	0.83	0.62
293SLAM rinderpest infection, 06hr, biol_rep2	13545-145H8	35.09	2.70	0.00	0.22	0.00	0.67	0.45	0.00	1.12
293SLAM rinderpest infection, 06hr, biol_rep3	13546-145H9	33.34	3.10	0.19	0.19	0.58	0.58	0.39	0.97	1.36
293SLAM rinderpest infection, 12hr, biol_rep1	13547-145I1	49.90	2.61	0.44	0.44	0.00	0.65	0.44	0.87	2.61
293SLAM rinderpest infection, 12hr, biol_rep2	13548-145I2	42.39	1.94	0.00	0.00	0.48	0.00	0.00	0.24	1.21
293SLAM rinderpest infection, 12hr, biol_rep3	13549-145I3	26.29	1.92	0.21	0.43	0.00	0.21	0.21	0.00	0.85
293SLAM rinderpest infection, 24hr, biol_rep1	13550-145I4	56.22	2.32	0.00	0.00	0.00	0.00	1.16	0.58	0.00
293SLAM rinderpest infection, 24hr, biol_rep2	13551-145I5	55.38	3.64	0.00	0.00	0.00	1.21	1.62	2.83	1.21
293SLAM rinderpest infection, 24hr, biol_rep3	13552-145I6	59.36	3.25	0.00	0.81	0.41	0.00	0.81	0.00	0.81
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr00min, biol_rep1	13625-146H7	15.15	0.32	0.16	0.16	0.00	0.16	0.32	0.32	0.32
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr00min, biol_rep2	13626-146H8	18.79	1.20	0.00	0.00	0.45	0.15	0.15	0.30	0.15
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr00min, biol_rep3	13627-146H9	13.83	0.66	0.00	0.00	0.00	0.00	0.00	0.22	0.44
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr15min, biol_rep1	13628-146I1	11.82	1.26	0.25	0.00	0.00	0.75	0.00	0.25	0.25
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr15min, biol_rep2	13629-146I2	12.89	1.53	0.00	0.22	0.00	0.00	0.22	0.22	0.44
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr15min, biol_rep3	13630-146I3	14.76	1.69	0.00	0.00	0.00	0.42	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr30min, biol_rep1	13631-146I4	13.86	0.53	0.00	0.00	0.00	0.00	0.53	0.00	0.53
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr30min, biol_rep2	13632-146I5	15.19	0.60	0.00	0.00	0.00	0.30	0.00	0.00	0.30
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr30min, biol_rep3	13633-146I6	14.43	0.94	0.53	0.13	0.00	0.27	0.00	0.13	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr45min, biol_rep1	13634-146I7	15.54	1.21	0.00	0.00	0.00	0.00	0.00	0.17	0.17
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr45min, biol_rep2	13635-146I8	13.96	1.29	0.13	0.13	0.13	0.26	0.00	0.13	0.13
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr45min, biol_rep3	13636-146I9	13.83	0.73	0.00	0.00	0.00	0.00	0.24	0.49	0.24
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr00min, biol_rep1	13637-147A1	14.96	1.29	0.26	0.26	0.00	0.00	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr00min, biol_rep2	13638-147A2	18.04	1.27	0.00	0.32	0.00	0.32	0.63	0.32	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr00min, biol_rep3	13639-147A3	15.38	1.65	0.00	0.00	0.00	0.00	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr20min, biol_rep1	13640-147A4	20.98	1.65	0.00	0.00	0.00	0.24	0.00	0.24	1.41
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr20min, biol_rep2	13641-147A5	14.38	0.97	0.16	0.00	0.00	0.16	0.00	0.48	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr20min, biol_rep3	13642-147A6	21.17	0.36	0.00	0.18	0.18	0.00	0.00	0.18	0.36
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr40min, biol_rep1	13643-147A7	11.72	1.88	0.00	0.00	0.21	0.63	0.00	0.00	0.21
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr40min, biol_rep2	13644-147A8	15.24	1.17	0.00	0.00	0.00	0.20	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr40min, biol_rep3	13645-147A9	14.56	0.84	0.21	0.21	0.21	0.21	0.21	0.00	0.42
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr00min, biol_rep1	13646-147B1	21.61	0.99	0.00	0.16	0.00	0.49	0.49	0.00	0.33
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr00min, biol_rep2	13647-147B2	13.28	0.56	0.00	0.00	0.00	0.19	0.19	0.00	0.37
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr00min, biol_rep3	13648-147B3	14.75	0.77	0.00	0.19	0.38	0.00	0.00	0.00	0.38
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr30min, biol_rep1	13649-147B4	18.80	0.82	0.00	0.20	0.20	0.00	0.00	0.41	0.20
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr30min, biol_rep2	13650-147B5	17.13	1.61	0.20	0.00	0.00	0.00	0.40	0.40	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr30min, biol_rep3	13651-147B6	14.86	1.89	0.00	0.27	0.00	0.27	0.54	0.54	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr00min, biol_rep1	13652-147B7	19.45	1.44	0.00	0.24	0.48	0.24	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr00min, biol_rep2	13653-147B8	11.76	1.18	0.00	0.24	0.00	0.24	0.00	0.00	0.24
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr00min, biol_rep3	13654-147B9	16.54	0.44	0.29	0.29	0.00	0.29	0.29	0.29	0.29
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr30min, biol_rep1	13655-147C1	19.82	0.00	0.00	0.00	0.00	0.00	0.21	0.00	0.21
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr30min, biol_rep2	13656-147C2	18.01	1.22	0.00	0.00	0.00	0.35	0.35	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr30min, biol_rep3	13657-147C3	20.68	0.40	0.20	0.00	0.00	0.00	0.20	0.00	0.40
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 04hr00min, biol_rep1	13658-147C4	16.52	0.47	0.00	0.70	0.00	0.00	0.00	0.23	0.47
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 04hr00min, biol_rep2	13659-147C5	15.83	0.72	0.00	0.00	0.00	0.24	0.24	0.24	0.48
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 04hr00min, biol_rep3	13660-147C6	15.20	0.60	0.00	0.00	0.00	0.30	0.30	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 05hr00min, biol_rep1	13661-147C7	18.91	1.20	0.00	0.00	0.00	0.00	0.24	0.24	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 05hr00min, biol_rep2	13662-147C8	18.80	0.81	0.20	0.40	0.00	0.00	0.20	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 05hr00min, biol_rep3	13663-147C9	18.45	1.64	0.00	0.00	0.20	0.00	0.41	0.20	0.82
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 06hr00min, biol_rep1	13664-147D1	21.57	0.67	0.44	0.00	0.22	0.22	0.44	0.00	0.67
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 06hr00min, biol_rep2	13665-147D2	391.78	27.98	27.98	13.99	27.98	27.98	0.00	0.00	27.98
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 06hr00min, biol_rep3	13666-147D3	14.90	0.71	0.00	0.00	0.00	0.00	0.00	0.35	0.71
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 07hr00min, biol_rep1	13667-147D4	18.23	0.33	0.00	0.00	0.00	0.00	0.33	0.33	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 07hr00min, biol_rep2	13668-147D5	52.01	1.68	0.84	1.68	2.52	0.00	0.84	0.00	9.23
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 07hr00min, biol_rep3	13669-147D6	23.42	1.38	0.46	0.00	0.00	0.00	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 08hr00min, biol_rep1	13670-147D7	24.96	0.00	0.00	0.00	0.00	0.00	0.65	0.00	0.32
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 08hr00min, biol_rep2	13671-147D8	18.95	1.28	0.32	0.00	0.00	0.32	0.32	0.32	0.32
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 08hr00min, biol_rep3	13672-147D9	21.06	0.63	0.00	0.00	0.31	0.63	0.00	0.63	0.63
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 12hr00min, biol_rep2	13674-147E2	17.63	2.12	0.00	0.71	0.00	0.00	0.00	0.00	1.41
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 12hr00min, biol_rep3	13675-147E3	14.02	1.68	0.00	0.00	0.00	0.00	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 16hr00min, biol_rep1	13676-147E4	31.85	1.59	3.18	0.80	2.39	2.39	0.00	0.80	2.39
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 16hr00min, biol_rep2	13677-147E5	15.63	0.34	0.00	0.00	0.00	0.00	0.00	0.34	1.36
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 16hr00min, biol_rep3	13678-147E6	25.34	0.65	0.00	0.32	0.00	0.00	0.00	0.32	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 24hr00min, biol_rep1	13679-147E7	19.52	2.13	0.35	0.00	0.00	0.00	0.35	0.35	0.71
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 24hr00min, biol_rep2	13680-147E8	484.92	32.33	16.16	0.00	0.00	16.16	0.00	0.00	32.33
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 24hr00min, biol_rep3	13681-147E9	252.72	0.00	31.59	7.90	0.00	15.79	0.00	7.90	15.79
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 42hr00min, biol_rep1	13682-147F1	18.04	2.44	0.00	0.00	0.00	0.00	0.00	0.49	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 42hr00min, biol_rep2	13683-147F2	15.87	0.00	0.00	0.50	0.00	0.00	0.00	0.50	0.50
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 42hr00min, biol_rep3	13684-147F3	16.89	0.00	0.00	0.00	0.00	0.00	0.00	0.94	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 60hr00min, biol_rep1	13685-147F4	14.90	0.33	0.00	0.00	0.00	0.00	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 60hr00min, biol_rep2	13686-147F5	19.18	0.62	0.62	0.00	0.00	0.31	0.00	0.31	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 60hr00min, biol_rep3	13687-147F6	16.82	0.31	0.00	0.00	0.31	0.00	0.00	0.00	0.00
Adipocyte - breast, donor1	11376-118A8	25.66	0.63	0.00	0.16	0.63	0.00	0.79	0.32	0.48
Adipocyte - breast, donor2	11327-117E4	19.57	1.12	1.12	0.96	1.12	0.48	0.80	0.64	0.00
Adipocyte - omental, donor1	11473-119C6	26.34	1.02	0.13	0.25	0.13	0.38	0.64	0.51	0.00
Adipocyte - omental, donor2	11474-119C7	15.70	1.49	0.00	0.75	0.00	0.00	0.00	0.00	0.00
Adipocyte - omental, donor3	11475-119C8	13.40	0.67	0.33	0.33	0.33	0.33	0.00	0.00	0.67
Adipocyte - perirenal, donor1	11476-119C9	9.57	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.64
Adipocyte - subcutaneous, donor1	11259-116F8	3.30	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Adipocyte - subcutaneous, donor2	11336-117F4	22.58	0.00	0.00	0.00	0.00	0.00	0.00	0.45	0.45
Adipocyte - subcutaneous, donor3	11408-118E4	9.21	0.70	0.00	0.70	0.00	0.17	0.00	0.52	0.00
Adipocyte differentiation, day04, donor1	13019-139D4	24.45	0.00	0.20	0.20	0.39	0.00	0.78	0.00	0.00
Adipocyte differentiation, day04, donor2	13022-139D7	18.53	0.26	0.00	0.26	0.00	0.51	0.51	0.00	0.00
Adipocyte differentiation, day04, donor3	13025-139E1	16.45	0.56	0.00	0.28	0.00	0.00	0.28	0.00	0.00
Adipocyte differentiation, day04, donor4	13028-139E4	26.45	0.00	0.00	0.00	0.00	0.00	0.00	0.00	1.18
Adipocyte differentiation, day08, donor1	13020-139D5	32.90	0.32	0.16	0.40	0.16	0.08	0.24	0.08	0.16
Adipocyte differentiation, day08, donor2	13023-139D8	22.27	0.65	0.00	0.00	0.00	0.00	0.32	0.00	0.00
Adipocyte differentiation, day08, donor3	13026-139E2	16.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Adipocyte differentiation, day08, donor4	13029-139E5	11.13	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Adipocyte differentiation, day12, donor1	13021-139D6	12.48	0.00	0.00	0.42	0.00	0.00	0.00	0.00	0.00
Adipocyte differentiation, day12, donor2	13024-139D9	14.82	0.50	0.00	0.25	0.25	0.00	0.25	0.00	0.25
Adipocyte differentiation, day12, donor3	13027-139E3	14.40	0.00	0.00	0.00	0.33	0.00	0.00	0.00	0.33
Adipocyte differentiation, day12, donor4	13030-139E6	13.09	0.00	0.00	0.00	0.30	0.00	0.00	0.00	0.00
Alveolar Epithelial Cells, donor1	11510-119G7	5.08	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.22
Alveolar Epithelial Cells, donor2	11590-120G6	4.30	0.36	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Alveolar Epithelial Cells, donor3	11671-122G6	2.40	0.00	0.00	0.00	0.00	0.00	0.00	0.00	1.20
Amniotic Epithelial Cells, donor1	11533-120A3	10.79	0.36	0.18	0.00	0.18	0.00	0.00	0.18	0.00
Amniotic Epithelial Cells, donor2	11613-122A2	3.35	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Amniotic Epithelial Cells, donor3	11694-123A2	4.93	0.62	0.00	0.00	0.00	0.21	0.00	0.41	0.21
Anulus Pulposus Cell, donor1	11248-116E6	15.45	1.26	0.23	0.11	0.23	0.11	0.23	0.34	0.34
Anulus Pulposus Cell, donor2	11463-119B5	9.31	0.24	0.24	0.24	0.00	0.00	0.24	0.00	0.24
Aortic smooth muscle cell response to FGF2, 00hr00min, biol_rep1 (LK1)	12642-134G5	17.07	0.90	0.00	0.45	1.35	0.00	0.00	0.00	0.90
Aortic smooth muscle cell response to FGF2, 00hr00min, biol_rep2 (LK2)	12740-135I4	11.72	2.17	0.00	0.00	0.43	0.87	0.00	0.43	0.43
Aortic smooth muscle cell response to FGF2, 00hr00min, biol_rep3 (LK3)	12838-137B3	17.12	2.14	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 00hr15min, biol_rep1 (LK4)	12643-134G6	15.25	0.60	0.30	0.60	1.20	0.90	0.60	0.90	0.30
Aortic smooth muscle cell response to FGF2, 00hr15min, biol_rep2 (LK5)	12741-135I5	17.71	1.26	0.00	2.53	2.53	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 00hr15min, biol_rep3 (LK6)	12839-137B4	6.60	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.66
Aortic smooth muscle cell response to FGF2, 00hr30min, biol_rep1 (LK7)	12644-134G7	12.35	0.00	0.00	0.97	0.32	0.32	0.00	0.32	0.32
Aortic smooth muscle cell response to FGF2, 00hr30min, biol_rep2 (LK8)	12742-135I6	10.68	0.49	0.00	0.00	0.00	0.00	0.00	0.00	0.49
Aortic smooth muscle cell response to FGF2, 00hr30min, biol_rep3 (LK9)	12840-137B5	9.50	0.59	0.00	0.00	0.00	0.59	0.00	0.00	0.59
Aortic smooth muscle cell response to FGF2, 00hr45min, biol_rep1 (LK10)	12645-134G8	11.30	0.75	0.00	0.00	0.00	0.38	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 00hr45min, biol_rep2 (LK11)	12743-135I7	10.16	0.00	0.00	0.00	0.00	0.00	0.00	0.73	0.00
Aortic smooth muscle cell response to FGF2, 00hr45min, biol_rep3 (LK12)	12841-137B6	2.51	1.25	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 01hr, biol_rep1 (LK13)	12646-134G9	14.83	0.33	0.00	0.16	0.16	0.00	0.00	0.16	0.16
Aortic smooth muscle cell response to FGF2, 01hr, biol_rep2 (LK14)	12744-135I8	25.93	1.36	1.36	0.00	0.00	0.00	0.00	0.00	2.73
Aortic smooth muscle cell response to FGF2, 01hr, biol_rep3 (LK15)	12842-137B7	14.93	0.30	0.00	0.00	0.00	0.00	0.15	0.30	0.00
Aortic smooth muscle cell response to FGF2, 02hr, biol_rep1 (LK16)	12647-134H1	13.93	1.61	0.54	0.54	0.54	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 02hr, biol_rep2 (LK17)	12745-135I9	11.71	0.57	0.00	0.19	0.00	0.19	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 02hr, biol_rep3 (LK18)	12843-137B8	9.36	1.07	0.00	0.53	0.00	0.27	0.53	0.00	0.27
Aortic smooth muscle cell response to FGF2, 03hr, biol_rep1 (LK19)	12648-134H2	13.66	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 03hr, biol_rep2 (LK20)	12746-136A1	9.95	0.50	0.17	0.33	0.33	0.00	0.17	0.00	0.17
Aortic smooth muscle cell response to FGF2, 03hr, biol_rep3 (LK21)	12844-137B9	13.21	0.00	1.20	0.00	0.00	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 04hr, biol_rep1 (LK22)	12649-134H3	14.16	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 04hr, biol_rep2 (LK23)	12747-136A2	14.07	1.03	0.34	0.69	0.17	0.17	0.00	0.51	0.34
Aortic smooth muscle cell response to FGF2, 04hr, biol_rep3 (LK24)	12845-137C1	8.39	4.19	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 05hr, biol_rep1 (LK25)	12650-134H4	10.68	0.49	0.49	0.00	0.97	0.00	0.49	0.49	0.49
Aortic smooth muscle cell response to FGF2, 05hr, biol_rep2 (LK26)	12748-136A3	9.87	0.00	0.00	0.00	0.38	0.38	0.00	0.00	0.38
Aortic smooth muscle cell response to FGF2, 05hr, biol_rep3 (LK27)	12846-137C2	13.33	0.00	1.21	0.00	0.00	0.00	0.00	0.00	1.21
Aortic smooth muscle cell response to FGF2, 06hr, biol_rep1 (LK28)	12651-134H5	15.96	0.57	0.57	0.57	1.14	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 06hr, biol_rep2 (LK29)	12749-136A4	14.32	1.07	0.00	0.00	0.00	0.43	0.21	0.64	0.00
Aortic smooth muscle cell response to FGF2, 06hr, biol_rep3 (LK30)	12847-137C3	9.55	0.77	0.00	0.00	0.26	0.26	0.26	0.26	0.26
Aortic smooth muscle cell response to IL1b, 00hr00min, biol_rep1 (LK31)	12652-134H6	10.79	0.94	0.00	0.00	0.00	0.00	0.00	0.00	0.47
Aortic smooth muscle cell response to IL1b, 00hr00min, biol_rep2 (LK32)	12750-136A5	9.97	0.32	0.32	0.00	0.64	0.96	0.00	0.00	0.64
Aortic smooth muscle cell response to IL1b, 00hr00min, biol_rep3 (LK33)	12848-137C4	7.13	1.43	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 00hr15min, biol_rep1 (LK34)	12653-134H7	15.21	0.58	0.00	0.00	0.58	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 00hr15min, biol_rep2 (LK35)	12751-136A6	14.15	1.20	0.00	0.60	0.30	0.00	0.00	0.60	0.30
Aortic smooth muscle cell response to IL1b, 00hr15min, biol_rep3 (LK36)	12849-137C5	8.32	2.38	0.00	0.00	1.19	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 00hr30min, biol_rep1 (LK37)	12654-134H8	16.27	1.02	0.00	0.00	0.51	0.51	0.00	0.51	0.51
Aortic smooth muscle cell response to IL1b, 00hr30min, biol_rep2 (LK38)	12752-136A7	12.73	1.27	0.25	0.51	0.00	0.76	0.51	0.51	1.02
Aortic smooth muscle cell response to IL1b, 00hr30min, biol_rep3 (LK39)	12850-137C6	5.72	0.64	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 00hr45min, biol_rep1 (LK40)	12655-134H9	13.38	0.43	0.00	0.00	0.00	0.43	0.43	0.00	0.00
Aortic smooth muscle cell response to IL1b, 00hr45min, biol_rep2 (LK41)	12753-136A8	13.55	0.42	0.00	0.42	0.00	0.00	0.21	0.21	0.21
Aortic smooth muscle cell response to IL1b, 00hr45min, biol_rep3 (LK42)	12851-137C7	6.09	0.29	0.00	0.00	0.00	0.00	0.29	0.00	0.00
Aortic smooth muscle cell response to IL1b, 01hr, biol_rep1 (LK43)	12656-134I1	12.28	0.00	1.89	0.00	1.89	0.94	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 01hr, biol_rep2 (LK44)	12754-136A9	13.05	0.85	0.17	0.34	0.00	0.34	0.17	0.17	0.17
Aortic smooth muscle cell response to IL1b, 01hr, biol_rep3 (LK45)	12852-137C8	6.95	6.95	0.00	0.00	0.00	0.00	0.00	0.00	2.32
Aortic smooth muscle cell response to IL1b, 02hr, biol_rep1 (LK46)	12657-134I2	19.01	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 02hr, biol_rep2 (LK47)	12755-136B1	12.01	0.86	0.21	0.43	0.21	0.21	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 02hr, biol_rep3 (LK48)	12853-137C9	13.84	0.00	0.00	0.00	0.00	0.00	0.60	0.60	0.60
Aortic smooth muscle cell response to IL1b, 03hr, biol_rep1 (LK49)	12658-134I3	6.56	0.73	0.00	0.73	0.00	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 03hr, biol_rep2 (LK50)	12756-136B2	12.41	1.15	0.23	0.69	0.46	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 03hr, biol_rep3 (LK51)	12854-137D1	10.20	2.55	5.10	0.00	0.00	0.00	0.00	0.00	2.55
Aortic smooth muscle cell response to IL1b, 04hr, biol_rep1 (LK52)	12659-134I4	12.97	0.25	0.00	0.25	0.00	0.00	0.51	0.00	0.00
Aortic smooth muscle cell response to IL1b, 04hr, biol_rep2 (LK53)	12757-136B3	14.04	1.03	0.00	0.21	0.21	0.21	0.00	0.41	0.41
Aortic smooth muscle cell response to IL1b, 04hr, biol_rep3 (LK54)	12855-137D2	11.32	0.92	0.31	0.00	0.31	0.00	0.31	0.31	0.00
Aortic smooth muscle cell response to IL1b, 05hr, biol_rep1 (LK55)	12660-134I5	11.47	0.96	0.48	0.00	0.00	1.91	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 05hr, biol_rep2 (LK56)	12758-136B4	12.64	1.77	0.22	0.44	0.00	0.89	0.22	0.22	0.44
Aortic smooth muscle cell response to IL1b, 05hr, biol_rep3 (LK57)	12856-137D3	3.05	1.53	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 06hr, biol_rep1 (LK58)	12661-134I6	8.86	0.00	0.00	0.00	0.55	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 06hr, biol_rep2 (LK59)	12759-136B5	18.27	1.59	0.00	0.53	0.00	0.53	0.00	0.26	0.00
Aortic smooth muscle cell response to IL1b, 06hr, biol_rep3 (LK60)	12857-137D4	12.72	0.73	0.36	0.36	0.73	1.09	0.73	0.00	0.00
Astrocyte - cerebellum, donor1	11500-119F6	9.33	0.12	0.00	0.00	0.00	0.00	0.25	0.00	0.12
Astrocyte - cerebellum, donor2	11580-120F5	6.68	0.00	0.00	0.00	0.00	0.00	0.17	0.17	0.00
Astrocyte - cerebellum, donor3	11661-122F5	3.36	0.00	0.21	0.00	0.00	0.00	0.00	0.00	0.00
Astrocyte - cerebral cortex, donor1	11235-116D2	32.42	1.05	0.70	0.70	0.70	1.05	0.00	0.35	0.35
Astrocyte - cerebral cortex, donor2	11316-117D2	34.46	1.62	1.29	1.62	1.29	0.16	0.81	0.65	0.00
Astrocyte - cerebral cortex, donor3	11392-118C6	28.04	0.60	1.19	0.60	0.75	0.60	0.15	0.15	0.15
B lymphoblastoid cell line: GM12878 ENCODE, biol_rep1	10821-111C2	55.16	1.26	1.03	1.61	1.61	0.92	0.80	0.80	0.57
B lymphoblastoid cell line: GM12878 ENCODE, biol_rep2	10822-111C3	54.50	3.38	1.00	0.63	1.63	1.88	0.50	0.88	0.25
B lymphoblastoid cell line: GM12878 ENCODE, biol_rep3	10823-111C4	49.84	2.28	1.14	1.37	1.71	0.34	0.34	0.57	0.68
Basophils, donor1	12241-129G9	25.37	0.00	0.00	0.00	0.00	0.00	0.52	0.00	0.00
Basophils, donor2	12242-129H1	42.93	0.36	0.00	0.00	0.00	0.00	1.44	0.00	0.00
Basophils, donor3	12243-129H2	22.20	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Bronchial Epithelial Cell, donor1	11511-119G8	1.94	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Bronchial Epithelial Cell, donor2	11591-120G7	4.11	0.00	0.00	0.00	0.00	0.46	0.00	0.00	0.00
Bronchial Epithelial Cell, donor3	11672-122G7	0.00	0.00	0.00	0.00	0.00	0.00	0.00	7.17	0.00
Bronchial Epithelial Cell, donor4	11453-119A4	9.41	0.63	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Bronchial Epithelial Cell, donor5	11457-119A8	5.82	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Bronchial Epithelial Cell, donor6	11461-119B3	5.53	0.46	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Bronchial Epithelial Cell, donor7	11769-123I5	14.22	2.70	1.44	0.90	1.08	0.90	0.18	0.36	0.36
Burkitt's lymphoma cell line:DAUDI	10422-106C8	40.71	2.16	0.41	0.93	0.72	0.72	1.96	0.72	0.62
Burkitt's lymphoma cell line:RAJI	10476-106I8	61.02	3.49	1.86	2.56	1.40	2.56	0.00	1.40	0.23
CD133+ stem cells - adult bone marrow derived, pool1	12224-129F1	32.94	0.64	0.00	0.00	0.00	0.00	1.28	0.00	0.32
CD133+ stem cells - cord blood derived, pool1	12223-129E9	20.68	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
CD14+ Monocytes, donor1	11224-116B9	41.14	0.00	0.00	0.56	0.00	0.00	0.56	0.00	0.56
CD14+ Monocytes, donor2	11305-117B9	27.84	0.19	0.56	0.19	0.19	0.19	0.37	0.00	0.19
CD14+ Monocytes, donor3	11381-118B4	27.88	0.44	0.22	0.22	0.00	0.00	0.44	0.22	0.00
CD14+ monocyte derived endothelial progenitor cells, donor1	11229-116C5	33.68	0.00	0.57	0.00	0.28	0.28	1.70	0.28	0.28
CD14+ monocyte derived endothelial progenitor cells, donor2	11310-117C5	36.39	0.76	0.00	0.00	0.00	0.38	1.52	0.00	0.00
CD14+ monocyte derived endothelial progenitor cells, donor3	11386-118B9	44.05	0.00	0.33	0.66	0.00	0.00	0.33	0.00	0.00
CD14+ monocytes - mock treated, donor1	11863-125A9	36.86	2.46	0.29	1.45	0.14	0.87	0.87	1.01	1.30
CD14+ monocytes - mock treated, donor2	11873-125C1	35.00	0.91	0.60	0.60	2.72	0.91	0.60	1.21	0.00
CD14+ monocytes - mock treated, donor3	11883-125D2	47.14	1.18	1.42	0.71	0.71	0.47	1.90	0.24	0.71
CD14+ monocytes - treated with B-glucan, donor1	11869-125B6	31.30	2.01	0.50	0.84	0.50	1.00	1.00	0.84	0.67
CD14+ monocytes - treated with B-glucan, donor2	11879-125C7	32.02	1.38	1.10	1.93	0.83	0.55	2.76	0.83	0.83
CD14+ monocytes - treated with B-glucan, donor3	11889-125D8	51.07	0.74	0.74	0.50	0.74	0.74	1.49	0.50	0.99
CD14+ monocytes - treated with BCG, donor1	11860-125A6	30.15	0.78	0.20	1.57	0.98	0.98	0.78	0.78	0.00
CD14+ monocytes - treated with BCG, donor2	11870-125B7	26.71	0.71	0.53	0.89	0.36	0.53	0.71	0.36	0.18
CD14+ monocytes - treated with BCG, donor3	11880-125C8	46.14	1.09	0.00	0.00	0.22	0.22	0.22	0.00	0.44
CD14+ monocytes - treated with Candida, donor1	11868-125B5	43.31	0.23	0.23	0.23	0.70	0.23	0.70	0.23	0.00
CD14+ monocytes - treated with Candida, donor2	11878-125C6	41.19	1.58	1.58	0.00	0.00	0.53	2.64	0.00	0.00
CD14+ monocytes - treated with Candida, donor3	11888-125D7	36.61	1.11	0.00	0.00	0.00	0.00	0.00	1.11	0.00
CD14+ monocytes - treated with Cryptococcus, donor1	11867-125B4	36.44	2.08	1.04	1.04	0.89	1.04	1.78	1.34	0.74
CD14+ monocytes - treated with Cryptococcus, donor2	11877-125C5	34.52	0.40	1.80	0.20	1.00	1.00	1.00	0.40	0.60
CD14+ monocytes - treated with Cryptococcus, donor3	11887-125D6	61.00	0.42	0.42	0.21	0.00	0.62	1.67	0.00	0.00
CD14+ monocytes - treated with Group A streptococci, donor1	11864-125B1	42.33	0.69	0.23	0.46	0.69	0.69	1.60	0.92	0.46
CD14+ monocytes - treated with Group A streptococci, donor2	11874-125C2	38.45	0.45	0.68	0.45	0.23	0.23	1.36	0.23	0.00
CD14+ monocytes - treated with Group A streptococci, donor3	11884-125D3	36.66	0.44	1.31	0.44	0.87	0.44	0.87	0.00	0.00
CD14+ monocytes - treated with IFN + N-hexane, donor1	11861-125A7	39.00	0.54	0.54	0.27	0.54	0.27	1.34	0.81	0.54
CD14+ monocytes - treated with IFN + N-hexane, donor2	11871-125B8	30.18	0.70	2.09	0.87	1.22	0.70	2.62	0.70	0.52
CD14+ monocytes - treated with IFN + N-hexane, donor3	11881-125C9	45.03	2.52	0.42	1.26	1.68	0.42	2.10	0.00	0.42
CD14+ monocytes - treated with Salmonella, donor1	11866-125B3	29.94	2.20	0.55	0.55	1.47	1.29	0.92	0.55	0.92
CD14+ monocytes - treated with Salmonella, donor2	11876-125C4	26.07	0.00	1.06	1.06	1.06	1.41	1.06	0.70	0.70
CD14+ monocytes - treated with Salmonella, donor3	11886-125D5	45.63	0.88	1.32	0.88	0.00	0.44	0.44	0.88	0.44
CD14+ monocytes - treated with Trehalose dimycolate (TDM), donor1	11862-125A8	35.57	1.57	0.52	1.39	1.05	1.57	0.87	0.70	0.70
CD14+ monocytes - treated with Trehalose dimycolate (TDM), donor2	11872-125B9	29.36	0.00	0.00	1.12	0.74	1.49	1.12	0.00	1.12
CD14+ monocytes - treated with Trehalose dimycolate (TDM), donor3	11882-125D1	55.40	1.08	0.65	0.22	0.43	0.43	0.86	0.00	0.43
CD14+ monocytes - treated with lipopolysaccharide, donor1	11865-125B2	24.98	0.82	1.23	0.82	0.00	0.82	1.64	0.00	1.23
CD14+ monocytes - treated with lipopolysaccharide, donor2	11875-125C3	35.70	0.23	0.23	0.46	0.00	0.46	1.39	0.23	0.00
CD14+ monocytes - treated with lipopolysaccharide, donor3	11885-125D4	51.50	0.23	0.46	0.23	0.23	0.00	1.62	0.23	0.00
CD14+CD16+ Monocytes, donor1	11789-124B7	33.57	0.22	0.00	0.00	0.22	0.00	0.44	0.00	0.22
CD14+CD16+ Monocytes, donor2	11801-124D1	27.72	0.92	0.00	0.23	0.00	0.23	0.00	0.23	0.00
CD14+CD16+ Monocytes, donor3	11912-125G4	21.01	0.00	0.00	0.00	0.00	0.00	0.22	0.00	0.00
CD14+CD16- Monocytes, donor1	11788-124B6	34.88	0.31	0.31	0.31	0.16	0.62	0.47	0.16	0.16
CD14+CD16- Monocytes, donor2	11799-124C8	24.45	0.35	0.52	0.00	0.17	0.35	0.52	0.00	0.35
CD14+CD16- Monocytes, donor3	11910-125G2	55.30	0.67	0.22	0.89	0.22	0.89	1.11	0.00	0.67
CD14-CD16+ Monocytes, donor1	11790-124B8	28.58	0.00	0.00	0.00	0.00	0.00	0.51	0.00	0.00
CD14-CD16+ Monocytes, donor2	11800-124C9	30.08	0.44	0.22	0.22	0.00	0.22	0.22	0.00	0.66
CD14-CD16+ Monocytes, donor3	11911-125G3	31.58	0.42	0.42	0.00	0.00	0.00	0.42	0.00	0.00
CD19+ B Cells (pluriselect), donor090309, donation1	12189-129B2	34.55	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
CD19+ B Cells (pluriselect), donor090309, donation2	12194-129B7	46.78	1.36	0.68	0.00	0.00	0.00	0.68	0.00	0.68
CD19+ B Cells (pluriselect), donor090309, donation3	12199-129C3	37.28	0.00	0.00	0.00	0.00	0.00	1.04	0.00	0.00
CD19+ B Cells (pluriselect), donor090325, donation1	12151-128F9	43.18	0.53	0.00	0.53	0.53	0.53	0.53	0.00	1.07
CD19+ B Cells (pluriselect), donor090325, donation2	12174-128I5	42.35	0.00	0.00	0.00	0.00	0.00	0.54	0.54	0.00
CD19+ B Cells (pluriselect), donor090612, donation1	12204-129C8	45.63	0.00	0.00	0.00	0.70	0.00	0.00	0.00	1.40
CD19+ B Cells (pluriselect), donor090612, donation2	12209-129D4	36.86	0.00	0.00	0.00	0.00	0.00	1.57	0.00	0.00
CD19+ B Cells (pluriselect), donor090612, donation3	12214-129D9	43.50	0.00	0.00	0.00	0.00	0.00	1.32	0.00	0.00
CD19+ B Cells, donor1	11544-120B5	35.34	0.82	0.00	0.00	0.00	0.00	0.00	0.00	0.00
CD19+ B Cells, donor2	11624-122B4	36.27	0.73	0.00	0.00	0.00	0.00	0.00	0.00	0.73
CD19+ B Cells, donor3	11705-123B4	33.82	0.50	0.00	0.00	0.00	0.00	1.01	0.00	0.50
CD34 cells differentiated to erythrocyte lineage, biol_ rep1	11931-125I5	76.77	2.02	0.81	0.81	1.21	1.21	1.21	1.21	1.21
CD34 cells differentiated to erythrocyte lineage, biol_ rep2	11932-125I6	49.14	0.80	0.80	1.60	0.80	0.00	1.60	0.40	0.40
CD34+ Progenitors, donor1	11545-120B6	28.11	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
CD34+ Progenitors, donor2	11625-122B5	44.38	0.00	0.00	0.56	0.00	0.56	1.12	0.00	0.00
CD34+ stem cells - adult bone marrow derived, donor1, tech_rep1	12225-129F2	35.70	0.38	0.38	0.38	0.00	0.38	2.63	0.75	0.00
CD34+ stem cells - adult bone marrow derived, donor1, tech_rep2	12225-129F2	33.82	0.23	0.00	0.00	0.45	0.00	0.45	0.00	0.23
CD4+ T Cells, donor1	11225-116C1	61.06	1.07	1.43	0.00	1.43	0.00	2.14	0.71	0.71
CD4+ T Cells, donor2	11306-117C1	48.38	1.22	2.45	0.00	0.61	1.22	2.45	1.22	0.00
CD4+ T Cells, donor3	11382-118B5	52.15	1.52	1.22	1.52	2.13	1.22	1.52	1.22	0.91
CD4+CD25+CD45RA+ naive regulatory T cells expanded, donor1	11793-124C2	47.98	0.26	0.26	0.00	0.51	0.51	1.79	0.51	0.00
CD4+CD25+CD45RA+ naive regulatory T cells expanded, donor2	11915-125G7	50.98	0.67	0.00	0.67	0.00	0.67	0.45	0.67	0.45
CD4+CD25+CD45RA+ naive regulatory T cells expanded, donor3	11919-125H2	51.17	0.57	0.00	0.00	0.00	0.29	2.01	0.29	0.29
CD4+CD25+CD45RA+ naive regulatory T cells, donor1	11780-124A7	57.37	0.00	0.00	0.00	0.00	0.00	0.95	0.47	0.47
CD4+CD25+CD45RA+ naive regulatory T cells, donor2	11796-124C5	62.51	1.40	0.00	0.00	0.00	0.00	1.40	0.00	0.00
CD4+CD25+CD45RA+ naive regulatory T cells, donor3	11907-125F8	49.44	0.00	0.00	0.00	0.00	3.30	3.30	0.00	0.00
CD4+CD25+CD45RA- memory regulatory T cells expanded, donor1	11794-124C3	37.14	0.43	0.14	0.00	0.29	0.29	1.88	0.29	0.14
CD4+CD25+CD45RA- memory regulatory T cells expanded, donor2	11916-125G8	35.42	3.39	0.68	0.85	0.34	0.51	1.53	0.68	1.02
CD4+CD25+CD45RA- memory regulatory T cells expanded, donor3	11920-125H3	33.21	1.77	0.32	0.64	0.32	0.81	1.45	0.32	1.13
CD4+CD25+CD45RA- memory regulatory T cells, donor1	11782-124A9	41.69	0.45	0.00	0.00	0.00	0.00	1.79	0.00	0.45
CD4+CD25+CD45RA- memory regulatory T cells, donor2	11797-124C6	49.26	0.35	0.00	0.00	0.00	0.00	1.05	0.35	0.70
CD4+CD25+CD45RA- memory regulatory T cells, donor3	11908-125F9	70.40	1.76	0.00	0.00	0.00	0.00	1.32	0.00	0.00
CD4+CD25-CD45RA+ naive conventional T cells expanded, donor1	11791-124B9	48.49	1.26	0.00	0.42	0.00	0.00	0.42	0.42	0.84
CD4+CD25-CD45RA+ naive conventional T cells expanded, donor2	11913-125G5	37.19	2.08	1.04	0.62	1.25	1.04	0.21	0.62	0.62
CD4+CD25-CD45RA+ naive conventional T cells expanded, donor3	11917-125G9	24.73	1.67	0.33	0.67	0.33	0.00	0.00	0.67	0.33
CD4+CD25-CD45RA+ naive conventional T cells, donor1	11784-124B2	78.86	2.18	0.54	1.36	0.27	0.27	2.45	0.00	0.00
CD4+CD25-CD45RA+ naive conventional T cells, donor2	11795-124C4	84.68	1.61	0.54	0.00	0.54	0.00	1.61	0.00	0.00
CD4+CD25-CD45RA+ naive conventional T cells, donor3	11906-125F7	62.76	0.00	0.00	1.79	0.00	1.79	0.00	0.00	0.00
CD4+CD25-CD45RA- memory conventional T cells expanded, donor1	11792-124C1	36.34	1.48	0.19	0.19	0.19	0.19	1.48	0.19	0.37
CD4+CD25-CD45RA- memory conventional T cells expanded, donor2	11914-125G6	39.42	1.08	0.00	0.00	0.00	0.43	1.30	0.00	0.43
CD4+CD25-CD45RA- memory conventional T cells expanded, donor3	11918-125H1	41.61	0.42	0.00	0.00	0.00	0.21	0.84	0.21	0.21
CD4+CD25-CD45RA- memory conventional T cells, donor1	11786-124B4	42.47	0.00	0.00	0.00	0.00	0.51	2.53	0.00	0.00
CD4+CD25-CD45RA- memory conventional T cells, donor2	11798-124C7	43.33	0.00	0.43	0.00	0.43	0.87	2.17	0.00	0.43
CD4+CD25-CD45RA- memory conventional T cells, donor3	11909-125G1	69.29	0.87	0.44	0.00	0.87	0.00	0.87	0.44	0.00
CD8+ T Cells (pluriselect), donor090309, donation1	12186-129A8	56.91	0.00	0.00	0.00	0.00	0.00	3.46	0.00	0.99
CD8+ T Cells (pluriselect), donor090309, donation2	12191-129B4	48.93	0.00	0.00	0.00	0.00	0.00	1.85	0.00	0.92
CD8+ T Cells (pluriselect), donor090309, donation3	12196-129B9	43.27	0.00	0.00	1.40	0.00	0.00	0.00	0.00	1.40
CD8+ T Cells (pluriselect), donor090325, donation1	12148-128F6	67.57	0.28	0.00	0.00	0.00	0.28	0.55	0.28	0.00
CD8+ T Cells (pluriselect), donor090325, donation2	12171-128I2	84.91	0.74	0.25	0.25	0.00	0.25	1.72	0.00	0.25
CD8+ T Cells (pluriselect), donor090612, donation1	12201-129C5	70.84	0.00	0.00	0.00	0.00	0.00	4.62	0.00	0.00
CD8+ T Cells (pluriselect), donor090612, donation2	12206-129D1	63.39	0.36	0.00	0.72	0.00	0.00	3.22	0.36	0.36
CD8+ T Cells (pluriselect), donor090612, donation3	12211-129D6	60.94	0.00	0.00	0.00	0.00	0.00	5.54	0.00	0.00
CD8+ T Cells, donor1	11226-116C2	66.79	1.96	1.64	0.33	1.31	0.00	1.31	0.33	0.65
CD8+ T Cells, donor2	11307-117C2	44.68	1.50	2.25	0.75	0.75	0.38	0.38	1.13	0.38
CD8+ T Cells, donor3	11383-118B6	48.48	1.26	1.01	1.01	0.76	1.01	1.51	1.01	0.50
COBL-a rinderpest infection, 00hr, biol_rep1	13553-145I7	19.73	4.13	0.46	0.46	0.23	0.69	0.00	0.23	2.98
COBL-a rinderpest infection, 00hr, biol_rep2	13554-145I8	23.01	3.59	0.48	0.72	0.24	0.24	0.00	1.20	1.44
COBL-a rinderpest infection, 00hr, biol_rep3	13555-145I9	25.44	4.65	0.00	0.82	0.27	0.00	0.27	0.00	2.46
COBL-a rinderpest infection, 06hr, biol_rep1	13556-146A1	31.22	2.10	0.60	0.00	0.30	0.00	0.00	0.00	0.90
COBL-a rinderpest infection, 06hr, biol_rep2	13557-146A2	24.72	2.88	0.24	0.00	0.00	0.24	0.24	0.48	0.48
COBL-a rinderpest infection, 06hr, biol_rep3	13558-146A3	20.69	2.50	0.68	0.23	0.45	0.00	0.00	0.45	0.68
COBL-a rinderpest infection, 12hr, biol_rep1	13559-146A4	19.34	2.82	0.22	0.22	0.43	0.22	0.00	0.00	0.43
COBL-a rinderpest infection, 12hr, biol_rep2	13560-146A5	22.11	2.37	0.00	0.26	0.26	1.05	0.00	1.05	1.05
COBL-a rinderpest infection, 12hr, biol_rep3	13561-146A6	22.98	2.81	0.23	0.23	0.23	0.23	0.00	0.00	1.41
COBL-a rinderpest infection, 24hr, biol_rep1	13562-146A7	21.13	3.62	0.00	0.60	0.30	0.00	0.30	0.91	0.60
COBL-a rinderpest infection, 24hr, biol_rep2	13563-146A8	22.37	2.61	0.29	0.00	0.00	0.58	0.00	1.16	0.87
COBL-a rinderpest infection, 24hr, biol_rep3	13564-146A9	21.85	2.13	0.00	0.27	0.00	0.27	0.00	0.27	0.53
COBL-a rinderpest infection, 48hr, biol_rep1	13565-146B1	18.82	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
COBL-a rinderpest infection, 48hr, biol_rep2	13566-146B2	15.48	0.46	0.46	0.00	0.00	0.00	0.46	0.00	0.46
COBL-a rinderpest infection, 48hr, biol_rep3	13567-146B3	21.63	0.00	0.00	0.00	0.00	0.00	0.00	0.75	0.75
COBL-a rinderpest(-C) infection, 06hr, biol_rep1	13568-146B4	18.73	1.80	0.00	0.00	0.00	0.00	0.00	0.00	0.00
COBL-a rinderpest(-C) infection, 06hr, biol_rep2	13569-146B5	23.02	1.44	0.00	0.00	0.00	0.00	0.00	0.58	0.86
COBL-a rinderpest(-C) infection, 06hr, biol_rep3	13570-146B6	19.56	0.71	0.24	0.47	0.24	0.24	0.24	0.47	0.94
COBL-a rinderpest(-C) infection, 12hr, biol_rep1	13571-146B7	28.52	1.90	0.63	0.32	0.00	0.32	0.00	0.32	1.27
COBL-a rinderpest(-C) infection, 12hr, biol_rep2	13572-146B8	26.14	1.23	0.00	0.31	0.00	0.00	0.00	0.62	0.62
COBL-a rinderpest(-C) infection, 12hr, biol_rep3	13573-146B9	28.21	1.28	0.00	0.32	0.00	0.32	0.32	1.28	0.00
COBL-a rinderpest(-C) infection, 24hr, biol_rep1	13574-146C1	22.18	2.29	0.38	0.38	0.00	0.00	0.00	0.38	1.15
COBL-a rinderpest(-C) infection, 24hr, biol_rep2	13575-146C2	24.83	2.36	0.00	0.00	0.00	0.00	0.00	0.00	1.58
COBL-a rinderpest(-C) infection, 24hr, biol_rep3	13576-146C3	15.13	1.51	0.00	0.76	0.00	1.51	0.00	0.00	1.51
COBL-a rinderpest(-C) infection, 48hr, biol_rep1	13577-146C4	38.54	2.41	0.80	0.80	0.00	0.00	0.80	0.80	0.00
COBL-a rinderpest(-C) infection, 48hr, biol_rep2	13578-146C5	41.27	2.80	0.00	0.00	0.00	0.00	2.10	0.70	0.70
COBL-a rinderpest(-C) infection, 48hr, biol_rep3	13579-146C6	40.07	1.00	0.00	0.00	0.00	0.00	0.00	1.00	1.00
Cardiac Myocyte, donor1	11525-119I4	20.11	0.00	1.83	0.00	1.83	3.66	0.00	0.00	0.00
Cardiac Myocyte, donor2	11605-120I3	12.35	0.49	0.00	0.49	0.00	0.00	0.00	0.49	0.49
Cardiac Myocyte, donor3	11686-122I3	9.47	0.32	0.11	0.00	0.00	0.00	0.00	0.21	0.11
Chondrocyte - de diff, donor1	11261-116G1	14.56	2.08	0.35	0.00	0.69	0.00	0.35	0.00	1.39
Chondrocyte - de diff, donor2	11338-117F6	8.17	0.36	0.00	0.36	0.00	0.36	0.00	0.36	0.36
Chondrocyte - de diff, donor3	11410-118E6	11.95	0.91	0.23	1.25	0.46	0.34	0.11	0.23	0.23
Chondrocyte - re diff, donor2	11339-117F7	31.33	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Chondrocyte - re diff, donor3	11411-118E7	13.35	0.40	0.00	0.00	0.00	0.40	0.40	0.00	0.00
Ciliary Epithelial Cells, donor1	11242-116D9	39.13	0.69	0.46	0.57	0.11	0.00	0.46	0.11	0.34
Ciliary Epithelial Cells, donor2	11323-117D9	22.23	1.50	0.86	0.86	0.00	0.00	0.00	0.43	0.43
Ciliary Epithelial Cells, donor3	11399-118D4	21.95	0.71	0.97	0.53	0.53	0.18	0.62	0.44	0.35
Clontech Human Universal Reference Total RNA, pool1	10000-101A1	30.08	0.37	0.46	0.09	0.37	0.18	0.46	0.28	0.09
Corneal Epithelial Cells, donor1	11526-119I5	3.07	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Corneal Epithelial Cells, donor2	11606-120I4	3.41	1.14	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Corneal Epithelial Cells, donor3	11687-122I4	4.60	0.00	0.26	0.26	0.00	0.00	0.00	0.26	0.00
Dendritic Cells - monocyte immature derived, donor1, rep2	11227-116C3	28.23	0.50	0.33	0.00	0.00	0.00	0.17	0.17	0.00
Dendritic Cells - monocyte immature derived, donor1, tech_rep1	11227-116C3	22.08	0.00	0.00	0.32	0.32	0.00	0.32	0.00	0.63
Dendritic Cells - monocyte immature derived, donor2	11308-117C3	34.51	0.00	0.00	3.45	0.00	0.00	0.00	0.00	0.00
Dendritic Cells - monocyte immature derived, donor3	11384-118B7	12.53	0.43	0.54	0.32	0.54	0.32	0.22	0.00	0.00
Dendritic Cells - plasmacytoid, donor1	11228-116C4	37.58	0.00	0.00	0.00	0.68	0.34	0.00	0.00	0.00
Dendritic Cells - plasmacytoid, donor2	11309-117C4	41.78	0.65	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Dendritic Cells - plasmacytoid, donor3	11385-118B8	45.49	0.00	0.48	0.00	0.00	0.00	0.48	0.00	0.00
Endothelial Cells - Aortic, donor0	11207-116A1	7.50	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Endothelial Cells - Aortic, donor1	11263-116G3	9.39	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Endothelial Cells - Aortic, donor2	11340-117F8	5.66	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Endothelial Cells - Aortic, donor3	11412-118E8	5.50	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Endothelial Cells - Artery, donor1	11264-116G4	7.85	0.00	0.00	0.00	0.00	0.00	0.29	0.00	0.00
Endothelial Cells - Artery, donor2	11341-117F9	13.18	0.94	0.94	0.94	0.00	0.00	0.00	0.47	0.24
Endothelial Cells - Artery, donor3	11413-118E9	12.45	0.00	0.00	0.00	0.00	0.00	0.00	0.18	0.00
Endothelial Cells - Lymphatic, donor1	11236-116D3	21.94	0.44	0.00	0.00	0.22	0.22	0.00	0.22	0.22
Endothelial Cells - Lymphatic, donor2	11317-117D3	24.04	0.00	0.30	0.00	0.00	0.30	2.13	0.00	0.00
Endothelial Cells - Lymphatic, donor3	11393-118C7	31.29	1.13	0.00	0.28	0.28	0.00	0.00	0.28	0.00
Endothelial Cells - Microvascular, donor1	11265-116G5	5.05	0.00	0.30	0.00	0.00	0.00	0.00	0.00	0.30
Endothelial Cells - Microvascular, donor2	11342-117G1	6.25	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Endothelial Cells - Microvascular, donor3	11414-118F1	5.67	0.43	0.14	0.14	0.14	0.00	0.00	0.43	0.14
Endothelial Cells - Thoracic, donor1	11266-116G6	19.21	0.80	0.00	0.00	0.00	0.00	0.00	0.00	0.40
Endothelial Cells - Thoracic, donor2	11343-117G2	8.39	0.52	0.00	0.00	0.52	0.00	0.52	0.00	0.00
Endothelial Cells - Umbilical vein, donor1	11243-116E1	35.66	0.37	0.50	0.25	0.50	0.12	0.75	0.37	0.00
Endothelial Cells - Umbilical vein, donor2	11324-117E1	18.25	0.22	0.22	0.43	0.00	0.00	0.22	0.43	0.00
Endothelial Cells - Umbilical vein, donor3	11400-118D5	22.59	0.00	0.49	0.49	0.49	0.24	0.24	0.24	0.00
Endothelial Cells - Vein, donor1	11267-116G7	6.83	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Endothelial Cells - Vein, donor2	11344-117G3	9.08	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Endothelial Cells - Vein, donor3	11416-118F3	8.01	0.00	0.16	0.16	0.16	0.00	0.00	0.00	0.00
Eosinophils, donor1	12244-129H3	91.48	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Eosinophils, donor2	12245-129H4	169.98	0.00	3.30	1.65	4.95	4.95	8.25	0.00	3.30
Eosinophils, donor3	12246-129H5	74.90	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Esophageal Epithelial Cells, donor1	11507-119G4	2.44	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Esophageal Epithelial Cells, donor2	11587-120G3	4.16	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Esophageal Epithelial Cells, donor3	11668-122G3	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Ewing's sarcoma cell line:Hs 863.T	10705-109H3	18.06	0.82	0.00	0.41	0.82	0.00	0.41	0.82	0.00
Fibroblast - Aortic Adventitial donor2 (cytoplasmic fraction)	14331-155F2	5.26	0.44	0.00	0.00	0.00	0.00	0.22	0.33	0.00
Fibroblast - Aortic Adventitial donor3 (cytoplasmic fraction)	14310-155C8	5.42	1.19	0.00	0.00	0.11	0.22	0.00	0.43	0.33
Fibroblast - Aortic Adventitial, donor1	11245-116E3	22.80	1.46	0.24	0.49	0.24	0.12	0.24	0.49	0.24
Fibroblast - Aortic Adventitial, donor2 (nuclear fraction)	14332-155F3	63.73	1.36	0.68	0.68	0.14	0.41	0.55	0.14	0.27
Fibroblast - Aortic Adventitial, donor2	11326-117E3	12.34	0.95	0.11	0.21	0.11	0.21	0.42	0.53	0.42
Fibroblast - Aortic Adventitial, donor3 (nuclear fraction)	14311-155C9	46.90	3.16	1.58	0.53	1.58	1.05	0.00	1.05	0.26
Fibroblast - Aortic Adventitial, donor3	11401-118D6	18.60	1.99	0.66	1.33	0.00	2.66	0.00	0.00	0.33
Fibroblast - Cardiac, donor1	11268-116G8	13.61	0.45	0.45	0.00	0.00	0.00	0.00	0.00	0.00
Fibroblast - Cardiac, donor2	11345-117G4	11.37	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Fibroblast - Cardiac, donor3	11417-118F4	8.52	0.63	0.63	0.00	0.00	0.32	0.00	0.32	0.00
Fibroblast - Cardiac, donor4	11452-119A3	48.80	0.30	0.00	0.00	0.00	0.61	0.30	0.00	0.00
Fibroblast - Cardiac, donor5	11456-119A7	22.84	0.38	0.13	0.13	0.25	0.13	0.13	0.00	0.13
Fibroblast - Cardiac, donor6	11460-119B2	23.95	0.15	0.00	0.00	0.30	0.30	0.30	0.15	0.00
Fibroblast - Choroid Plexus, donor1	11492-119E7	12.33	0.27	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Fibroblast - Choroid Plexus, donor2	11572-120E6	17.26	0.43	0.43	0.00	0.43	0.00	0.00	1.29	0.43
Fibroblast - Choroid Plexus, donor3	11653-122E6	10.25	7.32	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Fibroblast - Conjunctival, donor1	11531-120A1	7.15	0.46	0.00	0.46	0.00	0.00	0.00	0.00	0.00
Fibroblast - Conjunctival, donor3	11692-122I9	27.31	2.04	0.00	0.34	0.51	0.34	0.68	0.17	0.34
Fibroblast - Dermal, donor1	11269-116G9	10.10	0.47	0.23	0.00	0.00	0.00	0.94	0.00	0.47
Fibroblast - Dermal, donor2	11346-117G5	11.32	0.00	0.00	0.00	0.00	0.00	0.00	0.47	0.00
Fibroblast - Dermal, donor3	11418-118F5	11.73	1.33	0.73	0.73	0.12	0.48	0.00	0.73	0.36
Fibroblast - Dermal, donor4	11450-119A1	27.47	0.11	0.00	0.00	0.23	0.00	0.23	0.00	0.11
Fibroblast - Dermal, donor5	11454-119A5	33.84	0.87	0.35	0.17	0.00	0.00	0.35	0.17	0.00
Fibroblast - Dermal, donor6	11458-119A9	35.57	0.32	0.32	0.16	0.16	0.00	0.32	0.16	0.00
Fibroblast - Gingival, donor1	11237-116D4	34.36	0.62	0.00	0.21	0.42	0.42	0.21	0.00	0.21
Fibroblast - Gingival, donor10 (periodontitis)	11928-125I2	22.53	1.05	0.26	0.26	0.00	0.52	0.00	0.52	0.26
Fibroblast - Gingival, donor2	11318-117D4	25.83	2.24	0.66	1.05	0.53	0.66	0.13	0.53	0.66
Fibroblast - Gingival, donor3	11394-118C8	25.62	0.48	0.19	0.19	0.29	0.00	0.19	0.10	0.00
Fibroblast - Gingival, donor4 (GFH2)	11222-116B7	14.54	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Fibroblast - Gingival, donor5 (GFH3)	11303-117B7	14.27	0.70	0.53	0.53	0.00	0.18	0.18	0.18	0.35
Fibroblast - Gingival, donor6 (aggressive periodontitis)	11921-125H4	27.59	0.78	0.47	0.62	0.16	0.31	0.16	0.16	0.62
Fibroblast - Gingival, donor6 (control)	11922-125H5	20.83	0.95	0.00	0.14	0.00	0.27	0.81	0.14	0.27
Fibroblast - Gingival, donor7 (aggressive periodontitis)	11923-125H6	15.53	0.00	0.00	0.00	0.00	0.00	0.35	0.00	0.00
Fibroblast - Gingival, donor7 (control)	11924-125H7	28.52	0.44	0.15	0.00	0.29	0.44	0.44	0.58	0.29
Fibroblast - Gingival, donor8 (chronic periodontitis)	11925-125H8	32.18	1.64	0.41	0.27	0.14	0.14	0.14	0.14	0.41
Fibroblast - Gingival, donor8 (control)	11926-125H9	31.26	1.32	0.11	0.22	0.11	0.22	0.22	0.33	0.33
Fibroblast - Gingival, donor9 (control)	11927-125I1	32.43	0.88	0.00	0.29	0.44	0.15	0.15	0.00	0.29
Fibroblast - Lung, donor1	11270-116H1	5.44	1.36	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Fibroblast - Lung, donor2	11347-117G6	38.80	0.00	0.00	0.00	0.00	0.00	0.00	0.00	1.49
Fibroblast - Lung, donor3	11419-118F6	13.30	0.84	0.00	0.42	0.21	0.00	0.21	0.00	0.00
Fibroblast - Lymphatic, donor1	11506-119G3	10.83	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Fibroblast - Lymphatic, donor2	11586-120G2	11.19	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Fibroblast - Lymphatic, donor3	11667-122G2	1.40	0.00	0.00	0.00	0.00	0.00	0.28	0.00	0.00
Fibroblast - Mammary, donor1	11540-120B1	10.56	0.00	0.41	0.41	0.00	0.00	0.00	0.00	0.00
Fibroblast - Mammary, donor2	11620-122A9	3.99	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Fibroblast - Mammary, donor3	11701-123A9	11.91	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Fibroblast - Periodontal Ligament, donor1	11238-116D5	25.80	0.78	0.58	0.58	0.00	0.39	0.58	0.39	0.58
Fibroblast - Periodontal Ligament, donor2	11319-117D5	38.07	0.30	0.30	0.91	0.30	0.15	0.30	0.30	0.30
Fibroblast - Periodontal Ligament, donor3	11395-118C9	60.89	0.31	0.61	0.00	0.92	0.00	0.92	0.31	0.31
Fibroblast - Periodontal Ligament, donor4 (PL29)	11223-116B8	18.32	0.00	0.38	0.38	0.00	0.00	0.00	0.76	0.00
Fibroblast - Periodontal Ligament, donor5 (PL30)	11304-117B8	16.20	0.27	0.00	0.00	0.27	0.00	0.27	0.00	0.00
Fibroblast - Periodontal Ligament, donor6 (PLH3)	11380-118B3	14.26	0.23	0.12	0.23	0.12	0.23	0.23	0.00	0.12
Fibroblast - Pulmonary Artery, donor1	11250-116E8	9.51	0.44	0.33	0.22	0.11	0.00	0.11	0.00	0.22
Fibroblast - Villous Mesenchymal, donor1	11535-120A5	6.50	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Fibroblast - Villous Mesenchymal, donor2	11615-122A4	5.35	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Fibroblast - Villous Mesenchymal, donor3	11696-123A4	7.51	0.00	0.00	0.00	0.40	0.40	0.40	0.00	0.00
Fibroblast - skin dystrophia myotonica, donor1 (nuclear fraction)	14329-155E9	61.52	4.37	1.19	2.18	1.39	1.98	0.40	2.38	0.99
Fibroblast - skin dystrophia myotonica, donor1	11556-120C8	20.96	3.02	0.36	0.00	0.18	0.53	0.00	0.71	0.36
Fibroblast - skin dystrophia myotonica, donor2	11557-120C9	25.23	2.17	0.20	0.00	0.39	0.59	0.00	0.59	0.20
Fibroblast - skin dystrophia myotonica, donor3 (nuclear fraction)	14308-155C6	30.69	2.41	0.00	0.60	1.20	0.90	0.60	0.90	0.00
Fibroblast - skin dystrophia myotonica, donor3	11560-120D3	33.46	0.65	0.22	0.54	0.00	0.22	0.00	0.43	0.43
Fibroblast - skin normal, donor1 (nuclear fraction)	14323-155E3	47.32	3.54	0.00	0.51	0.51	1.01	0.00	0.51	0.76
Fibroblast - skin normal, donor1	11553-120C5	18.54	1.64	0.00	0.00	0.16	0.33	0.00	0.16	0.16
Fibroblast - skin normal, donor2 (nuclear fraction)	14302-155B9	82.01	4.41	1.40	1.60	0.80	1.60	1.00	1.20	0.60
Fibroblast - skin normal, donor2	11561-120D4	30.34	0.60	0.10	0.00	0.10	0.00	0.20	0.30	0.10
Fibroblast - skin spinal muscular atrophy, donor1 (nuclear fraction)	14326-155E6	62.26	4.23	2.42	0.60	0.91	3.02	0.30	1.81	1.51
Fibroblast - skin spinal muscular atrophy, donor1	11555-120C7	28.33	0.41	0.08	0.00	0.17	0.41	0.50	0.25	0.25
Fibroblast - skin spinal muscular atrophy, donor2	11558-120D1	36.24	1.71	0.00	0.00	0.17	0.17	0.34	0.85	0.00
Fibroblast - skin spinal muscular atrophy, donor3 (nuclear fraction)	14305-155C3	45.98	1.97	0.33	0.00	1.97	1.31	0.00	0.99	0.66
Fibroblast - skin spinal muscular atrophy, donor3	11559-120D2	29.93	0.75	0.21	0.11	0.11	0.43	0.00	0.11	0.21
Fibroblast - skin walker warburg, donor1	11554-120C6	10.96	0.51	0.34	0.17	0.00	0.17	0.00	0.84	0.00
Fibroblast - skin, normal donor1 (cytoplasmic fraction)	14322-155E2	9.41	1.25	0.00	0.16	0.00	0.00	0.00	0.16	0.31
Fibroblast - skin, normal donor2 (cytoplasmic fraction)	14301-155B8	310.24	22.16	0.00	0.00	22.16	0.00	0.00	0.00	0.00
Fingernail (including nail plate, eponychium and hyponychium), donor2	10301-104H4	31.38	0.00	0.87	0.00	0.00	1.74	0.00	0.00	0.00
Gingival epithelial cells, donor1 (GEA11)	11221-116B6	14.04	0.17	0.00	0.17	0.00	0.00	0.17	0.00	0.17
Gingival epithelial cells, donor2 (GEA14)	11302-117B6	22.38	0.26	0.52	0.00	0.00	0.00	0.00	0.26	0.00
Gingival epithelial cells, donor3 (GEA15)	11379-118B2	18.91	0.26	0.00	0.26	0.26	0.00	0.51	0.00	0.00
H1 embryonic stem cells differentiation to CD34+ HSC, day00, biol_rep1	13523-145F4	20.67	0.77	0.00	0.00	0.00	0.00	0.77	0.00	0.00
H1 embryonic stem cells differentiation to CD34+ HSC, day00, biol_rep2	13524-145F5	20.42	1.28	0.64	0.00	0.64	0.00	0.64	0.64	0.64
H1 embryonic stem cells differentiation to CD34+ HSC, day00, biol_rep3	13525-145F6	43.65	0.86	0.86	0.86	0.57	0.57	0.29	0.57	0.86
H1 embryonic stem cells differentiation to CD34+ HSC, day03, biol_rep1	13526-145F7	53.77	2.48	2.21	1.65	0.28	0.83	0.28	1.38	1.93
H1 embryonic stem cells differentiation to CD34+ HSC, day03, biol_rep2	13527-145F8	40.87	1.14	0.46	0.00	0.46	0.91	0.23	0.00	1.37
H1 embryonic stem cells differentiation to CD34+ HSC, day03, biol_rep3	13528-145F9	40.62	2.18	0.79	0.59	0.20	0.40	0.79	0.79	1.39
H1 embryonic stem cells differentiation to CD34+ HSC, day09, biol_rep1	13529-145G1	49.96	3.17	0.00	1.32	0.79	0.79	0.26	1.06	1.06
H1 embryonic stem cells differentiation to CD34+ HSC, day09, biol_rep2	13530-145G2	44.68	0.33	0.33	1.30	1.30	0.00	0.00	0.00	0.33
H1 embryonic stem cells differentiation to CD34+ HSC, day09, biol_rep3	13531-145G3	49.53	3.54	1.33	2.65	0.88	1.33	0.00	2.21	2.65
H9 Embryoid body cells, melanocytic induction, day00, biol_rep1 (H9EB-1 d0)	12627-134E8	35.75	2.54	0.42	0.99	1.27	0.99	0.00	0.28	0.28
H9 Embryoid body cells, melanocytic induction, day00, biol_rep2 (H9EB-2 d0)	12725-135G7	40.02	2.22	0.99	1.11	1.23	0.86	0.00	0.25	1.23
H9 Embryoid body cells, melanocytic induction, day00, biol_rep3 (H9EB-3 d0)	12823-136I6	27.94	2.69	0.81	0.54	0.27	1.07	0.27	0.54	0.81
H9 Embryoid body cells, melanocytic induction, day01, biol_rep1 (H9EB-1 d1)	12628-134E9	34.69	3.10	1.24	0.87	1.12	1.24	0.74	0.25	0.62
H9 Embryoid body cells, melanocytic induction, day01, biol_rep2 (H9EB-2 d1)	12726-135G8	31.28	3.18	0.83	1.25	0.55	0.55	0.42	0.69	0.28
H9 Embryoid body cells, melanocytic induction, day01, biol_rep3 (H9EB-3 d1)	12824-136I7	29.07	2.03	1.22	1.83	0.41	0.61	0.81	0.61	0.81
H9 Embryoid body cells, melanocytic induction, day03, biol_rep1 (H9EB-1 d3)	12629-134F1	34.68	2.74	0.91	0.23	0.46	0.91	1.60	1.60	0.00
H9 Embryoid body cells, melanocytic induction, day03, biol_rep2 (H9EB-2 d3)	12727-135G9	29.02	2.12	1.25	1.00	0.87	0.87	0.12	0.75	1.00
H9 Embryoid body cells, melanocytic induction, day03, biol_rep3 (H9EB-3 d3)	12825-136I8	25.35	1.53	1.09	0.66	0.44	0.66	0.87	0.66	0.44
H9 Embryoid body cells, melanocytic induction, day06, biol_rep1 (H9EB-1 d6)	12630-134F2	50.53	2.66	0.89	2.07	0.89	0.59	2.07	0.30	0.00
H9 Embryoid body cells, melanocytic induction, day06, biol_rep2 (H9EB-2 d6)	12728-135H1	57.07	6.52	1.11	1.75	2.70	2.54	1.27	1.11	1.59
H9 Embryoid body cells, melanocytic induction, day06, biol_rep3 (H9EB-3 d6)	12826-136I9	29.04	1.79	0.89	0.89	0.45	0.45	0.22	0.67	0.22
H9 Embryoid body cells, melanocytic induction, day09, biol_rep1 (H9EB-1 d9)	12631-134F3	82.06	12.30	4.23	7.06	3.23	2.42	4.84	4.84	3.23
H9 Embryoid body cells, melanocytic induction, day09, biol_rep2 (H9EB-2 d9)	12729-135H2	76.34	12.72	2.37	3.05	3.05	4.07	2.04	2.21	3.56
H9 Embryoid body cells, melanocytic induction, day09, biol_rep3 (H9EB-3 d9)	12827-137A1	75.37	3.72	0.62	0.53	0.71	0.80	2.04	1.51	0.35
H9 Embryoid body cells, melanocytic induction, day12, biol_rep1 (H9EB-1 d12)	12632-134F4	189.38	4.16	2.71	3.02	2.50	2.50	8.32	3.85	2.19
H9 Embryoid body cells, melanocytic induction, day12, biol_rep1 (H9EB-1 d12)	12632-134F4	163.43	3.93	3.42	2.39	1.02	1.20	6.32	2.56	1.02
H9 Embryoid body cells, melanocytic induction, day12, biol_rep2 (H9EB-2 d12)	12730-135H3	93.95	14.27	4.09	4.87	2.99	6.20	3.87	2.55	2.77
H9 Embryoid body cells, melanocytic induction, day12, biol_rep3 (H9EB-3 d12)	12828-137A2	74.04	2.58	1.83	0.92	0.92	1.00	3.99	0.92	1.16
H9 Embryoid body cells, melanocytic induction, day12, biol_rep3 (H9EB-3 d12)	12828-137A2	68.20	3.68	1.43	0.82	1.43	0.61	2.04	0.82	0.41
H9 Embryoid body cells, melanocytic induction, day15, biol_rep1 (H9EB-1 d15)	12633-134F5	60.86	7.43	2.06	2.27	2.27	2.27	4.75	2.27	1.65
H9 Embryoid body cells, melanocytic induction, day15, biol_rep2 (H9EB-2 d15)	12731-135H4	74.71	12.91	2.19	2.77	2.65	5.30	3.46	1.73	3.00
H9 Embryoid body cells, melanocytic induction, day15, biol_rep3 (H9EB-3 d15)	12829-137A3	68.21	5.00	3.84	2.00	2.00	3.34	4.34	2.50	1.50
H9 Embryoid body cells, melanocytic induction, day18, biol_rep1 (H9EB-1 d18)	12634-134F6	88.61	11.02	7.72	4.19	3.97	3.31	7.27	5.29	2.42
H9 Embryoid body cells, melanocytic induction, day18, biol_rep2 (H9EB-2 d18)	12732-135H5	112.91	16.23	4.30	4.80	3.81	4.18	4.80	2.46	3.44
H9 Embryoid body cells, melanocytic induction, day18, biol_rep3 (H9EB-3 d18)	12830-137A4	57.22	6.97	2.43	2.43	2.11	2.43	2.59	1.30	2.76
H9 Embryoid body cells, melanocytic induction, day21, biol_rep1 (H9EB-1 d21)	12635-134F7	85.63	8.98	6.09	5.77	2.25	2.89	5.45	4.17	2.89
H9 Embryoid body cells, melanocytic induction, day21, biol_rep2 (H9EB-2 d21)	12733-135H6	92.29	15.16	3.60	3.22	3.79	4.36	5.50	2.84	3.70
H9 Embryoid body cells, melanocytic induction, day21, biol_rep3 (H9EB-3 d21)	12831-137A5	79.72	9.81	3.48	4.59	3.16	2.37	4.27	3.32	1.90
H9 Embryoid body cells, melanocytic induction, day24, biol_rep1 (H9EB-1 d24)	12636-134F8	110.08	18.25	5.78	5.17	4.56	5.78	6.08	4.26	3.04
H9 Embryoid body cells, melanocytic induction, day24, biol_rep2 (H9EB-2 d24)	12734-135H7	115.72	18.19	4.29	6.48	3.87	6.48	6.17	2.93	4.39
H9 Embryoid body cells, melanocytic induction, day24, biol_rep3 (H9EB-3 d24)	12832-137A6	60.16	6.15	1.98	3.95	1.98	2.20	2.63	2.42	1.54
H9 Embryoid body cells, melanocytic induction, day27, biol_rep1 (H9EB-1 d27)	12637-134F9	102.96	14.03	6.45	8.70	5.33	5.05	6.73	6.17	3.37
H9 Embryoid body cells, melanocytic induction, day27, biol_rep2 (H9EB-2 d27)	12735-135H8	130.83	6.76	6.20	6.39	4.07	10.46	9.81	1.20	4.35
H9 Embryoid body cells, melanocytic induction, day27, biol_rep3 (H9EB-3 d27)	12833-137A7	73.00	12.84	3.48	2.67	3.74	2.41	5.88	3.74	4.01
H9 Embryoid body cells, melanocytic induction, day30, biol_rep1 (H9EB-1 d30)	12638-134G1	110.62	19.74	9.18	8.26	7.04	4.74	13.62	6.27	5.20
H9 Embryoid body cells, melanocytic induction, day30, biol_rep2 (H9EB-2 d30)	12736-135H9	75.13	15.41	4.66	3.76	3.50	6.48	7.38	2.72	4.53
H9 Embryoid body cells, melanocytic induction, day30, biol_rep3 (H9EB-3 d30)	12834-137A8	50.69	1.63	0.27	1.08	0.81	0.27	2.17	0.81	0.54
H9 Embryoid body cells, melanocytic induction, day34, biol_rep1 (H9EB-1 d34)	12639-134G2	78.90	11.06	6.64	6.45	4.06	5.53	6.64	3.87	3.87
H9 Embryoid body cells, melanocytic induction, day34, biol_rep2 (H9EB-2 d34)	12737-135I1	63.60	8.99	3.51	4.61	3.29	1.97	3.07	1.97	1.75
H9 Embryoid body cells, melanocytic induction, day34, biol_rep3 (H9EB-3 d34)	12835-137A9	70.41	5.95	0.99	1.98	1.98	0.00	0.99	0.99	0.99
H9 Embryoid body cells, melanocytic induction, day41, biol_rep1 (H9EB-1 d41)	12640-134G3	44.59	3.83	1.85	2.37	2.24	0.92	2.51	1.45	0.79
H9 Embryoid body cells, melanocytic induction, day41, biol_rep2 (H9EB-2 d41)	12738-135I2	36.11	3.03	1.41	2.02	1.82	2.22	0.81	1.01	1.01
H9 Embryoid body cells, melanocytic induction, day41, biol_rep3 (H9EB-3 d41)	12836-137B1	92.77	0.25	1.27	0.76	0.76	0.25	0.51	0.51	0.25
H9 Embryonic Stem cells, biol_rep1 (H9ES-1)	12626-134E7	61.31	0.80	0.40	0.80	1.39	0.40	0.00	0.20	0.40
H9 Embryonic Stem cells, biol_rep2 (H9ES-2)	12724-135G6	35.28	4.01	2.00	0.92	1.08	0.92	0.15	0.46	1.08
H9 Embryonic Stem cells, biol_rep3 (H9ES-3)	12822-136I5	53.19	4.09	1.23	1.84	1.43	0.82	0.61	0.00	1.23
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day00, biol_rep1 (UH-1)	13364-143F7	24.41	0.31	0.00	0.00	0.00	0.00	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day00, biol_rep2 (UH-2)	13365-143F8	22.89	0.00	0.00	0.00	0.00	0.00	0.28	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day00, biol_rep3 (UH-3)	13366-143F9	51.19	2.77	0.92	0.00	1.38	0.46	1.84	0.46	0.92
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day01, biol_rep1	13328-143B7	34.65	12.37	0.00	0.00	0.00	4.95	0.00	2.47	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day01, biol_rep2	13340-143D1	40.23	2.32	0.00	0.39	0.39	0.00	0.39	0.77	0.39
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day01, biol_rep3	13352-143E4	25.67	8.02	0.00	0.00	0.00	0.00	1.60	0.00	1.60
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day02, biol_rep1	13329-143B8	39.99	5.22	3.48	0.00	0.00	1.74	0.00	1.74	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day02, biol_rep2	13341-143D2	40.68	2.60	0.33	0.65	0.33	0.65	0.65	0.33	0.65
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day02, biol_rep3	13353-143E5	55.18	4.12	0.41	1.24	1.65	1.24	0.00	1.24	1.24
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day03, biol_rep1	13330-143B9	66.65	23.33	3.33	3.33	0.00	0.00	0.00	3.33	3.33
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day03, biol_rep2	13342-143D3	42.79	3.08	0.28	0.84	1.40	0.56	0.56	1.96	0.28
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day03, biol_rep3	13354-143E6	47.07	2.94	1.31	1.31	1.31	0.65	0.00	1.63	0.65
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day04, biol_rep1	13331-143C1	52.85	10.07	0.00	0.84	1.68	0.00	0.00	2.52	5.87
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day04, biol_rep2	13343-143D4	61.07	3.82	0.95	0.32	1.59	1.27	0.64	0.95	0.64
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day04, biol_rep3	13355-143E7	47.89	3.06	0.00	1.36	0.68	0.34	0.34	1.36	1.02
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day05, biol_rep1	13332-143C2	20.88	6.26	0.00	0.00	0.00	2.09	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day05, biol_rep2	13344-143D5	48.11	2.86	1.15	0.57	1.15	0.57	0.00	2.86	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day05, biol_rep3	13356-143E8	31.37	1.78	0.89	0.00	0.89	0.59	0.30	0.30	0.30
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day06, biol_rep1	13333-143C3	38.97	10.16	0.00	1.69	0.00	1.69	0.00	6.78	3.39
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day06, biol_rep2	13345-143D6	55.92	2.49	0.83	0.83	2.49	1.24	1.24	1.24	2.07
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day06, biol_rep3	13357-143E9	57.53	3.45	0.92	1.15	1.38	0.46	0.46	0.46	1.15
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day07, biol_rep1	13334-143C4	57.95	5.27	0.00	0.00	0.00	0.00	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day07, biol_rep2	13346-143D7	47.28	1.15	0.77	0.77	1.15	0.00	0.00	0.00	1.15
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day07, biol_rep3	13358-143F1	46.94	0.98	1.30	1.30	0.33	1.63	0.00	1.30	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day08, biol_rep1	13335-143C5	19.40	2.01	0.00	0.00	0.00	0.67	0.00	0.67	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day08, biol_rep2	13347-143D8	51.24	4.62	0.39	1.16	0.77	1.54	0.00	0.77	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day08, biol_rep3	13359-143F2	65.39	2.05	1.37	2.40	2.74	1.37	0.34	1.03	2.40
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day09, biol_rep1	13336-143C6	62.12	12.42	2.48	0.00	0.00	0.00	2.48	7.45	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day09, biol_rep2	13348-143D9	55.21	2.36	0.47	0.47	0.47	2.36	0.47	0.00	1.42
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day09, biol_rep3	13360-143F3	51.90	5.43	0.60	0.00	1.21	0.60	0.00	0.60	0.60
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day10, biol_rep1	13337-143C7	40.69	1.53	0.51	0.00	0.51	0.00	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day10, biol_rep2	13349-143E1	59.43	3.99	1.20	0.40	1.60	1.99	1.20	0.00	0.40
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day10, biol_rep3	13361-143F4	48.84	1.97	0.49	1.48	1.48	0.49	0.00	0.99	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day11, biol_rep1	13338-143C8	59.02	4.72	0.00	1.18	1.18	0.00	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day11, biol_rep2	13350-143E2	46.68	1.75	1.17	1.17	0.00	1.17	0.00	1.17	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day11, biol_rep3	13362-143F5	52.23	1.32	0.00	0.88	0.44	0.88	0.44	1.32	0.44
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day12, biol_rep1	13339-143C9	56.80	7.63	0.00	1.70	0.85	0.00	0.00	0.85	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day12, biol_rep2	13351-143E3	25.07	1.79	0.60	0.60	0.60	0.00	0.00	0.60	0.60
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day12, biol_rep3	13363-143F6	33.97	3.40	0.49	0.49	0.49	0.97	0.97	0.97	2.43
Hair Follicle Dermal Papilla Cells, donor1	11271-116H2	5.71	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Hair Follicle Dermal Papilla Cells, donor2	11348-117G7	11.64	0.42	0.42	0.00	0.00	0.00	0.83	0.42	0.00
Hair Follicle Dermal Papilla Cells, donor3	11420-118F7	5.62	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Hair Follicle Outer Root Sheath Cells, donor1	11504-119G1	19.35	1.90	0.32	0.63	0.32	0.63	0.32	0.32	0.00
Hair Follicle Outer Root Sheath Cells, donor2	11584-120F9	10.03	0.42	0.00	0.00	0.00	0.00	0.00	0.42	0.00
Hep-2 cells mock treated, biol_rep1	11898-125E8	8.94	0.46	0.12	0.46	0.23	0.35	0.00	0.35	0.58
Hep-2 cells mock treated, biol_rep2	11899-125E9	12.32	1.01	0.68	0.34	0.17	0.00	0.00	0.34	0.34
Hep-2 cells mock treated, biol_rep3	11900-125F1	16.15	0.91	0.23	0.00	0.00	0.00	0.00	0.00	0.23
Hep-2 cells treated with Streptococci strain 5448, biol_rep1	11890-125D9	11.70	0.66	0.22	0.00	0.22	0.00	0.11	0.33	0.11
Hep-2 cells treated with Streptococci strain 5448, biol_rep2	11891-125E1	8.60	0.86	0.43	0.43	1.50	0.00	0.21	0.21	0.21
Hep-2 cells treated with Streptococci strain 5448, biol_rep3	11892-125E2	10.76	1.72	0.00	0.43	0.43	0.00	0.00	0.43	0.43
Hep-2 cells treated with Streptococci strain JRS4, biol_rep1	11894-125E4	6.60	0.50	0.12	0.12	0.25	0.00	0.00	0.25	0.37
Hep-2 cells treated with Streptococci strain JRS4, biol_rep2	11895-125E5	9.95	0.69	0.51	0.17	0.00	0.17	0.17	0.17	0.00
Hep-2 cells treated with Streptococci strain JRS4, biol_rep3	11896-125E6	7.05	0.32	0.32	0.00	0.32	0.00	0.00	0.00	0.00
Hepatic Sinusoidal Endothelial Cells, donor1	11521-119H9	5.60	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Hepatic Sinusoidal Endothelial Cells, donor2	11601-120H8	3.90	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Hepatic Sinusoidal Endothelial Cells, donor3	11682-122H8	10.58	0.00	2.64	0.00	0.00	2.64	0.00	0.00	0.00
Hepatic Stellate Cells (lipocyte), donor1	11524-119I3	5.64	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Hepatic Stellate Cells (lipocyte), donor2	11604-120I2	3.63	0.73	0.73	0.73	0.00	0.00	0.00	0.00	0.00
Hepatic Stellate Cells (lipocyte), donor3	11685-122I2	10.67	2.10	0.17	0.70	0.52	0.00	0.35	0.35	0.70
Hepatocyte, donor1	11523-119I2	13.32	14.53	9.68	4.84	3.63	0.00	1.21	3.63	1.21
Hepatocyte, donor2	11603-120I1	6.46	3.23	3.23	4.31	4.31	0.00	1.08	3.23	1.08
Hepatocyte, donor3	11684-122I1	12.27	4.91	11.04	4.91	9.82	8.59	0.61	3.68	3.68
Hodgkin's lymphoma cell line:HD-Mar2	10435-106E3	61.35	1.31	1.96	0.65	0.65	0.65	0.65	0.00	1.31
Intestinal epithelial cells (polarized), donor1	11246-116E4	37.23	1.22	0.17	0.35	0.35	0.17	0.35	0.70	1.05
Iris Pigment Epithelial Cells, donor1	11530-119I9	18.25	1.23	0.27	0.27	0.27	0.41	0.27	0.14	0.14
K562 erythroblastic leukemia response to hemin, 00hr00min, biol_rep1	13079-140B1	3.18	0.00	0.00	0.00	0.00	0.00	3.18	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr00min, biol_rep2	13145-140I4	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr00min, biol_rep3	13211-141G7	27.08	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr15min, biol_rep1	13080-140B2	6.92	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr15min, biol_rep2	13146-140I5	7.51	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr15min, biol_rep3	13212-141G8	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr30min, biol_rep1	13081-140B3	10.25	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr30min, biol_rep2	13147-140I6	13.71	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr30min, biol_rep3	13213-141G9	6.50	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr45min, biol_rep1	13082-140B4	6.67	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr45min, biol_rep2	13148-140I7	14.52	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr45min, biol_rep3	13214-141H1	9.26	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr00min, biol_rep1	13083-140B5	3.33	0.00	0.00	0.00	0.00	0.00	1.11	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr00min, biol_rep2	13149-140I8	20.95	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr00min, biol_rep3	13215-141H2	10.08	0.00	0.63	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr20min, biol_rep1	13084-140B6	13.92	0.00	0.00	0.00	0.00	0.00	1.55	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr20min, biol_rep2	13150-140I9	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr20min, biol_rep3	13216-141H3	12.92	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr40min, biol_rep1	13085-140B7	11.27	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr40min, biol_rep2	13151-141A1	23.90	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr40min, biol_rep3	13217-141H4	8.15	0.00	0.00	0.00	0.00	0.00	0.81	0.00	0.00
K562 erythroblastic leukemia response to hemin, 02hr00min, biol_rep1	13086-140B8	7.14	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 02hr00min, biol_rep2	13152-141A2	14.37	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 02hr00min, biol_rep3	13218-141H5	11.25	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 02hr30min, biol_rep1	13087-140B9	3.69	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 02hr30min, biol_rep2	13153-141A3	30.16	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 02hr30min, biol_rep3	13219-141H6	8.02	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 03hr00min, biol_rep1	13088-140C1	2.72	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 03hr00min, biol_rep2	13154-141A4	29.48	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 03hr00min, biol_rep3	13220-141H7	8.61	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 03hr30min, biol_rep1	13089-140C2	6.35	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 03hr30min, biol_rep2	13155-141A5	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 03hr30min, biol_rep3	13221-141H8	12.12	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 04hr, biol_rep1	13090-140C3	7.29	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 04hr, biol_rep2	13156-141A6	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 04hr, biol_rep3	13222-141H9	6.43	0.71	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 06hr, biol_rep1	13091-140C4	6.64	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 06hr, biol_rep2	13157-141A7	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 06hr, biol_rep3	13223-141I1	3.70	0.31	0.00	0.00	0.00	0.00	0.62	0.00	0.00
K562 erythroblastic leukemia response to hemin, 12hr, biol_rep1	13092-140C5	8.78	0.00	0.00	0.00	0.00	0.00	1.76	0.00	0.00
K562 erythroblastic leukemia response to hemin, 12hr, biol_rep2	13158-141A8	15.72	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 12hr, biol_rep3	13224-141I2	6.26	0.00	0.70	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 24hr, biol_rep1	13093-140C6	4.43	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 24hr, biol_rep2	13159-141A9	9.73	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 24hr, biol_rep3	13225-141I3	9.59	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day02, biol_rep1	13094-140C7	2.25	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day02, biol_rep2	13160-141B1	3.48	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day02, biol_rep3	13226-141I4	10.67	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day03, biol_rep1	13095-140C8	8.31	0.00	1.39	0.00	0.00	0.00	1.39	0.00	0.00
K562 erythroblastic leukemia response to hemin, day03, biol_rep2	13161-141B2	2.85	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day03, biol_rep3	13227-141I5	7.36	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day04, biol_rep1	13096-140C9	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day04, biol_rep2	13162-141B3	6.21	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day04, biol_rep3	13228-141I6	6.34	0.00	0.00	0.00	0.00	0.00	1.06	0.00	0.00
Keratinocyte - epidermal, donor1	11272-116H3	20.07	1.06	0.00	0.33	0.33	0.33	0.24	0.41	0.00
Keratinocyte - epidermal, donor2	11349-117G8	1.76	0.59	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Keratinocyte - epidermal, donor3	11421-118F8	18.84	1.51	0.47	0.76	0.66	1.04	0.00	0.66	0.66
Keratinocyte - oral, donor1	11251-116E9	30.42	1.93	0.57	0.45	0.11	0.23	0.34	1.02	0.45
Keratocytes, donor1	11527-119I6	5.50	0.00	0.00	0.00	0.00	0.00	0.34	0.00	0.00
Keratocytes, donor2	11607-120I5	4.69	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Keratocytes, donor3	11688-122I5	13.63	0.20	1.19	0.59	0.79	0.40	0.20	0.00	0.20
Krukenberg tumor cell line:HSKTC	10687-109F3	19.78	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Lens Epithelial Cells, donor1	11529-119I8	11.87	2.16	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Lens Epithelial Cells, donor2	11609-120I7	17.18	0.46	0.12	0.69	0.69	0.23	0.12	0.12	0.69
Lens Epithelial Cells, donor3	11690-122I7	26.74	0.61	0.50	0.00	0.20	0.00	0.30	0.30	0.10
Lymphatic Endothelial cells response to VEGFC, 00hr00min, biol_rep1 (MM XIX - 1)	12260-130A1	6.88	0.24	0.00	0.00	0.00	0.00	0.00	0.12	0.12
Lymphatic Endothelial cells response to VEGFC, 00hr00min, biol_rep2 (MM XIV - 1)	12382-131E6	5.30	0.00	0.56	0.28	0.00	0.00	0.00	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr00min, biol_rep3 (MM XXII - 1 )	12504-133A2	13.85	2.99	0.16	0.63	0.63	0.63	0.00	0.16	0.47
Lymphatic Endothelial cells response to VEGFC, 00hr15min, biol_rep1 (MM XIX - 2)	12261-130A2	5.91	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr15min, biol_rep2 (MM XIV - 2)	12383-131E7	4.73	0.00	0.00	0.00	0.00	0.00	0.32	0.00	0.32
Lymphatic Endothelial cells response to VEGFC, 00hr15min, biol_rep3 (MM XXII - 2)	12505-133A3	4.20	0.32	0.22	0.11	0.11	0.00	0.11	0.22	0.22
Lymphatic Endothelial cells response to VEGFC, 00hr30min, biol_rep1 (MM XIX - 3)	12262-130A3	9.03	0.00	0.00	0.82	0.41	0.41	0.41	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr30min, biol_rep2 (MM XIV - 3)	12384-131E8	1.77	0.00	0.25	0.00	0.00	0.00	0.51	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr30min, biol_rep3 (MM XXII - 3)	12506-133A4	3.38	0.56	0.14	0.28	0.00	0.14	0.00	0.42	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr45min, biol_rep1 (MM XIX - 4)	12263-130A4	9.10	0.00	0.00	0.00	0.00	0.00	0.00	0.40	0.40
Lymphatic Endothelial cells response to VEGFC, 00hr45min, biol_rep2 (MM XIV - 4)	12385-131E9	5.43	0.00	0.19	0.19	0.39	0.00	0.00	0.19	0.78
Lymphatic Endothelial cells response to VEGFC, 00hr45min, biol_rep3 (MM XXII - 4)	12507-133A5	2.41	0.00	0.19	0.00	0.00	0.00	0.19	0.19	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr00min, biol_rep1 (MM XIX - 5)	12264-130A5	6.62	1.39	0.00	0.00	0.70	0.35	0.00	0.35	0.35
Lymphatic Endothelial cells response to VEGFC, 01hr00min, biol_rep2 (MM XIV - 5)	12386-131F1	4.29	0.24	0.00	0.00	0.00	0.00	0.24	0.24	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr00min, biol_rep3 (MM XXII - 5)	12508-133A6	4.53	0.69	0.14	0.27	0.14	0.55	0.00	0.14	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr20min, biol_rep1 (MM XIX - 6)	12265-130A6	6.78	0.62	0.00	0.31	0.31	0.62	0.00	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr20min, biol_rep2 (MM XIV - 6)	12387-131F2	4.68	0.62	0.00	0.31	0.00	0.00	0.00	0.31	0.31
Lymphatic Endothelial cells response to VEGFC, 01hr20min, biol_rep3 (MM XXII - 6)	12509-133A7	5.12	0.00	0.37	0.55	0.18	0.18	0.00	0.00	0.18
Lymphatic Endothelial cells response to VEGFC, 01hr40min, biol_rep1 (MM XIX - 7)	12266-130A7	8.23	0.99	0.33	0.00	0.33	0.33	0.00	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr40min, biol_rep2 (MM XIV - 7)	12388-131F3	4.39	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr40min, biol_rep3 (MM XXII - 7)	12510-133A8	3.49	0.25	0.25	0.25	0.25	0.00	0.00	0.50	0.00
Lymphatic Endothelial cells response to VEGFC, 02hr00min, biol_rep1 (MM XIX - 8)	12267-130A8	8.24	0.48	0.00	0.97	0.48	0.00	0.00	0.48	0.00
Lymphatic Endothelial cells response to VEGFC, 02hr00min, biol_rep2 (MM XIV - 8)	12389-131F4	7.27	0.27	0.00	0.00	0.00	0.00	0.00	0.27	0.00
Lymphatic Endothelial cells response to VEGFC, 02hr00min, biol_rep3 (MM XXII - 8)	12511-133A9	3.63	0.61	0.30	0.30	0.15	0.30	0.00	0.00	0.15
Lymphatic Endothelial cells response to VEGFC, 02hr30min, biol_rep1 (MM XIX - 9)	12268-130A9	10.37	0.52	0.00	0.00	0.00	1.04	0.00	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 02hr30min, biol_rep2 (MM XIV - 9)	12390-131F5	8.59	0.21	0.00	0.21	0.21	0.00	0.21	0.63	0.21
Lymphatic Endothelial cells response to VEGFC, 02hr30min, biol_rep3 (MM XXII - 9)	12512-133B1	4.36	0.30	0.15	0.45	0.15	0.00	0.00	0.30	0.00
Lymphatic Endothelial cells response to VEGFC, 03hr00min, biol_rep1 (MM XIX - 10)	12269-130B1	8.94	0.00	0.00	0.00	0.00	0.00	0.69	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 03hr00min, biol_rep2 (MM XIV - 10)	12391-131F6	6.40	0.00	0.38	0.00	0.19	0.19	0.00	0.00	0.19
Lymphatic Endothelial cells response to VEGFC, 03hr00min, biol_rep3 (MM XXII - 10)	12513-133B2	4.14	0.53	0.32	0.00	0.00	0.11	0.00	0.21	0.32
Lymphatic Endothelial cells response to VEGFC, 03hr30min, biol_rep1 (MM XIX - 11)	12270-130B2	7.75	0.00	0.00	0.48	0.00	0.00	0.00	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 03hr30min, biol_rep2 (MM XIV - 11)	12392-131F7	8.93	0.00	0.00	0.00	0.00	0.00	0.33	0.33	0.33
Lymphatic Endothelial cells response to VEGFC, 03hr30min, biol_rep3 (MM XXII - 11)	12514-133B3	2.85	0.62	0.00	0.25	0.00	0.00	0.00	0.25	0.12
Lymphatic Endothelial cells response to VEGFC, 04hr, biol_rep1 (MM XIX - 12)	12271-130B3	16.66	0.00	0.00	0.00	0.37	0.00	0.37	1.11	0.00
Lymphatic Endothelial cells response to VEGFC, 04hr, biol_rep2 (MM XIV - 12)	12393-131F8	7.17	1.24	0.00	0.00	0.00	0.25	0.00	0.00	0.25
Lymphatic Endothelial cells response to VEGFC, 04hr, biol_rep3 (MM XXII - 12)	12515-133B4	2.89	0.14	0.00	0.55	0.00	0.00	0.00	0.14	0.27
Lymphatic Endothelial cells response to VEGFC, 05hr, biol_rep1 (MM XIX - 13)	12272-130B4	13.19	0.64	0.32	0.00	0.00	0.00	0.00	0.32	0.32
Lymphatic Endothelial cells response to VEGFC, 05hr, biol_rep2 (MM XIV - 13)	12394-131F9	13.39	0.61	0.00	0.00	0.61	0.00	0.00	0.61	0.61
Lymphatic Endothelial cells response to VEGFC, 05hr, biol_rep3 (MM XXII - 13)	12516-133B5	5.60	0.84	0.00	0.42	0.28	0.28	0.00	0.28	0.28
Lymphatic Endothelial cells response to VEGFC, 06hr, biol_rep1 (MM XIX - 14)	12273-130B5	7.82	0.36	0.36	0.36	0.36	0.71	0.00	0.36	0.00
Lymphatic Endothelial cells response to VEGFC, 06hr, biol_rep2 (MM XIV - 14)	12395-131G1	3.88	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 06hr, biol_rep3 (MM XXII - 14)	12517-133B6	3.42	0.16	0.00	0.31	0.16	0.16	0.47	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 07hr, biol_rep1 (MM XIX - 15)	12274-130B6	6.09	0.00	0.00	0.36	0.00	0.00	0.00	0.36	0.00
Lymphatic Endothelial cells response to VEGFC, 07hr, biol_rep2 (MM XIV - 15)	12396-131G2	5.23	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 07hr, biol_rep3 (MM XXII - 15)	12518-133B7	2.12	0.24	0.00	0.24	0.00	0.24	0.00	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 08hr, biol_rep1 (MM XIX - 16)	12275-130B7	10.02	0.87	0.00	0.12	0.12	0.12	0.12	0.37	0.25
Lymphatic Endothelial cells response to VEGFC, 08hr, biol_rep2 (MM XIV - 16)	12397-131G3	5.38	0.00	0.26	0.00	0.00	0.26	0.00	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 08hr, biol_rep3 (MM XXII - 16)	12519-133B8	5.67	0.30	0.00	0.60	0.60	0.30	0.00	0.30	0.00
MCF7 breast cancer cell line response to EGF1, 00hr00min, biol_rep1	13031-139E7	9.06	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 00hr00min, biol_rep2	13097-140D1	11.51	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 00hr00min, biol_rep3	13163-141B4	9.65	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 00hr15min, biol_rep1	13032-139E8	9.73	0.00	0.00	0.00	0.85	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 00hr15min, biol_rep2	13098-140D2	7.74	0.70	0.00	0.00	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 00hr15min, biol_rep3	13164-141B5	7.47	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 00hr30min, biol_rep1	13033-139E9	10.31	0.00	0.00	0.00	0.00	0.52	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 00hr30min, biol_rep2	13099-140D3	10.71	0.00	0.00	0.00	1.19	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 00hr30min, biol_rep3	13165-141B6	10.86	0.00	0.00	0.23	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 00hr45min, biol_rep1	13034-139F1	15.41	1.16	0.29	0.29	0.00	0.29	0.29	0.29	0.87
MCF7 breast cancer cell line response to EGF1, 00hr45min, biol_rep2	13100-140D4	16.21	0.90	0.00	1.35	0.45	0.45	0.45	0.45	0.45
MCF7 breast cancer cell line response to EGF1, 00hr45min, biol_rep3	13166-141B7	13.55	0.00	0.00	0.00	0.00	0.00	0.14	0.41	0.00
MCF7 breast cancer cell line response to EGF1, 01hr00min, biol_rep1	13035-139F2	12.32	0.00	0.00	0.00	0.00	0.51	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 01hr00min, biol_rep2	13101-140D5	12.70	1.06	0.71	0.71	0.00	0.00	0.00	0.35	0.00
MCF7 breast cancer cell line response to EGF1, 01hr00min, biol_rep3	13167-141B8	9.33	0.00	0.00	0.67	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 01hr20min, biol_rep1	13036-139F3	11.21	0.51	0.00	0.00	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 01hr20min, biol_rep2	13102-140D6	12.27	0.27	0.27	0.27	0.27	0.53	0.27	0.80	0.00
MCF7 breast cancer cell line response to EGF1, 01hr20min, biol_rep3	13168-141B9	17.76	0.94	0.94	0.19	0.00	0.38	0.38	0.57	0.19
MCF7 breast cancer cell line response to EGF1, 01hr40min, biol_rep1	13037-139F4	13.50	0.00	0.00	0.00	0.61	0.00	1.84	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 01hr40min, biol_rep2	13103-140D7	7.34	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 01hr40min, biol_rep3	13169-141C1	16.03	1.25	0.21	0.42	0.42	0.42	0.21	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 02hr00min, biol_rep1	13038-139F5	13.73	0.84	0.00	0.00	0.56	0.28	0.00	0.56	0.28
MCF7 breast cancer cell line response to EGF1, 02hr00min, biol_rep2	13104-140D8	8.24	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 02hr00min, biol_rep3	13170-141C2	14.81	0.87	0.58	0.00	0.29	0.29	0.00	0.29	0.58
MCF7 breast cancer cell line response to EGF1, 02hr30min, biol_rep1	13039-139F6	15.84	0.90	0.60	0.00	0.30	0.00	0.00	0.60	0.30
MCF7 breast cancer cell line response to EGF1, 02hr30min, biol_rep2	13105-140D9	9.41	1.11	0.55	0.00	0.00	0.00	0.00	0.55	0.00
MCF7 breast cancer cell line response to EGF1, 02hr30min, biol_rep3	13171-141C3	13.79	0.35	0.00	0.00	0.00	0.00	0.71	0.35	0.00
MCF7 breast cancer cell line response to EGF1, 03hr00min, biol_rep1	13040-139F7	11.06	0.00	0.37	0.00	0.00	0.37	1.11	0.37	0.00
MCF7 breast cancer cell line response to EGF1, 03hr00min, biol_rep2	13106-140E1	9.21	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 03hr00min, biol_rep3	13172-141C4	11.13	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 03hr30min, biol_rep1	13041-139F8	9.62	0.00	0.00	0.00	0.57	0.00	0.00	0.00	0.57
MCF7 breast cancer cell line response to EGF1, 03hr30min, biol_rep2	13107-140E2	14.77	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 03hr30min, biol_rep3	13173-141C5	12.65	0.00	0.00	0.00	0.00	0.00	0.00	0.45	0.00
MCF7 breast cancer cell line response to EGF1, 04hr, biol_rep1	13042-139F9	15.80	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 04hr, biol_rep2	13108-140E3	8.96	0.75	0.00	0.00	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 04hr, biol_rep3	13174-141C6	10.78	0.74	0.00	0.00	0.37	0.00	0.37	0.37	0.00
MCF7 breast cancer cell line response to EGF1, 05hr, biol_rep1	13043-139G1	16.37	0.86	0.00	0.00	0.00	0.43	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 05hr, biol_rep2	13109-140E4	8.56	0.00	0.00	0.00	0.86	0.00	0.00	0.00	0.86
MCF7 breast cancer cell line response to EGF1, 05hr, biol_rep3	13175-141C7	16.33	0.33	0.67	0.00	0.00	1.00	0.33	0.33	0.00
MCF7 breast cancer cell line response to EGF1, 06hr, biol_rep1	13044-139G2	10.86	0.00	0.00	0.00	0.00	0.00	0.00	0.60	0.00
MCF7 breast cancer cell line response to EGF1, 06hr, biol_rep2	13110-140E5	9.24	0.71	0.00	0.00	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 06hr, biol_rep3	13176-141C8	11.34	0.69	0.34	0.34	0.69	0.34	0.00	0.34	0.00
MCF7 breast cancer cell line response to EGF1, 07hr, biol_rep1	13045-139G3	8.59	0.00	0.00	0.00	0.00	0.00	0.54	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 07hr, biol_rep2	13111-140E6	8.75	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 07hr, biol_rep3	13177-141C9	7.78	1.85	0.00	0.00	0.37	0.00	0.37	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 08hr, biol_rep1	13046-139G4	13.96	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 08hr, biol_rep2	13112-140E7	7.40	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 08hr, biol_rep3	13178-141D1	11.20	1.20	0.00	0.00	0.40	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 00hr15min, biol_rep1	13048-139G6	10.90	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 00hr15min, biol_rep2	13114-140E9	17.63	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 00hr15min, biol_rep3	13180-141D3	15.29	0.00	0.00	0.00	0.00	0.00	0.49	0.00	0.00
MCF7 breast cancer cell line response to HRG, 00hr30min, biol_rep1	13049-139G7	9.41	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 00hr30min, biol_rep2	13115-140F1	14.58	0.00	0.00	0.00	0.50	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 00hr30min, biol_rep3	13181-141D4	9.01	0.00	0.45	0.00	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 00hr45min, biol_rep1	13050-139G8	13.77	1.72	0.00	0.00	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 00hr45min, biol_rep2	13116-140F2	10.24	0.00	0.00	0.45	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 00hr45min, biol_rep3	13182-141D5	16.42	0.39	0.00	0.00	0.39	0.00	0.00	0.39	0.00
MCF7 breast cancer cell line response to HRG, 01hr00min, biol_rep1	13051-139G9	15.17	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 01hr00min, biol_rep2	13117-140F3	10.38	0.52	0.00	0.00	0.00	0.00	0.52	0.00	0.00
MCF7 breast cancer cell line response to HRG, 01hr00min, biol_rep3	13183-141D6	12.25	0.00	0.00	0.44	0.00	0.88	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 01hr20min, biol_rep1	13052-139H1	10.62	0.56	0.56	0.56	0.56	0.00	0.00	0.00	1.12
MCF7 breast cancer cell line response to HRG, 01hr20min, biol_rep2	13118-140F4	8.83	0.44	0.00	0.00	0.00	0.00	0.88	0.00	0.00
MCF7 breast cancer cell line response to HRG, 01hr20min, biol_rep3	13184-141D7	17.74	0.00	0.00	0.00	0.39	0.39	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 01hr40min, biol_rep1	13053-139H2	12.66	0.00	0.51	0.00	0.00	0.00	0.51	0.00	0.00
MCF7 breast cancer cell line response to HRG, 01hr40min, biol_rep2	13119-140F5	9.13	0.00	0.00	0.00	0.48	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 01hr40min, biol_rep3	13185-141D8	14.71	0.40	0.00	0.40	0.00	0.00	0.40	0.00	0.00
MCF7 breast cancer cell line response to HRG, 02hr00min, biol_rep1	13054-139H3	9.11	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 02hr00min, biol_rep2	13120-140F6	10.38	0.00	0.00	0.69	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 02hr00min, biol_rep3	13186-141D9	11.78	0.00	0.38	0.00	0.00	0.00	0.38	0.00	0.00
MCF7 breast cancer cell line response to HRG, 02hr30min, biol_rep1	13055-139H4	15.49	0.52	0.00	0.00	0.00	0.00	0.52	0.00	0.00
MCF7 breast cancer cell line response to HRG, 02hr30min, biol_rep2	13121-140F7	11.49	0.60	0.00	0.00	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 02hr30min, biol_rep3	13187-141E1	14.89	0.63	0.00	0.00	0.00	0.32	0.32	0.00	0.32
MCF7 breast cancer cell line response to HRG, 03hr00min, biol_rep1	13056-139H5	12.79	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 03hr00min, biol_rep2	13122-140F8	10.34	0.00	0.00	0.00	0.57	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 03hr00min, biol_rep3	13188-141E2	12.86	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 03hr30min, biol_rep1	13057-139H6	13.44	0.00	0.71	0.00	0.71	0.00	0.00	0.71	0.00
MCF7 breast cancer cell line response to HRG, 03hr30min, biol_rep2	13123-140F9	10.78	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 03hr30min, biol_rep3	13189-141E3	14.14	0.00	0.00	0.00	0.00	0.42	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 04hr, biol_rep1	13058-139H7	14.88	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 04hr, biol_rep2	13124-140G1	10.86	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 04hr, biol_rep3	13190-141E4	11.62	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 05hr, biol_rep1	13059-139H8	7.36	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 05hr, biol_rep2	13125-140G2	11.23	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 05hr, biol_rep3	13191-141E5	9.29	0.00	0.00	0.00	0.81	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 06hr, biol_rep1	13060-139H9	10.10	0.00	0.00	0.00	0.00	0.00	0.00	0.92	0.00
MCF7 breast cancer cell line response to HRG, 06hr, biol_rep2	13126-140G3	8.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 06hr, biol_rep3	13192-141E6	13.11	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 07hr, biol_rep1	13061-139I1	12.27	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 07hr, biol_rep2	13127-140G4	11.49	0.00	0.00	0.00	0.55	0.00	0.00	0.00	0.55
MCF7 breast cancer cell line response to HRG, 07hr, biol_rep3	13193-141E7	10.25	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 08hr, biol_rep1	13062-139I2	11.70	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 08hr, biol_rep2	13128-140G5	11.27	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 08hr, biol_rep3	13194-141E8	8.31	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Macrophage - monocyte derived, donor1	11232-116C8	23.70	0.00	0.00	0.00	0.00	0.00	0.46	0.46	0.00
Macrophage - monocyte derived, donor2	11313-117C8	19.08	0.18	0.00	0.55	0.00	0.00	0.73	0.00	0.00
Macrophage - monocyte derived, donor3	11389-118C3	17.43	0.39	0.66	0.39	0.26	0.13	0.26	0.13	0.26
Mallassez-derived cells, donor1 (MZH3)	12142-128E9	9.56	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Mallassez-derived cells, donor2	11929-125I3	27.57	1.58	0.32	0.16	0.63	0.48	0.16	0.16	0.16
Mallassez-derived cells, donor3	11930-125I4	17.93	0.83	0.14	0.00	0.00	0.00	0.14	0.28	0.28
Mammary Epithelial Cell, donor1	11273-116H4	23.02	2.19	1.30	1.49	0.90	1.00	0.30	0.20	0.70
Mammary Epithelial Cell, donor2	11350-117G9	19.11	3.19	1.45	0.58	0.00	0.00	0.00	0.87	0.29
Mammary Epithelial Cell, donor3	11422-118F9	9.23	0.25	0.25	0.00	0.00	0.00	0.25	0.00	0.00
Mast cell - stimulated, donor1	11487-119E2	346.43	0.00	1.36	2.71	0.68	0.68	4.07	2.71	0.00
Mast cell, donor1	11563-120D6	37.96	0.76	0.43	0.43	0.22	0.43	0.87	0.43	0.22
Mast cell, donor2	11565-120D8	93.61	1.19	0.30	0.30	0.30	0.30	1.49	0.00	0.30
Mast cell, donor3	11566-120D9	96.80	0.68	0.23	0.23	0.68	0.00	2.03	0.00	0.23
Mast cell, donor4	11567-120E1	86.52	0.00	0.00	0.35	0.18	0.35	0.53	0.00	0.00
Mast cell, expanded and stimulated, donor5	11940-126A5	52.56	1.33	0.11	0.11	0.11	0.78	0.67	0.44	0.89
Mast cell, expanded and stimulated, donor8	11942-126A7	49.61	0.58	0.00	0.00	0.00	0.00	1.17	0.00	1.75
Mast cell, expanded, donor5	11939-126A4	41.87	0.69	0.34	0.11	0.11	0.11	0.46	0.11	0.00
Mast cell, expanded, donor8	11941-126A6	52.39	1.00	0.17	0.17	0.17	0.33	3.01	0.33	0.00
Melanocyte - dark, donor1	11502-119F8	12.54	0.40	0.20	0.00	0.10	0.00	0.40	0.10	0.10
Melanocyte - dark, donor2	11582-120F7	9.34	0.00	0.00	0.35	0.69	0.35	0.00	0.00	0.35
Melanocyte - dark, donor3	11663-122F7	49.98	4.20	0.36	0.65	0.51	0.51	1.23	0.94	0.94
Melanocyte - light, donor1	11274-116H5	40.20	0.71	1.18	0.71	1.41	0.24	4.94	0.24	0.24
Melanocyte - light, donor2	11351-117H1	16.38	0.00	0.00	0.00	0.00	0.00	0.68	0.00	0.00
Melanocyte - light, donor3	11423-118G1	8.67	0.87	0.00	0.00	0.00	0.00	0.87	0.00	0.00
Melanocyte, donor1 (MC+1)	12641-134G4	58.41	3.54	1.46	2.08	1.46	1.15	1.67	0.31	0.73
Melanocyte, donor2 (MC+2)	12739-135I3	65.08	5.65	2.69	1.61	1.88	1.88	1.88	2.15	0.54
Melanocyte, donor3 (MC+3)	12837-137B2	43.93	2.68	0.80	0.80	0.00	0.27	0.80	0.54	1.07
Meningeal Cells, donor1	11493-119E8	12.53	0.00	0.00	0.12	0.00	0.00	0.12	0.25	0.00
Meningeal Cells, donor2	11573-120E7	13.20	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Meningeal Cells, donor3	11654-122E7	26.33	1.30	0.41	0.16	0.24	0.24	0.24	0.73	0.65
Mesenchymal Stem Cells - Vertebral, donor1	11219-116B4	13.69	0.29	0.57	0.00	0.00	0.29	0.00	0.00	0.00
Mesenchymal Stem Cells - Wharton's Jelly, donor1	11548-120B9	23.35	0.00	0.00	0.20	0.50	0.10	0.60	0.20	0.20
Mesenchymal Stem Cells - adipose, donor1	11537-120A7	2.63	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Mesenchymal Stem Cells - adipose, donor2	11617-122A6	1.31	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Mesenchymal Stem Cells - adipose, donor3	11698-123A6	16.50	0.72	0.72	0.72	0.00	0.72	0.00	0.00	0.00
Mesenchymal Stem Cells - amniotic membrane, donor1	11547-120B8	18.21	2.12	0.00	0.00	0.21	0.00	0.00	0.64	0.00
Mesenchymal Stem Cells - amniotic membrane, donor2	11627-122B7	11.56	1.01	0.50	0.50	0.00	0.00	0.00	0.50	1.01
Mesenchymal Stem Cells - bone marrow, donor1	11536-120A6	5.49	0.44	0.22	0.00	0.22	0.00	0.00	0.22	0.22
Mesenchymal Stem Cells - bone marrow, donor2	11616-122A5	8.77	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Mesenchymal Stem Cells - bone marrow, donor3	11697-123A5	6.55	0.00	0.00	0.00	0.20	0.00	0.20	0.00	0.00
Mesenchymal Stem Cells - bone marrow, donor4	11464-119B6	15.10	0.97	0.00	0.42	0.00	0.14	0.00	0.14	0.00
Mesenchymal Stem Cells - hepatic, donor1	11538-120A8	3.72	0.37	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Mesenchymal Stem Cells - hepatic, donor2	11618-122A7	23.95	1.97	0.79	0.66	0.66	0.39	0.66	0.92	0.66
Mesenchymal Stem Cells - umbilical, donor1	11539-120A9	5.04	0.00	0.59	0.30	0.00	0.00	0.00	0.30	0.00
Mesenchymal Stem Cells - umbilical, donor2	11619-122A8	4.67	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Mesenchymal Stem Cells - umbilical, donor3	11700-123A8	5.12	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Mesenchymal stem cells - adipose, donor0	11217-116B2	10.63	0.00	0.35	0.35	0.35	0.00	0.00	0.00	0.00
Mesenchymal stem cells - hepatic, donor0	11218-116B3	17.83	0.31	0.00	0.31	0.31	0.31	0.00	0.00	0.31
Mesenchymal stem cells - umbilical, donor0	11214-116A8	7.98	0.73	0.73	1.45	0.00	0.00	0.73	0.73	0.00
Mesothelial Cells, donor1	11247-116E5	14.05	0.53	0.00	0.27	0.27	0.27	0.00	0.00	0.53
Mesothelial Cells, donor2	12156-128G5	11.51	0.00	0.00	0.00	0.00	0.00	0.50	0.00	0.00
Mesothelial Cells, donor3	11402-118D7	14.45	1.37	0.58	0.79	0.58	0.58	0.14	0.72	0.07
Monocyte-derived macrophages response to LPS, 00hr00min, donor1 (t1 Subject1)	12698-135D7	31.06	0.00	1.35	0.00	0.00	1.35	1.35	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr00min, donor2 (t1 Subject2)	12796-136F6	25.86	0.74	0.49	0.74	0.25	0.49	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr00min, donor3 (t1 Subject3)	12894-137H5	18.85	0.59	0.59	0.00	0.29	0.29	0.59	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr15min, donor1 (t2 Subject1)	12699-135D8	17.29	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr15min, donor2 (t2 Subject2)	12797-136F7	19.22	0.00	0.31	0.31	0.00	0.00	0.62	0.31	0.00
Monocyte-derived macrophages response to LPS, 00hr15min, donor3 (t2 Subject3)	12895-137H6	12.86	0.62	0.41	0.41	0.83	0.00	0.41	0.00	0.21
Monocyte-derived macrophages response to LPS, 00hr30min, donor1 (t3 Subject1)	12700-135D9	13.90	0.00	2.32	2.32	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr30min, donor2 (t3 Subject2)	12798-136F8	21.77	0.50	0.25	0.00	0.50	0.50	0.25	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr30min, donor3 (t3 Subject3)	12896-137H7	17.69	0.00	0.00	0.47	0.47	0.00	0.47	0.00	0.47
Monocyte-derived macrophages response to LPS, 00hr45min, donor1 (t4 Subject1)	12701-135E1	38.93	0.00	0.00	0.00	19.47	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr45min, donor2 (t4 Subject2)	12799-136F9	16.87	0.41	0.00	0.20	0.00	0.00	0.20	0.00	0.20
Monocyte-derived macrophages response to LPS, 00hr45min, donor3 (t4 Subject3)	12897-137H8	17.42	0.00	0.40	0.00	0.00	0.40	0.40	0.40	0.00
Monocyte-derived macrophages response to LPS, 01hr00min, donor1 (t5 Subject1)	12702-135E2	8.55	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr00min, donor2 (t5 Subject2)	12800-136G1	12.39	1.77	0.00	0.00	0.00	0.88	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr00min, donor3 (t5 Subject3)	12898-137H9	9.50	0.76	0.38	0.76	0.00	0.00	0.00	1.14	0.00
Monocyte-derived macrophages response to LPS, 01hr20min, donor1 (t6 Subject1)	12703-135E3	10.53	0.00	0.00	1.32	0.00	0.00	2.63	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr20min, donor2 (t6 Subject2)	12801-136G2	12.73	0.00	0.42	0.42	0.00	0.21	0.42	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr20min, donor3 (t6 Subject3)	12899-137I1	6.45	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr40min, donor1 (t7 Subject1)	12704-135E4	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr40min, donor2 (t7 Subject2)	12802-136G3	12.22	0.00	0.30	0.60	0.30	0.00	0.00	0.00	0.30
Monocyte-derived macrophages response to LPS, 01hr40min, donor3 (t7 Subject3)	12900-137I2	10.06	0.00	1.68	0.00	0.00	1.68	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 02hr00min, donor1 (t8 Subject1)	12705-135E5	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 02hr00min, donor2 (t8 Subject2)	12803-136G4	10.29	1.25	0.00	0.00	0.00	0.25	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 02hr00min, donor3 (t8 Subject3)	12901-137I3	11.88	0.24	0.00	0.00	0.00	1.19	0.48	0.24	0.00
Monocyte-derived macrophages response to LPS, 02hr30min, donor1 (t9 Subject1)	12706-135E6	9.40	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.55
Monocyte-derived macrophages response to LPS, 02hr30min, donor2 (t9 Subject2)	12804-136G5	8.98	0.46	0.00	0.00	0.23	0.23	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 02hr30min, donor3 (t9 Subject3)	12902-137I4	10.31	0.00	0.21	0.21	0.00	0.63	0.42	0.21	0.00
Monocyte-derived macrophages response to LPS, 03hr00min, donor1 (t10 Subject1)	12707-135E7	12.23	0.20	0.00	0.20	0.00	0.20	0.00	0.00	0.20
Monocyte-derived macrophages response to LPS, 03hr00min, donor2 (t10 Subject2)	12805-136G6	11.16	0.43	0.21	0.21	0.00	0.21	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 03hr00min, donor3 (t10 Subject3)	12903-137I5	11.56	0.67	0.22	0.22	0.00	0.00	0.67	0.00	0.00
Monocyte-derived macrophages response to LPS, 03hr30min, donor1 (t11 Subject1)	12708-135E8	10.32	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 03hr30min, donor2 (t11 Subject2)	12806-136G7	7.88	0.00	0.44	0.22	0.22	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 03hr30min, donor3 (t11 Subject3)	12904-137I6	7.10	0.00	0.00	0.51	0.00	0.00	0.00	0.00	0.51
Monocyte-derived macrophages response to LPS, 04hr, donor1 (t12 Subject1)	12709-135E9	8.28	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 04hr, donor2 (t12 Subject2)	12807-136G8	12.50	0.27	0.00	0.54	0.82	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 04hr, donor3 (t12 Subject3)	12905-137I7	9.70	0.00	0.29	0.00	0.29	0.00	0.29	0.29	0.29
Monocyte-derived macrophages response to LPS, 05hr, donor1 (t13 Subject1)	12710-135F1	6.54	0.00	0.00	1.09	1.09	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 05hr, donor2 (t13 Subject2)	12808-136G9	6.73	0.00	0.00	0.00	0.00	0.48	0.48	0.00	0.00
Monocyte-derived macrophages response to LPS, 05hr, donor3 (t13 Subject3)	12906-137I8	9.61	0.00	0.40	0.00	0.40	0.40	0.40	0.00	0.00
Monocyte-derived macrophages response to LPS, 06hr, donor1 (t14 Subject1)	12711-135F2	5.48	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 06hr, donor2 (t14 Subject2)	12809-136H1	6.51	0.50	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 06hr, donor3 (t14 Subject3)	12907-137I9	26.95	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 07hr, donor1 (t15 Subject1)	12712-135F3	2.04	0.00	0.00	0.00	2.04	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 07hr, donor2 (t15 Subject2)	12810-136H2	5.69	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 07hr, donor3 (t15 Subject3)	12908-138A1	5.52	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 08hr, donor1 (t16 Subject1)	12713-135F4	8.97	0.00	0.00	0.00	0.00	0.00	0.64	0.00	0.00
Monocyte-derived macrophages response to LPS, 08hr, donor2 (t16 Subject2)	12811-136H3	10.91	0.25	0.00	0.00	0.25	0.00	0.25	0.00	0.00
Monocyte-derived macrophages response to LPS, 08hr, donor3 (t16 Subject3)	12909-138A2	13.92	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 10hr, donor1 (t17 Subject1)	12714-135F5	4.42	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 10hr, donor2 (t17 Subject2)	12812-136H4	8.21	0.00	0.34	0.00	0.00	0.00	0.00	0.00	0.34
Monocyte-derived macrophages response to LPS, 10hr, donor3 (t17 Subject3)	12910-138A3	5.69	0.44	0.44	0.00	0.88	0.44	0.88	0.00	0.00
Monocyte-derived macrophages response to LPS, 12hr, donor1 (t18 Subject1)	12715-135F6	10.65	0.00	0.00	0.00	0.00	0.36	0.36	0.00	0.00
Monocyte-derived macrophages response to LPS, 12hr, donor2 (t18 Subject2)	12813-136H5	10.94	0.56	0.28	0.56	0.28	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 12hr, donor3 (t18 Subject3)	12911-138A4	9.56	0.00	0.00	0.00	0.00	0.00	0.42	0.00	0.00
Monocyte-derived macrophages response to LPS, 14hr, donor1 (t19 Subject1)	12716-135F7	6.99	0.00	0.00	0.58	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 14hr, donor2 (t19 Subject2)	12814-136H6	10.86	0.00	0.00	0.30	0.60	0.30	0.60	0.60	0.90
Monocyte-derived macrophages response to LPS, 14hr, donor3 (t19 Subject3)	12912-138A5	15.86	0.42	0.42	0.00	0.00	0.00	0.42	0.00	0.00
Monocyte-derived macrophages response to LPS, 16hr, donor1 (t20 Subject1)	12717-135F8	14.44	0.00	7.22	7.22	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 16hr, donor2 (t20 Subject2)	12815-136H7	12.01	0.00	0.92	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 16hr, donor3 (t20 Subject3)	12913-138A6	14.80	0.57	0.00	0.00	0.00	0.00	0.57	0.00	0.00
Monocyte-derived macrophages response to LPS, 18hr, donor1 (t21 Subject1)	12718-135F9	15.06	0.14	0.28	0.00	0.00	0.14	0.28	0.00	0.00
Monocyte-derived macrophages response to LPS, 18hr, donor2 (t21 Subject2)	12816-136H8	8.55	0.52	0.26	0.26	0.00	0.00	0.26	0.00	0.00
Monocyte-derived macrophages response to LPS, 18hr, donor3 (t21 Subject3)	12914-138A7	12.87	0.00	0.00	0.00	0.43	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 20hr, donor1 (t22 Subject1)	12719-135G1	10.80	0.00	0.64	0.00	0.64	0.64	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 20hr, donor2 (t22 Subject2)	12817-136H9	13.08	0.00	0.27	0.00	0.00	0.27	0.80	0.00	0.00
Monocyte-derived macrophages response to LPS, 20hr, donor3 (t22 Subject3)	12915-138A8	20.35	0.30	0.60	0.60	0.30	1.20	0.00	0.00	0.30
Monocyte-derived macrophages response to LPS, 22hr, donor1 (t23 Subject1)	12720-135G2	11.44	0.14	0.14	0.00	0.28	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 22hr, donor2 (t23 Subject2)	12818-136I1	9.87	0.00	0.32	0.00	0.00	0.32	0.32	0.00	0.00
Monocyte-derived macrophages response to LPS, 22hr, donor3 (t23 Subject3)	12916-138A9	17.47	0.22	0.22	0.22	0.00	0.00	0.00	0.00	0.22
Monocyte-derived macrophages response to LPS, 24hr, donor1 (t24 Subject1)	12721-135G3	11.00	0.38	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 24hr, donor2 (t24 Subject2)	12819-136I2	16.48	0.00	0.00	0.28	0.28	0.28	0.00	0.00	0.28
Monocyte-derived macrophages response to LPS, 24hr, donor3 (t24 Subject3)	12917-138B1	14.99	0.25	0.25	0.49	0.25	0.00	0.49	0.00	0.25
Monocyte-derived macrophages response to LPS, 36hr, donor1 (t25 Subject1)	12722-135G4	8.47	0.00	0.00	0.65	0.00	0.00	0.65	0.00	0.00
Monocyte-derived macrophages response to LPS, 36hr, donor2 (t25 Subject2)	12820-136I3	15.88	0.29	0.59	0.00	0.00	0.00	0.29	0.29	0.88
Monocyte-derived macrophages response to LPS, 36hr, donor3 (t25 Subject3)	12918-138B2	18.74	1.15	0.29	0.00	0.00	0.00	0.00	0.00	0.29
Monocyte-derived macrophages response to LPS, 48hr, donor1 (t26 Subject1)	12723-135G5	34.21	0.82	0.41	0.00	0.00	0.41	0.00	0.41	0.41
Monocyte-derived macrophages response to LPS, 48hr, donor2 (t26 Subject2)	12821-136I4	17.57	0.60	0.00	0.60	0.60	0.30	0.00	0.00	0.30
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor1 (868_121:MI_0h)	13304-142I1	3.77	0.00	0.00	0.00	0.00	0.00	3.77	0.00	0.00
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor2 (150_120:MI_0h)	13316-143A4	8.91	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor3 (536_119:MI_0h)	13322-143B1	12.81	1.31	0.00	0.66	0.00	0.33	0.00	0.66	0.00
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor4 (227_121:MI_0h)	13310-142I7	11.57	0.00	1.05	1.05	1.05	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor1 (868_121:MI_24h)	13309-142I6	20.36	0.40	0.00	0.00	0.00	0.00	0.20	0.00	0.20
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor2 (150_120:MI_24h)	13321-143A9	8.38	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor3 (536_119:MI_24h)	13327-143B6	15.02	2.25	0.38	0.38	0.00	0.00	0.38	1.13	0.38
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor4 (227_121:MI_24h)	13315-143A3	13.05	0.00	0.27	0.00	0.53	0.00	0.00	0.00	0.27
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor1 (868_121:Ud_0h)	13305-142I2	14.82	0.23	0.34	0.00	0.11	0.23	0.11	0.00	0.11
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor2 (150_120:Ud_0h)	13317-143A5	6.63	0.00	0.74	0.74	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor3 (536_119:Ud_0h)	13323-143B2	14.66	1.47	0.37	0.37	0.73	0.37	0.00	0.37	0.37
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor4 (227_121:Ud_0h)	13311-142I8	18.67	6.22	0.00	3.11	0.00	0.00	0.00	1.56	1.56
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor1 (868_121:Ud_2h)	13306-142I3	14.96	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor2 (150_120:Ud_2h)	13318-143A6	3.86	7.73	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor3 (536_119:Ud_2h)	13324-143B3	13.13	0.00	0.00	1.01	0.00	1.01	0.00	1.01	0.00
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor4 (227_121:Ud_2h)	13312-142I9	8.85	0.00	0.00	0.00	0.00	0.00	0.42	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor1 (868_121:Ud_7h)	13307-142I4	10.90	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor2 (150_120:Ud_7h)	13319-143A7	3.18	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor3 (536_119:Ud_7h)	13325-143B4	4.86	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor4 (227_121:Ud_7h)	13313-143A1	9.06	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor1 (868_121:Ud_24h)	13308-142I5	11.42	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor2 (150_120:Ud_24h)	13320-143A8	16.31	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor3 (536_119:Ud_24h)	13326-143B5	19.01	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor4 (227_121:Ud_24h)	13314-143A2	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Multipotent Cord Blood Unrestricted Somatic Stem Cells, donor1	11549-120C1	13.79	1.72	0.00	0.22	0.00	0.00	0.22	0.43	0.22
Multipotent Cord Blood Unrestricted Somatic Stem Cells, donor2	11629-122B9	14.11	2.61	0.52	0.00	0.52	1.05	0.52	0.52	0.52
Myoblast differentiation to myotubes, day00, Duchenne Muscular Dystrophy donor1	13496-145C4	15.35	0.67	0.00	0.00	0.00	0.00	0.67	0.00	0.00
Myoblast differentiation to myotubes, day00, Duchenne Muscular Dystrophy donor2	13505-145D4	8.76	0.42	0.00	0.42	0.00	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day00, Duchenne Muscular Dystrophy donor3	13514-145E4	39.74	0.19	0.38	0.19	0.19	0.19	0.38	0.19	0.19
Myoblast differentiation to myotubes, day00, control donor1	13469-144I4	33.51	0.00	4.79	0.00	0.00	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day00, control donor2	13478-145A4	14.28	0.68	0.00	0.00	0.00	0.00	0.68	0.00	0.00
Myoblast differentiation to myotubes, day00, control donor3	13487-145B4	51.45	0.00	1.84	0.00	0.00	3.68	0.00	0.00	0.00
Myoblast differentiation to myotubes, day01, Duchenne Muscular Dystrophy donor1	13497-145C5	13.39	0.84	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day01, Duchenne Muscular Dystrophy donor2	13506-145D5	16.27	0.46	0.00	0.00	0.23	0.23	0.00	0.00	0.00
Myoblast differentiation to myotubes, day01, Duchenne Muscular Dystrophy donor3	13515-145E5	17.83	0.27	0.00	0.00	0.00	0.00	0.27	0.00	0.27
Myoblast differentiation to myotubes, day01, control donor1	13470-144I5	23.13	0.00	0.00	0.42	0.00	0.21	0.21	0.42	0.21
Myoblast differentiation to myotubes, day01, control donor2	13479-145A5	411.98	0.00	22.27	0.00	0.00	11.13	0.00	0.00	22.27
Myoblast differentiation to myotubes, day01, control donor3	13488-145B5	16.38	1.49	0.00	0.00	0.00	0.00	0.50	0.00	1.49
Myoblast differentiation to myotubes, day02, Duchenne Muscular Dystrophy donor1	13498-145C6	20.03	0.27	0.00	0.27	0.00	0.00	0.00	0.00	0.27
Myoblast differentiation to myotubes, day02, Duchenne Muscular Dystrophy donor2	13507-145D6	12.47	0.00	0.00	0.00	0.00	0.00	0.23	0.23	0.00
Myoblast differentiation to myotubes, day02, Duchenne Muscular Dystrophy donor3	13516-145E6	12.57	0.49	0.00	0.16	0.00	0.00	0.82	0.00	0.00
Myoblast differentiation to myotubes, day02, control donor1	13471-144I6	25.52	0.18	0.00	0.00	0.00	0.18	0.00	0.00	0.18
Myoblast differentiation to myotubes, day02, control donor2	13480-145A6	11.14	1.06	0.00	0.00	0.00	0.00	1.06	0.00	0.53
Myoblast differentiation to myotubes, day02, control donor3	13489-145B6	12.01	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day03, Duchenne Muscular Dystrophy donor1	13499-145C7	39.71	0.33	0.33	0.66	0.66	0.00	0.66	0.00	1.31
Myoblast differentiation to myotubes, day03, Duchenne Muscular Dystrophy donor2	13508-145D7	16.26	0.33	0.00	0.16	0.00	0.00	0.33	0.00	0.00
Myoblast differentiation to myotubes, day03, control donor1	13472-144I7	37.22	0.53	0.35	0.53	0.35	0.18	1.06	0.35	0.35
Myoblast differentiation to myotubes, day03, control donor2	13481-145A7	16.88	0.70	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day03, control donor3	13490-145B7	17.47	0.46	0.00	0.00	0.46	0.46	0.00	0.00	0.00
Myoblast differentiation to myotubes, day04, Duchenne Muscular Dystrophy donor1	13500-145C8	22.17	0.00	0.00	0.00	0.00	0.00	0.32	0.00	0.32
Myoblast differentiation to myotubes, day04, Duchenne Muscular Dystrophy donor2	13509-145D8	41.04	0.34	0.00	0.00	0.34	0.69	0.34	0.00	0.69
Myoblast differentiation to myotubes, day04, Duchenne Muscular Dystrophy donor3	13518-145E8	161.82	10.11	2.53	0.00	2.53	0.00	0.00	0.00	2.53
Myoblast differentiation to myotubes, day04, control donor1	13473-144I8	26.73	0.22	0.45	0.00	0.67	0.00	0.45	0.22	0.00
Myoblast differentiation to myotubes, day04, control donor2	13482-145A8	13.55	1.27	0.00	0.00	0.00	0.00	0.42	0.00	0.00
Myoblast differentiation to myotubes, day04, control donor3	13491-145B8	22.79	0.71	0.24	0.00	0.00	0.00	0.47	0.00	0.00
Myoblast differentiation to myotubes, day06, Duchenne Muscular Dystrophy donor1	13501-145C9	20.17	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.43
Myoblast differentiation to myotubes, day06, Duchenne Muscular Dystrophy donor2	13510-145D9	532.64	9.03	27.08	9.03	0.00	0.00	9.03	0.00	18.06
Myoblast differentiation to myotubes, day06, Duchenne Muscular Dystrophy donor3	13519-145E9	17.66	0.00	0.00	0.00	0.33	0.00	0.33	0.00	0.00
Myoblast differentiation to myotubes, day06, control donor1	13474-144I9	15.78	0.90	0.00	0.00	0.00	0.45	0.45	0.00	0.00
Myoblast differentiation to myotubes, day06, control donor2	13483-145A9	17.46	0.40	0.00	0.00	0.00	0.00	0.40	0.00	0.00
Myoblast differentiation to myotubes, day06, control donor3	13492-145B9	20.43	0.93	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day08, Duchenne Muscular Dystrophy donor1	13502-145D1	24.22	1.51	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day08, Duchenne Muscular Dystrophy donor2	13511-145E1	16.62	0.65	0.33	0.00	0.33	0.00	0.33	0.33	0.00
Myoblast differentiation to myotubes, day08, Duchenne Muscular Dystrophy donor3	13520-145F1	17.87	0.44	0.00	0.00	0.00	0.00	0.44	0.00	0.44
Myoblast differentiation to myotubes, day08, control donor1	13475-145A1	34.83	0.00	0.00	0.45	0.00	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day08, control donor2	13484-145B1	22.05	0.00	0.00	0.00	0.00	0.00	0.00	0.88	0.00
Myoblast differentiation to myotubes, day08, control donor3	13493-145C1	29.92	0.66	0.00	0.00	0.00	0.00	0.00	0.66	0.00
Myoblast differentiation to myotubes, day10, Duchenne Muscular Dystrophy donor1	13503-145D2	26.79	0.00	0.00	0.00	0.00	0.00	0.50	0.00	0.50
Myoblast differentiation to myotubes, day10, Duchenne Muscular Dystrophy donor2	13512-145E2	16.46	0.00	0.00	0.00	0.00	0.00	0.00	0.38	0.00
Myoblast differentiation to myotubes, day10, Duchenne Muscular Dystrophy donor3	13521-145F2	38.41	0.60	0.00	0.00	0.00	0.00	0.30	0.60	0.30
Myoblast differentiation to myotubes, day10, control donor1	13476-145A2	25.42	0.22	0.00	0.22	0.00	0.22	0.66	0.22	0.22
Myoblast differentiation to myotubes, day10, control donor2	13485-145B2	18.97	0.68	0.00	0.68	0.00	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day10, control donor3	13494-145C2	127.74	5.11	0.00	0.00	0.00	0.00	0.00	0.00	5.11
Myoblast differentiation to myotubes, day12, Duchenne Muscular Dystrophy donor1	13504-145D3	18.29	0.61	0.00	0.00	0.00	0.00	0.00	0.00	0.61
Myoblast differentiation to myotubes, day12, Duchenne Muscular Dystrophy donor2	13513-145E3	19.20	0.31	0.00	0.31	0.00	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day12, Duchenne Muscular Dystrophy donor3	13522-145F3	19.67	0.00	0.00	0.00	0.00	0.00	0.61	0.30	0.00
Myoblast differentiation to myotubes, day12, control donor1	13477-145A3	19.78	1.58	0.00	0.00	0.79	0.00	0.79	0.00	0.00
Myoblast differentiation to myotubes, day12, control donor2	13486-145B3	43.08	1.13	0.00	0.00	0.00	1.13	0.00	0.00	1.13
Myoblast differentiation to myotubes, day12, control donor3	13495-145C3	151.74	5.06	5.06	0.00	0.00	10.12	5.06	0.00	10.12
Myoblast, donor1	11241-116D8	19.88	0.75	0.37	0.12	0.00	0.37	0.37	0.50	0.12
Myoblast, donor2	11322-117D8	28.19	1.53	0.19	0.38	1.15	0.96	0.00	0.58	0.19
Myoblast, donor3	11398-118D3	30.27	1.35	0.00	0.17	0.00	0.17	0.67	0.00	0.00
NK T cell leukemia cell line:KHYG-1	10777-110G3	27.29	2.48	0.73	0.88	0.44	1.02	0.44	0.88	1.02
Natural Killer Cells, donor1	11230-116C6	61.50	0.62	1.23	0.92	0.62	0.00	1.23	0.31	0.31
Natural Killer Cells, donor2	11311-117C6	46.44	0.90	1.21	0.30	0.00	1.21	0.60	0.90	1.21
Natural Killer Cells, donor3	11387-118C1	46.93	1.47	1.10	1.29	0.92	0.55	1.10	0.92	0.74
Neural stem cells, donor1	11275-116H6	64.97	1.09	0.00	1.45	1.81	0.73	0.73	1.09	0.36
Neural stem cells, donor2	11352-117H2	121.32	0.00	0.00	0.00	0.00	0.00	5.78	0.00	0.00
Neurons, donor1	11494-119E9	46.65	0.00	0.00	1.14	3.41	3.41	1.14	0.00	1.14
Neurons, donor2	11574-120E8	37.65	1.54	0.00	0.22	0.22	0.22	0.22	0.00	0.44
Neurons, donor3	11655-122E8	55.09	2.47	0.00	2.47	0.00	0.82	0.82	0.82	0.82
Neutrophils, donor1	11233-116C9	71.46	2.78	0.00	0.93	1.86	0.00	1.86	0.93	0.93
Neutrophils, donor2	11314-117C9	37.69	2.90	2.90	2.90	2.90	2.90	2.90	11.60	0.00
Neutrophils, donor3	11390-118C4	125.83	0.61	1.22	0.00	0.00	0.00	1.83	0.61	0.00
Nucleus Pulposus Cell, donor1	11252-116F1	25.88	2.49	0.24	0.71	0.59	0.36	0.71	1.31	0.59
Nucleus Pulposus Cell, donor2	11409-118E5	7.81	0.65	0.00	0.00	0.33	0.33	0.65	0.65	0.00
Nucleus Pulposus Cell, donor3	11462-119B4	8.42	1.00	0.00	0.20	0.00	0.60	0.00	0.00	0.20
Olfactory epithelial cells, donor1	11933-125I7	18.17	2.34	0.55	0.69	0.55	0.41	0.00	0.41	0.96
Olfactory epithelial cells, donor2	11934-125I8	27.50	3.04	0.58	1.30	0.87	0.43	0.29	1.45	1.45
Olfactory epithelial cells, donor3	11935-125I9	23.84	2.04	0.57	0.34	0.57	0.79	0.57	0.68	0.45
Olfactory epithelial cells, donor4	11936-126A1	28.34	0.88	1.07	0.68	0.78	0.58	0.19	0.19	0.49
Oligodendrocyte - precursors, donor1	11496-119F2	19.26	1.20	0.60	0.60	0.00	0.60	0.00	0.60	0.00
Osteoblast - differentiated, donor1	11276-116H7	17.23	0.00	0.00	0.00	0.00	0.00	0.43	0.00	0.00
Osteoblast - differentiated, donor2	11353-117H3	5.72	0.00	0.00	1.14	0.00	0.00	0.00	0.00	0.00
Osteoblast - differentiated, donor3	11425-118G3	11.17	0.00	0.00	0.00	0.00	0.00	0.62	0.00	0.00
Osteoblast, donor1	11277-116H8	8.01	0.00	0.00	0.00	0.00	0.00	0.00	0.20	0.00
Osteoblast, donor2	11354-117H4	30.90	2.11	0.00	0.70	0.70	0.00	0.70	0.00	0.00
Osteoblast, donor3	11426-118G4	7.46	0.18	0.18	0.00	0.00	0.00	0.36	0.00	0.18
Pancreatic stromal cells, donor1	11249-116E7	28.05	0.67	0.42	0.34	0.34	0.17	0.17	0.93	0.51
Pericytes, donor1	11491-119E6	2.78	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Pericytes, donor2	11571-120E5	4.30	0.00	0.23	0.23	0.00	0.00	0.00	0.00	0.00
Pericytes, donor3	11652-122E5	5.09	0.00	0.00	0.00	0.00	0.20	0.00	0.00	0.00
Perineurial Cells, donor1	11499-119F5	21.70	0.34	0.11	0.34	0.34	0.00	0.00	0.11	0.79
Perineurial Cells, donor2	11579-120F4	20.52	0.83	0.28	0.00	0.18	0.09	0.28	0.00	0.37
Peripheral Blood Mononuclear Cells, donor1	11231-116C7	52.27	0.96	0.32	0.00	0.00	0.32	1.27	0.00	0.32
Peripheral Blood Mononuclear Cells, donor2	11312-117C7	30.12	0.24	0.24	0.00	0.24	0.49	0.98	0.49	0.00
Peripheral Blood Mononuclear Cells, donor3	11388-118C2	30.80	0.52	0.65	0.26	0.26	0.26	0.52	0.13	0.26
Placental Epithelial Cells, donor1	11278-116H9	13.63	0.00	0.00	0.24	0.00	0.00	0.24	0.00	0.00
Placental Epithelial Cells, donor2	11355-117H5	5.54	0.00	1.11	0.00	0.00	0.00	0.00	0.00	0.00
Placental Epithelial Cells, donor3	11427-118G5	11.58	0.20	0.20	0.20	0.00	0.00	0.00	0.00	0.00
Preadipocyte - breast donor2 (cytoplasmic fraction)	14319-155D8	8.54	1.27	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Preadipocyte - breast, donor1	11467-119B9	22.51	0.56	0.00	0.19	0.38	0.38	0.00	0.19	0.19
Preadipocyte - breast, donor2 (nuclear fraction)	14320-155D9	60.70	1.70	0.78	0.52	0.26	0.52	1.31	0.39	0.13
Preadipocyte - breast, donor2	11328-117E5	15.08	0.68	0.90	0.45	0.45	0.23	0.23	0.23	0.68
Preadipocyte - omental, donor1	11468-119C1	22.70	0.53	0.00	0.21	0.21	0.11	0.43	0.11	0.11
Preadipocyte - omental, donor2	11329-117E6	20.95	1.31	0.00	0.00	0.00	0.00	0.87	0.87	0.00
Preadipocyte - omental, donor3	11403-118D8	19.77	1.00	0.43	1.15	0.29	0.57	0.43	0.43	0.43
Preadipocyte - perirenal, donor1	11469-119C2	3.94	0.00	0.98	0.00	0.00	0.00	0.00	0.00	0.00
Preadipocyte - subcutaneous, donor1	11279-116I1	10.44	0.00	0.00	0.00	0.00	0.31	0.00	0.00	0.00
Preadipocyte - subcutaneous, donor2	11356-117H6	26.92	2.12	0.71	0.71	0.71	1.24	0.18	0.71	0.89
Preadipocyte - subcutaneous, donor3	11428-118G6	13.62	0.85	0.34	0.00	0.51	0.00	0.34	0.00	0.00
Preadipocyte - visceral, donor1	11280-116I2	28.78	1.12	0.47	0.65	0.56	0.56	0.19	0.37	0.37
Preadipocyte - visceral, donor2	11357-117H7	18.41	1.38	0.00	0.00	0.00	0.46	0.00	0.00	0.00
Preadipocyte - visceral, donor3	11429-118G7	18.81	0.21	0.21	0.21	0.31	0.21	0.10	0.10	0.21
Prostate Epithelial Cells (polarized), donor1	11253-116F2	36.36	2.72	0.75	0.75	0.75	1.21	0.60	0.60	0.45
Prostate Epithelial Cells, donor2	11331-117E8	13.41	0.41	0.68	0.00	0.27	0.14	0.14	0.27	0.00
Prostate Epithelial Cells, donor3	11404-118D9	19.04	1.90	0.80	0.86	0.67	1.29	0.00	0.86	0.55
Prostate Stromal Cells, donor1	11254-116F3	13.90	0.11	0.00	0.23	0.00	0.34	0.11	0.46	0.23
Prostate Stromal Cells, donor2	11332-117E9	19.18	2.51	0.36	0.36	0.18	0.72	0.00	1.61	0.00
Prostate Stromal Cells, donor3	11405-118E1	15.02	0.94	0.31	0.52	0.42	0.31	0.10	0.21	0.42
Renal Cortical Epithelial Cells, donor1	11516-119H4	5.47	0.00	0.36	0.00	0.00	0.00	0.00	0.00	0.00
Renal Cortical Epithelial Cells, donor2	11596-120H3	17.88	0.83	0.42	0.28	0.28	0.07	0.07	0.55	0.28
Renal Epithelial Cells, donor1	11517-119H5	6.09	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Renal Epithelial Cells, donor2	11597-120H4	2.13	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Renal Epithelial Cells, donor3	11678-122H4	24.03	2.43	0.21	0.21	0.21	0.64	0.00	0.64	0.85
Renal Glomerular Endothelial Cells, donor1	11514-119H2	4.77	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Renal Glomerular Endothelial Cells, donor2	11594-120H1	4.18	0.13	0.00	0.00	0.00	0.00	0.00	0.13	0.00
Renal Glomerular Endothelial Cells, donor3	11675-122H1	19.54	1.33	1.33	0.67	0.44	1.11	0.22	0.67	1.11
Renal Glomerular Endothelial Cells, donor4	11783-124B1	4.66	0.00	0.67	0.00	0.00	0.00	0.00	0.00	0.00
Renal Mesangial Cells, donor1	11518-119H6	5.72	0.00	0.00	0.00	0.00	0.00	0.22	0.00	0.00
Renal Mesangial Cells, donor2	11598-120H5	5.02	0.63	0.00	0.00	0.00	0.63	0.00	0.00	0.00
Renal Mesangial Cells, donor3	11679-122H5	1.94	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Renal Proximal Tubular Epithelial Cell, donor1	11515-119H3	7.52	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Renal Proximal Tubular Epithelial Cell, donor2	11595-120H2	3.80	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.42
Renal Proximal Tubular Epithelial Cell, donor3	11676-122H2	5.01	0.00	0.00	0.19	0.19	0.00	0.00	0.00	0.00
Retinal Pigment Epithelial Cells, donor0	11215-116A9	18.15	1.04	0.26	0.52	0.26	0.00	0.00	0.00	0.00
Retinal Pigment Epithelial Cells, donor1	11528-119I7	7.11	0.28	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Retinal Pigment Epithelial Cells, donor2	11608-120I6	2.06	0.00	1.03	0.00	0.00	0.00	0.00	0.00	0.00
Retinal Pigment Epithelial Cells, donor3	11689-122I6	18.82	1.51	0.00	0.00	0.00	0.25	0.25	0.75	0.25
SABiosciences XpressRef Human Universal Total RNA, pool1	10002-101A5	37.15	0.67	1.20	0.40	0.40	0.53	0.40	0.94	0.00
Saos-2 osteosarcoma cell line, untreated control, day28, biol_rep1 (B1 T17)	12697-135D6	29.48	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Saos-2 osteosarcoma cell line, untreated control, day28, biol_rep2 (B2 T17)	12795-136F5	64.94	7.71	2.20	1.65	1.10	1.10	0.55	1.65	6.05
Saos-2 osteosarcoma cell line, untreated control, day28, biol_rep3 (B3 T17)	12893-137H4	87.59	2.32	0.58	1.16	0.58	0.58	0.00	0.58	1.16
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr00min, biol_rep1 (A1 T0)	12662-134I7	40.44	0.52	0.26	0.26	0.26	0.13	0.26	0.26	0.13
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr00min, biol_rep2 (A2 T0)	12760-136B6	25.52	1.49	1.09	0.99	1.29	0.89	0.10	0.60	0.79
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr00min, biol_rep3 (A3 T0)	12858-137D5	31.57	0.33	0.33	0.33	0.33	0.00	0.33	0.33	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr15min, biol_rep1 (A1 T1)	12663-134I8	35.10	3.60	0.99	1.36	1.86	0.99	0.00	0.87	1.12
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr15min, biol_rep2 (A2 T1)	12761-136B7	26.46	1.63	0.35	0.35	1.05	0.82	0.00	0.47	0.58
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr15min, biol_rep3 (A3 T1)	12859-137D6	34.67	1.39	1.62	0.46	1.16	1.39	0.46	0.69	1.16
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr30min, biol_rep1 (A1 T2)	12664-134I9	26.97	0.96	0.27	0.68	0.68	0.82	0.14	0.68	0.55
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr30min, biol_rep2 (A2 T2)	12762-136B8	29.20	1.82	0.91	0.76	0.91	0.76	0.00	0.45	0.61
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr30min, biol_rep3 (A3 T2)	12860-137D7	25.98	0.18	0.00	0.00	0.00	0.00	0.18	0.18	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr45min, biol_rep1 (A1 T3)	12665-135A1	16.78	1.72	0.43	0.29	0.43	0.43	0.29	1.00	0.14
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr45min, biol_rep2 (A2 T3)	12763-136B9	19.75	1.29	0.54	0.97	0.32	0.75	0.00	0.32	0.54
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr45min, biol_rep3 (A3 T3)	12861-137D8	23.23	1.33	0.89	0.44	1.33	0.22	0.00	0.22	0.44
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr00min, biol_rep1 (A1 T4)	12666-135A2	16.82	0.38	0.57	0.19	0.57	0.19	0.00	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr00min, biol_rep2 (A2 T4)	12764-136C1	22.45	1.12	0.56	0.28	0.28	0.00	0.19	0.28	0.28
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr00min, biol_rep3 (A3 T4)	12862-137D9	47.73	3.95	0.94	0.75	0.19	0.19	0.38	0.38	1.13
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr20min, biol_rep1 (A1 T5)	12667-135A3	20.17	0.27	0.13	0.13	0.53	0.80	0.13	0.53	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr20min, biol_rep2 (A2 T5)	12765-136C2	29.10	1.17	0.78	1.27	0.88	0.49	0.10	0.78	0.49
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr20min, biol_rep3 (A3 T5)	12863-137E1	28.64	2.48	0.95	1.15	0.95	0.38	0.19	0.57	0.95
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr40min, biol_rep1 (A1 T6)	12668-135A4	21.15	0.43	0.32	0.11	0.43	0.64	0.21	0.00	0.11
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr40min, biol_rep2 (A2 T6)	12766-136C3	20.18	1.68	0.28	0.84	0.28	0.28	0.00	0.00	1.12
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr40min, biol_rep3 (A3 T6)	12864-137E2	29.05	1.37	1.37	0.68	1.71	1.71	0.17	0.17	0.85
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr00min, biol_rep1 (A1 T7)	12669-135A5	23.34	0.18	0.55	0.00	0.18	0.55	0.18	0.18	0.36
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr00min, biol_rep2 (A2 T7)	12767-136C4	23.79	1.35	0.25	0.74	0.61	0.74	0.25	0.98	0.98
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr00min, biol_rep3 (A3 T7)	12865-137E3	25.92	1.48	0.81	0.13	0.54	0.54	0.00	0.67	0.67
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr30min, biol_rep1 (A1 T8)	12670-135A6	21.70	1.18	0.47	0.24	0.47	0.00	0.00	0.47	0.24
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr30min, biol_rep2 (A2 T8)	12768-136C5	19.84	1.59	0.79	0.20	0.40	0.60	0.40	0.60	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr30min, biol_rep3 (A3 T8)	12866-137E4	26.19	1.17	0.23	0.70	0.23	0.94	0.00	0.47	0.23
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 03hr, biol_rep1 (A1 T9)	12671-135A7	15.55	1.24	0.21	0.41	0.21	0.41	0.00	0.41	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 03hr, biol_rep2 (A2 T9)	12769-136C6	30.97	1.77	0.44	0.44	0.22	0.22	0.22	0.00	1.55
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 03hr, biol_rep3 (A3 T9)	12867-137E5	24.86	1.04	0.21	1.04	2.09	0.63	0.21	0.42	0.21
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 04hr, biol_rep1 (A1 T10)	12672-135A8	26.24	1.62	0.67	0.27	0.67	0.54	0.13	0.67	0.27
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 04hr, biol_rep2 (A2 T10)	12770-136C7	24.86	0.85	0.34	0.34	0.17	0.34	0.00	0.51	0.17
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 04hr, biol_rep3 (A3 T10)	12868-137E6	31.23	0.77	1.35	1.54	2.51	0.96	0.00	0.58	0.96
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 08hr, biol_rep1 (A1 T11)	12673-135A9	21.32	1.55	0.34	0.69	0.86	0.69	0.00	0.34	1.03
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 08hr, biol_rep2 (A2 T11)	12771-136C8	26.06	0.41	0.41	0.69	0.41	0.82	0.27	1.10	0.27
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 08hr, biol_rep3 (A3 T11)	12869-137E7	35.95	0.82	1.31	1.64	1.31	1.48	0.16	0.49	0.66
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 24hr, biol_rep1 (A1 T12)	12674-135B1	22.84	1.36	0.51	0.17	0.34	0.51	0.34	0.17	0.17
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 24hr, biol_rep2 (A2 T12)	12772-136C9	27.37	1.18	0.59	1.18	1.92	1.04	0.00	0.30	0.74
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 24hr, biol_rep3 (A3 T12)	12870-137E8	26.92	0.27	1.07	0.27	0.80	0.80	0.00	0.53	1.07
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day04, biol_rep1 (A1 T13)	12675-135B2	21.85	0.41	0.41	0.00	0.28	0.41	0.00	0.55	0.41
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day04, biol_rep2 (A2 T13)	12773-136D1	20.24	1.43	0.95	1.19	0.95	0.24	0.00	0.00	0.48
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day04, biol_rep3 (A3 T13)	12871-137E9	41.92	0.40	1.21	0.20	1.01	0.20	0.20	1.21	0.40
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day07, biol_rep1 (A1 T14)	12676-135B3	15.82	0.94	0.57	0.66	0.75	0.28	0.19	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day07, biol_rep2 (A2 T14)	12774-136D2	34.94	3.14	1.05	1.05	2.45	2.45	0.00	1.40	1.40
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day07, biol_rep3 (A3 T14)	12872-137F1	24.78	0.30	0.91	0.00	1.21	0.91	0.00	0.91	0.30
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day14, biol_rep1 (A1 T15)	12677-135B4	18.36	1.10	0.37	0.12	0.12	0.12	0.12	0.12	0.49
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day14, biol_rep2 (A2 T15)	12775-136D3	65.94	0.58	0.58	0.73	0.44	0.44	0.58	0.73	0.29
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day14, biol_rep3 (A3 T15)	12873-137F2	23.12	0.00	0.00	0.00	0.61	0.00	0.00	0.00	1.22
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day21, biol_rep1 (A1 T16)	12678-135B5	14.47	1.51	0.00	0.00	0.30	0.30	0.00	0.90	0.30
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day21, biol_rep2 (A2 T16)	12776-136D4	21.26	1.13	0.68	0.45	1.36	0.23	0.68	0.45	0.68
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day21, biol_rep3 (A3 T16)	12874-137F3	29.65	0.90	0.60	0.90	1.50	1.50	0.30	0.60	0.30
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day28, biol_rep1 (A1 T17)	12679-135B6	22.91	0.35	0.00	0.24	0.12	0.12	0.24	0.35	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day28, biol_rep2 (A2 T17)	12777-136D5	26.47	0.00	0.00	0.21	0.21	0.21	0.21	0.00	0.64
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day28, biol_rep3 (A3 T17)	12875-137F4	37.26	2.40	0.00	0.00	0.00	0.60	1.20	0.00	0.00
Schwann Cells, donor1	11498-119F4	4.89	0.19	0.00	0.00	0.19	0.00	0.00	0.00	0.00
Schwann Cells, donor2	11578-120F3	20.41	0.00	0.00	0.00	0.00	3.40	0.00	0.00	0.00
Schwann Cells, donor3	11659-122F3	12.05	1.75	0.22	0.00	0.00	0.88	0.22	1.31	0.00
Sebocyte, donor1	11220-116B5	6.57	0.00	0.00	0.00	0.00	0.00	0.55	0.00	0.00
Sebocyte, donor2	11301-117B5	4.14	0.00	0.00	0.00	0.00	0.46	0.00	0.00	0.00
Sebocyte, donor3	11378-118B1	4.95	0.21	0.21	0.00	0.00	0.00	0.00	0.00	0.00
Sertoli Cells, donor1	11255-116F4	14.91	1.66	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Sertoli Cells, donor2	11333-117F1	19.77	2.82	2.82	0.00	5.65	0.00	0.00	2.82	0.00
Skeletal Muscle Cells, donor1	11281-116I3	27.19	1.14	0.18	0.53	0.35	0.00	0.09	0.35	0.18
Skeletal Muscle Cells, donor2	11358-117H8	6.51	0.00	0.00	0.00	0.00	0.00	0.00	0.72	0.00
Skeletal Muscle Cells, donor3	11430-118G8	11.70	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Skeletal Muscle Cells, donor4	11451-119A2	24.98	0.16	0.31	0.16	0.00	0.16	0.16	0.31	0.00
Skeletal Muscle Cells, donor5	11455-119A6	24.23	0.59	0.45	0.45	0.15	0.00	0.15	0.15	0.15
Skeletal Muscle Cells, donor6	11459-119B1	30.32	0.77	0.15	0.46	0.46	0.46	0.15	0.31	0.15
Skeletal Muscle Satellite Cells, donor1	11240-116D7	35.79	1.51	0.63	0.38	0.38	0.13	0.50	0.50	0.25
Skeletal Muscle Satellite Cells, donor2	11321-117D7	27.25	1.28	0.14	0.00	0.57	0.71	0.00	0.57	0.14
Skeletal Muscle Satellite Cells, donor3	11397-118D2	27.68	0.79	0.89	0.89	0.20	0.69	0.20	0.40	0.20
Skeletal muscle cells differentiated into Myotubes - multinucleated, donor1	11282-116I4	30.84	1.77	0.25	0.42	0.34	0.84	0.08	1.10	0.51
Skeletal muscle cells differentiated into Myotubes - multinucleated, donor2	11359-117H9	7.96	0.00	0.00	0.00	0.00	0.00	0.00	0.72	0.00
Skeletal muscle cells differentiated into Myotubes - multinucleated, donor3	11431-118G9	7.29	0.00	0.00	0.00	0.14	0.00	0.14	0.28	0.00
Skin - palm, donor1	10286-104F7	37.61	0.00	2.69	0.00	2.69	0.00	0.00	0.00	0.00
Small Airway Epithelial Cells donor2 (cytoplasmic fraction)	14334-155F5	8.22	1.01	0.00	0.00	0.14	0.00	0.14	0.29	0.14
Small Airway Epithelial Cells donor2 (nuclear fraction)	14335-155F6	76.88	1.64	0.00	0.00	0.82	0.00	0.82	0.82	0.82
Small Airway Epithelial Cells donor3 (cytoplasmic fraction)	14316-155D5	10.39	0.39	0.00	0.00	0.00	0.26	0.13	0.13	0.00
Small Airway Epithelial Cells, donor1	11256-116F5	16.96	0.42	0.14	0.28	0.28	0.14	0.14	0.00	0.14
Small Airway Epithelial Cells, donor2	11334-117F2	14.49	0.84	0.28	0.28	0.14	0.14	0.14	0.00	0.28
Small Airway Epithelial Cells, donor3 (nuclear fraction)	14317-155D6	97.05	1.90	1.27	0.63	1.06	0.63	1.27	0.63	0.42
Small Airway Epithelial Cells, donor3	11406-118E2	14.84	1.05	0.07	0.30	0.30	0.75	0.00	0.37	0.07
Smooth Muscle Cells - Aortic, donor0 (cytoplasmic fraction)	14313-155D2	3.39	0.93	0.00	0.00	0.31	0.00	0.00	0.31	0.31
Smooth Muscle Cells - Aortic, donor0 (nuclear fraction)	14314-155D3	37.80	1.56	0.22	0.22	0.44	0.89	0.00	0.44	0.44
Smooth Muscle Cells - Aortic, donor0	11210-116A4	11.76	0.00	0.00	0.00	0.00	0.00	0.59	0.00	0.00
Smooth Muscle Cells - Aortic, donor1	11283-116I5	9.28	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Smooth Muscle Cells - Aortic, donor2	11360-117I1	6.30	0.39	0.00	0.00	0.39	0.00	0.00	0.00	0.00
Smooth Muscle Cells - Aortic, donor3	11432-118H1	17.77	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Smooth Muscle Cells - Bladder, donor1	11519-119H7	14.01	2.00	0.00	1.00	0.00	2.00	1.00	1.00	0.00
Smooth Muscle Cells - Brachiocephalic, donor1	11284-116I6	13.44	0.13	0.00	0.00	0.00	0.00	0.13	0.13	0.00
Smooth Muscle Cells - Brachiocephalic, donor2	11361-117I2	16.40	0.89	1.99	1.55	1.77	0.44	0.00	0.44	0.66
Smooth Muscle Cells - Brachiocephalic, donor3	11433-118H2	9.73	0.00	0.00	0.00	0.00	0.13	0.13	0.00	0.00
Smooth Muscle Cells - Brain Vascular, donor1	11234-116D1	20.84	0.00	0.33	0.00	0.00	0.65	0.65	0.00	0.33
Smooth Muscle Cells - Brain Vascular, donor2	11315-117D1	28.94	0.30	0.00	0.00	0.00	0.30	0.59	0.00	0.30
Smooth Muscle Cells - Brain Vascular, donor3	11391-118C5	12.53	0.28	0.28	0.14	0.28	0.00	0.28	0.14	0.00
Smooth Muscle Cells - Bronchial, donor1	11512-119G9	1.95	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Smooth Muscle Cells - Bronchial, donor2	11592-120G8	21.31	1.52	1.22	0.30	1.22	1.22	0.00	0.00	0.00
Smooth Muscle Cells - Carotid, donor1	11285-116I7	8.84	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Smooth Muscle Cells - Carotid, donor2	11362-117I3	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Smooth Muscle Cells - Carotid, donor3	11434-118H3	7.63	0.48	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Smooth Muscle Cells - Colonic, donor1	11239-116D6	20.65	1.03	0.00	0.15	0.15	0.15	0.15	0.00	0.15
Smooth Muscle Cells - Colonic, donor2	11320-117D6	18.94	0.86	0.43	0.65	0.65	0.00	0.43	0.22	0.22
Smooth Muscle Cells - Colonic, donor3	11396-118D1	19.42	0.63	0.52	0.31	0.31	0.10	0.10	0.00	0.10
Smooth Muscle Cells - Coronary Artery, donor1	11286-116I8	8.51	0.00	0.00	0.00	0.00	0.00	0.15	0.00	0.00
Smooth Muscle Cells - Coronary Artery, donor2	11363-117I4	7.55	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Smooth Muscle Cells - Coronary Artery, donor3	11435-118H4	12.25	0.00	0.00	0.00	0.00	0.00	0.30	0.00	0.00
Smooth Muscle Cells - Esophageal, donor1	11508-119G5	3.76	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Smooth Muscle Cells - Esophageal, donor2	11588-120G4	26.62	2.59	0.47	0.08	0.16	0.24	0.16	0.39	0.31
Smooth Muscle Cells - Internal Thoracic Artery, donor1	11287-116I9	23.25	0.50	0.10	0.50	0.20	0.20	0.30	0.00	0.10
Smooth Muscle Cells - Internal Thoracic Artery, donor2	11364-117I5	17.07	0.91	0.23	1.37	0.23	1.14	0.00	0.46	0.23
Smooth Muscle Cells - Internal Thoracic Artery, donor3	11436-118H5	4.83	0.60	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Smooth Muscle Cells - Intestinal, donor1	11509-119G6	34.44	1.59	0.79	0.79	0.79	0.26	0.26	0.00	0.53
Smooth Muscle Cells - Prostate, donor1	11257-116F6	23.17	1.86	0.13	0.53	0.67	0.13	0.00	0.40	0.00
Smooth Muscle Cells - Prostate, donor2	11335-117F3	16.53	2.00	1.00	0.63	0.50	0.75	0.00	1.00	0.13
Smooth Muscle Cells - Prostate, donor3	11465-119B7	15.22	0.51	0.00	0.25	0.00	0.25	0.76	0.25	0.00
Smooth Muscle Cells - Pulmonary Artery, donor1	11288-117A1	15.08	0.75	0.00	0.00	0.30	0.00	0.30	0.00	0.30
Smooth Muscle Cells - Pulmonary Artery, donor2	11365-117I6	8.25	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Smooth Muscle Cells - Pulmonary Artery, donor3	11437-118H6	1.29	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Smooth Muscle Cells - Subclavian Artery, donor1	11289-117A2	13.02	0.00	0.00	0.00	0.00	0.00	0.00	0.47	0.00
Smooth Muscle Cells - Subclavian Artery, donor2	11366-117I7	7.57	0.50	0.50	0.00	0.00	0.00	0.00	0.00	0.00
Smooth Muscle Cells - Subclavian Artery, donor3	11438-118H7	9.72	0.31	0.31	0.00	0.00	0.00	0.00	0.00	0.00
Smooth Muscle Cells - Tracheal, donor1	11513-119H1	2.06	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Smooth Muscle Cells - Tracheal, donor2	11593-120G9	23.16	0.33	0.08	0.08	0.00	0.08	0.08	0.00	0.00
Smooth Muscle Cells - Tracheal, donor3	11674-122G9	18.22	0.47	0.47	0.47	0.47	0.47	0.00	0.00	0.00
Smooth Muscle Cells - Umbilical Artery, donor1	11290-117A3	6.91	0.00	0.00	0.00	0.00	0.14	0.00	0.00	0.00
Smooth Muscle Cells - Umbilical Artery, donor2	11367-117I8	7.90	0.51	0.00	0.00	0.00	0.00	0.25	0.00	0.00
Smooth Muscle Cells - Umbilical Artery, donor3	11439-118H8	5.45	0.00	0.00	0.00	0.00	0.00	0.19	0.00	0.00
Smooth Muscle Cells - Umbilical Vein, donor1	11541-120B2	25.01	1.40	0.42	0.28	0.14	0.28	0.00	0.56	0.14
Smooth Muscle Cells - Umbilical Vein, donor2	11621-122B1	15.33	0.50	0.08	0.17	0.08	0.00	0.08	0.17	0.00
Smooth Muscle Cells - Umbilical Vein, donor3	11702-123B1	2.86	0.00	0.00	0.00	0.00	0.00	0.00	0.48	0.00
Smooth Muscle Cells - Umbilical artery, donor0	11212-116A6	6.12	0.24	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Smooth Muscle Cells - Uterine, donor1	11258-116F7	22.09	1.10	0.22	0.00	0.22	0.00	0.22	0.66	0.44
Smooth Muscle Cells - Uterine, donor3	11466-119B8	17.55	0.00	1.17	0.00	0.00	0.00	0.00	0.00	0.00
Smooth muscle cells - airway, asthmatic, donor1	11960-126C7	18.46	0.39	0.97	0.39	0.00	0.19	0.39	0.19	0.78
Smooth muscle cells - airway, asthmatic, donor2	11961-126C8	18.25	1.59	1.06	0.53	0.79	1.32	0.00	0.26	0.53
Smooth muscle cells - airway, asthmatic, donor3	11962-126C9	36.82	4.09	0.00	0.74	0.00	1.49	0.00	1.49	0.74
Smooth muscle cells - airway, asthmatic, donor4	11963-126D1	27.31	3.59	0.72	1.08	0.36	0.36	0.36	0.00	1.44
Smooth muscle cells - airway, asthmatic, donor5	11964-126D2	11.64	0.57	0.28	0.28	0.00	0.00	0.00	0.00	0.00
Smooth muscle cells - airway, asthmatic, donor6	11965-126D3	14.18	3.15	1.18	0.00	0.00	0.00	0.00	1.18	1.18
Smooth muscle cells - airway, control, donor1	11966-126D4	20.82	1.27	1.02	0.76	0.76	0.25	0.25	0.25	1.02
Smooth muscle cells - airway, control, donor2	11967-126D5	23.56	1.60	0.00	1.20	0.40	0.00	0.40	0.80	0.40
Smooth muscle cells - airway, control, donor3	11968-126D6	17.56	0.00	0.42	0.42	0.84	0.00	0.00	0.00	0.84
Smooth muscle cells - airway, control, donor4	11969-126D7	12.83	0.46	0.00	0.00	0.46	0.00	0.00	0.46	0.46
Synoviocyte, donor1	11291-117A4	20.70	1.35	0.34	0.17	0.50	0.00	0.17	0.00	0.84
Synoviocyte, donor2	11368-117I9	15.25	1.01	0.50	0.67	0.67	0.00	0.34	0.17	0.17
Synoviocyte, donor3	11440-118H9	16.98	0.67	0.67	0.45	0.89	0.00	0.22	0.00	0.89
Trabecular Meshwork Cells, donor1	11532-120A2	8.22	0.00	0.00	0.36	0.00	0.00	0.00	0.00	0.00
Trabecular Meshwork Cells, donor2	11612-122A1	1.98	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Trabecular Meshwork Cells, donor3	11693-123A1	7.64	0.46	0.00	0.00	0.00	0.00	0.00	0.23	0.00
Tracheal Epithelial Cells, donor1	11292-117A5	17.06	0.29	0.07	0.00	0.00	0.00	0.00	0.00	0.22
Tracheal Epithelial Cells, donor2	11369-118A1	4.25	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Tracheal Epithelial Cells, donor3	11441-118I1	5.15	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Universal RNA - Human Normal Tissues Biochain, pool1	10007-101B4	39.98	0.86	1.48	0.74	0.49	0.25	0.74	0.49	0.25
Urethra, donor2	10319-105A4	53.95	3.60	3.60	5.40	12.59	5.40	0.00	0.00	7.19
Urothelial Cells, donor1	11520-119H8	2.13	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Urothelial Cells, donor2	11600-120H7	2.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Urothelial Cells, donor3	11681-122H7	2.75	0.23	0.00	0.23	0.00	0.00	0.00	0.00	0.00
Urothelial cells, donor0	11216-116B1	22.51	1.34	0.22	0.89	0.45	0.00	0.00	0.67	0.67
Whole blood (ribopure), donor090309, donation1	12179-129A1	53.39	0.89	0.00	0.89	1.78	0.00	0.00	0.89	0.00
Whole blood (ribopure), donor090309, donation2	12180-129A2	47.18	0.00	0.00	2.86	4.29	0.00	1.43	0.00	0.00
Whole blood (ribopure), donor090309, donation3	12181-129A3	41.07	0.00	0.00	1.37	0.00	0.68	0.00	0.68	0.00
Whole blood (ribopure), donor090325, donation1	12176-128I7	40.98	1.03	0.34	0.69	0.00	0.00	0.69	0.00	0.34
Whole blood (ribopure), donor090325, donation2	12177-128I8	42.42	0.00	0.00	0.00	0.58	0.00	1.74	0.58	0.00
Whole blood (ribopure), donor090612, donation1	12182-129A4	49.98	2.08	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Whole blood (ribopure), donor090612, donation2	12183-129A5	48.64	0.92	0.00	0.00	0.00	0.92	0.00	0.00	1.84
Whole blood (ribopure), donor090612, donation3	12184-129A6	28.30	0.00	2.74	0.00	0.00	0.00	0.91	0.00	0.00
Wilms' tumor cell line:G-401	10809-111A8	29.36	1.48	0.74	0.37	0.62	0.12	0.12	0.62	0.25
Wilms' tumor cell line:HFWT	10597-108E3	17.60	0.00	0.00	3.52	0.88	0.00	0.00	0.88	0.00
acantholytic squamous carcinoma cell line:HCC1806	10717-109I6	30.45	1.40	0.00	1.12	0.00	0.84	0.00	1.40	0.28
achilles tendon, donor2	10292-104G4	18.60	0.00	2.07	0.00	12.40	2.07	0.00	2.07	0.00
acute lymphoblastic leukemia (B-ALL) cell line:BALL-1	10455-106G5	41.30	4.59	1.27	2.04	2.80	1.78	1.02	1.78	1.27
acute lymphoblastic leukemia (B-ALL) cell line:NALM-6	10534-107G3	67.79	2.55	1.39	0.46	0.23	0.93	1.39	0.46	0.46
acute lymphoblastic leukemia (T-ALL) cell line:HPB-ALL	10429-106D6	80.01	3.80	1.42	0.71	0.95	0.47	1.07	0.71	1.42
acute lymphoblastic leukemia (T-ALL) cell line:Jurkat	10464-106H5	72.93	6.80	2.18	3.54	1.90	2.45	1.90	3.27	3.54
acute myeloid leukemia (FAB M0) cell line:KG-1	10827-111C8	36.82	3.65	1.12	1.12	1.41	1.41	0.84	2.25	2.53
acute myeloid leukemia (FAB M0) cell line:Kasumi-3	10789-110H6	36.16	0.21	0.00	0.00	0.85	0.42	1.90	0.00	0.00
acute myeloid leukemia (FAB M1) cell line:HYT-1	10828-111C9	40.02	1.36	3.54	1.91	2.99	1.09	0.00	0.27	1.63
acute myeloid leukemia (FAB M2) cell line:Kasumi-1	10788-110H5	32.61	0.00	0.44	0.00	0.44	0.88	0.00	0.44	0.88
acute myeloid leukemia (FAB M2) cell line:Kasumi-6	10792-110H9	65.75	6.94	2.45	1.63	1.63	2.86	1.23	1.63	2.86
acute myeloid leukemia (FAB M2) cell line:NKM-1	10765-110E9	40.38	2.72	0.78	1.16	1.94	0.78	0.78	0.39	1.16
acute myeloid leukemia (FAB M3) cell line:HL60	10829-111D1	50.97	5.70	2.58	2.21	1.66	1.66	0.37	2.76	2.76
acute myeloid leukemia (FAB M4) cell line:FKH-1	10830-111D2	42.91	0.00	7.80	15.60	3.90	0.00	0.00	0.00	0.00
acute myeloid leukemia (FAB M4) cell line:HNT-34	10831-111D3	61.58	4.42	3.72	1.16	0.93	0.93	1.39	1.86	2.09
acute myeloid leukemia (FAB M4eo) cell line:EoL-1	10832-111D4	56.18	7.51	1.55	2.33	1.55	1.04	0.26	3.37	1.55
acute myeloid leukemia (FAB M4eo) cell line:EoL-3	10833-111D5	49.39	5.84	1.46	2.63	1.75	1.75	0.58	3.21	0.88
acute myeloid leukemia (FAB M5) cell line:NOMO-1	10764-110E8	33.93	0.46	1.86	1.39	1.39	0.00	0.46	0.46	0.00
acute myeloid leukemia (FAB M5) cell line:P31/FUJ	10770-110F5	76.90	4.11	1.65	1.23	2.06	2.47	0.00	1.65	0.00
acute myeloid leukemia (FAB M5) cell line:THP-1 (cytoplasmic fraction)	14298-155B5	13.81	0.00	0.00	0.00	0.00	0.00	0.31	0.61	0.31
acute myeloid leukemia (FAB M5) cell line:THP-1 (fresh)	10399-106A3	32.43	2.13	0.43	0.85	0.43	0.43	0.85	0.43	0.00
acute myeloid leukemia (FAB M5) cell line:THP-1 (revived)	10400-106A4	37.61	1.21	0.61	0.30	0.91	0.30	0.30	0.00	0.30
acute myeloid leukemia (FAB M5) cell line:THP-1 (thawed)	10405-106A9	52.71	2.41	0.72	0.00	0.96	0.00	0.72	0.00	0.48
acute myeloid leukemia (FAB M5) cell line:U-937 DE-4	10834-111D6	46.33	5.12	3.79	2.45	1.11	1.56	1.34	1.56	1.56
acute myeloid leukemia (FAB M6) cell line:EEB	10835-111D7	40.36	1.00	0.67	0.67	0.33	0.33	0.00	0.00	0.00
acute myeloid leukemia (FAB M6) cell line:F-36E	10836-111D8	29.73	0.00	0.00	0.00	1.86	0.00	0.00	0.00	0.00
acute myeloid leukemia (FAB M6) cell line:F-36P	10837-111D9	13.56	1.51	0.38	0.75	0.00	0.00	0.00	0.38	0.00
acute myeloid leukemia (FAB M7) cell line:M-MOK	10699-109G6	68.47	0.87	1.31	2.18	0.00	0.00	0.00	0.00	0.00
acute myeloid leukemia (FAB M7) cell line:MKPL-1	10802-111A1	9.37	0.00	0.00	0.00	0.00	0.00	1.87	0.00	0.00
adenocarcinoma cell line:IM95m	10796-110I4	12.01	0.24	0.00	0.00	0.24	0.24	0.71	0.24	0.00
adipose tissue, adult, pool1	10010-101C1	55.07	1.86	0.62	0.47	0.78	0.62	0.93	0.16	0.16
adipose, donor1	10184-103D4	112.00	2.35	3.52	1.76	2.35	2.93	0.59	1.76	2.35
adipose, donor2	10185-103D5	37.71	4.06	0.81	0.00	0.00	0.81	0.41	0.41	0.81
adipose, donor3	10186-103D6	41.12	1.09	1.36	0.27	0.27	0.54	0.00	1.09	0.27
adipose, donor4	10187-103D7	37.27	0.87	0.87	2.60	1.73	2.60	0.00	0.87	2.60
adrenal cortex adenocarcinoma cell line:SW-13	10810-111A9	18.94	0.47	0.32	0.32	0.32	0.63	0.32	0.00	0.32
adrenal gland, adult, pool1	10081-102A9	7.28	0.00	0.00	3.64	0.00	0.00	0.00	0.00	0.00
adult T-cell leukemia cell line:ATN-1	10421-106C7	19.34	1.20	0.00	0.27	0.13	0.00	0.13	0.13	0.13
alveolar cell carcinoma cell line:SW 1573	10708-109H6	27.51	0.36	0.36	0.36	1.07	0.36	0.00	1.07	1.07
amniotic membrane cells, donor1	12235-129G3	33.15	1.16	0.23	0.23	0.00	0.23	0.23	0.46	0.23
amniotic membrane cells, donor2	12236-129G4	25.02	0.34	0.00	0.68	0.00	0.00	0.68	0.00	0.00
amniotic membrane cells, donor3	12237-129G5	42.72	1.77	0.88	1.47	0.29	0.29	0.59	1.47	0.59
amygdala - adult, donor10196	10167-103B5	78.26	7.11	2.37	7.11	3.56	1.19	0.00	3.56	1.19
amygdala, adult, donor10252	10151-102I7	81.72	2.64	8.31	3.45	3.85	4.06	2.23	1.62	1.62
amygdala, newborn, donor10223	10360-105E9	41.31	1.29	0.97	0.00	0.32	0.32	1.61	0.65	0.65
anaplastic carcinoma cell line:8305C	10428-106D5	22.16	0.51	0.25	0.38	0.25	0.00	0.25	0.38	0.13
anaplastic large cell lymphoma cell line:Ki-JK	10795-110I3	30.00	2.43	0.88	1.54	0.44	0.66	0.22	0.88	1.10
anaplastic squamous cell carcinoma cell line:RPMI 2650	10805-111A4	49.44	2.00	1.67	2.67	1.67	1.67	0.00	0.00	1.34
aorta, adult, pool1	10052-101G7	26.48	0.39	0.78	0.39	0.98	0.00	0.39	0.00	0.59
appendix, adult	10189-103D9	63.26	0.78	0.39	0.00	1.16	0.00	1.94	0.39	0.39
argyrophil small cell carcinoma cell line:TC-YIK	10589-108D4	62.60	6.19	2.06	1.72	0.69	2.75	0.00	1.72	3.78
artery, adult	10190-103E1	48.91	0.00	0.00	0.00	1.36	1.36	0.00	1.36	0.00
astrocytoma cell line:TM-31	10425-106D2	48.39	0.72	1.16	0.87	0.72	0.29	0.00	0.43	0.29
b cell line:RPMI1788	10427-106D4	33.61	2.68	0.59	0.74	0.59	0.59	0.59	0.59	0.30
basal cell carcinoma cell line:TE 354.T	10702-109G9	25.53	0.83	0.00	0.28	0.28	0.55	0.00	0.00	0.83
bile duct carcinoma cell line:HuCCT1	10432-106D9	21.04	0.79	0.10	0.10	0.10	0.10	0.00	0.20	0.40
bile duct carcinoma cell line:TFK-1	10496-107C1	35.65	1.51	0.50	0.33	0.33	0.50	0.33	0.67	0.67
biphenotypic B myelomonocytic leukemia cell line:MV-4-11	10718-109I7	30.20	0.00	0.00	0.00	1.12	0.56	0.56	0.00	0.00
bladder, adult, pool1	10011-101C2	73.55	0.76	0.98	0.54	0.54	0.33	0.43	0.65	0.54
blood, adult, pool1	10053-101G8	24.36	2.21	0.00	0.00	0.00	0.00	0.00	0.00	0.00
bone marrow stromal cell line:StromaNKtert	10686-109F2	24.83	0.00	0.86	0.00	0.00	0.86	0.00	0.00	0.00
bone marrow, adult	10192-103E3	43.19	4.72	3.37	0.00	2.02	1.35	0.00	4.05	1.35
brain, adult, donor1	10084-102B3	29.73	0.00	1.03	0.00	1.03	0.00	1.03	1.03	1.03
brain, adult, pool1	10012-101C3	97.10	3.45	5.23	2.90	1.11	1.11	2.56	1.34	0.78
brain, fetal, pool1	10085-102B4	26.71	0.00	5.34	0.00	2.67	0.00	2.67	0.00	0.00
breast carcinoma cell line:MCF7	10482-107A5	58.47	0.66	0.99	1.65	2.97	1.65	0.66	0.66	0.00
breast carcinoma cell line:MDA-MB-453	10419-106C5	66.66	1.37	0.87	0.75	0.50	0.12	0.50	0.25	0.50
breast, adult, donor1	10080-102A8	35.99	0.63	0.00	0.00	0.00	0.00	0.00	0.00	0.00
bronchial squamous cell carcinoma cell line:KNS-62	10760-110E4	25.66	1.78	0.76	0.64	0.13	1.91	0.00	0.89	0.25
bronchioalveolar carcinoma cell line:NCI-H358	10709-109H7	26.59	1.86	0.31	0.62	0.93	0.93	0.00	0.31	1.24
bronchioalveolar carcinoma cell line:NCI-H650	10715-109I4	31.31	1.61	0.23	0.00	0.00	0.00	0.46	0.46	0.46
bronchogenic carcinoma cell line:ChaGo-K-1	10710-109H8	15.25	0.97	0.24	0.73	0.24	0.48	0.24	0.24	0.97
carcinoid cell line:NCI-H1770	10703-109H1	34.79	0.94	0.47	0.47	2.35	0.00	0.47	0.00	0.00
carcinoid cell line:NCI-H727	10735-110B6	22.53	0.22	0.55	0.33	0.22	0.22	0.11	0.11	0.11
carcinoid cell line:SK-PN-DW	10719-109I8	37.08	2.54	0.32	1.90	2.54	0.00	0.00	0.63	0.63
carcinosarcoma cell line:JHUCS-1	10642-109A3	38.86	3.73	0.53	1.86	1.60	1.06	0.27	2.13	1.33
caudate nucleus - adult, donor10196	10177-103C6	125.49	4.61	3.45	1.15	3.45	3.45	2.30	0.00	3.45
caudate nucleus, adult, donor10252	10164-103B2	73.62	2.34	8.70	3.01	2.18	5.19	1.17	1.51	1.00
caudate nucleus, adult, donor10258	10379-105H1	48.90	1.53	1.53	1.53	0.76	0.76	0.00	0.76	1.53
caudate nucleus, newborn, donor10223	10354-105E3	63.36	0.73	0.00	0.00	0.37	0.00	1.10	0.37	0.00
cerebellum - adult, donor10196	10173-103C2	174.80	2.91	0.00	2.91	5.83	0.00	5.83	5.83	2.91
cerebellum, adult, donor10252	10166-103B4	117.86	5.98	13.45	8.75	5.12	4.48	2.14	3.20	1.49
cerebellum, adult, pool1	10083-102B2	56.23	2.76	1.72	1.03	0.00	0.69	0.00	1.38	0.69
cerebellum, newborn, donor10223	10357-105E6	78.05	4.15	4.15	0.00	0.00	2.49	0.83	1.66	2.49
cerebral meninges, adult	10188-103D8	66.31	1.01	2.77	1.51	1.51	1.51	1.01	0.00	0.25
cerebrospinal fluid, donor2	10294-104G6	28.50	1.46	1.46	2.19	4.39	2.92	1.46	0.00	2.92
cervical cancer cell line:D98-AH2	10552-107I3	16.97	1.44	0.43	0.29	0.14	0.00	0.14	0.00	0.14
cervical cancer cell line:ME-180	10553-107I4	24.69	1.16	0.17	0.50	0.00	0.00	0.33	0.17	0.00
cervix, adult, pool1	10013-101C4	83.78	2.10	1.68	0.94	1.26	0.94	1.15	0.21	0.10
cholangiocellular carcinoma cell line:HuH-28	10536-107G5	22.57	0.28	0.14	0.42	0.28	0.00	0.14	0.28	0.28
chondrosarcoma cell line:SW 1353	10700-109G7	14.37	0.00	1.31	1.31	1.31	1.31	0.00	0.00	0.00
choriocarcinoma cell line:BeWo	10423-106C9	48.09	2.24	0.50	0.00	0.50	0.25	0.50	0.37	0.00
choriocarcinoma cell line:SCH	10785-110H2	28.83	2.83	0.99	1.36	0.62	0.99	0.00	0.99	0.74
choriocarcinoma cell line:T3M-3	10618-108G6	30.83	0.71	0.47	0.71	0.47	0.00	0.00	0.24	0.00
chorionic membrane cells, donor1	12238-129G6	24.22	1.14	0.00	0.00	0.00	0.00	0.28	0.28	0.85
chorionic membrane cells, donor2	12239-129G7	22.47	0.40	0.30	0.50	0.10	0.20	0.30	0.10	0.30
chorionic membrane cells, donor3	12240-129G8	30.77	1.65	1.10	1.65	1.10	1.10	0.00	0.55	0.00
chronic lymphocytic leukemia (T-CLL) cell line:SKW-3	10416-106C2	20.20	1.01	0.00	0.00	2.02	0.00	0.00	0.00	0.00
chronic myeloblastic leukemia (CML) cell line:KCL-22	10801-110I9	21.13	0.96	0.38	0.58	0.00	0.38	0.19	0.38	0.38
chronic myelogenous leukemia (CML) cell line:MEG-A2	10766-110F1	42.45	1.48	0.42	0.42	0.42	0.21	1.27	0.84	0.63
chronic myelogenous leukemia cell line:K562 ENCODE, biol_rep1	10824-111C5	21.06	0.00	1.03	0.51	0.00	0.26	0.77	0.51	0.00
chronic myelogenous leukemia cell line:K562 ENCODE, biol_rep2	10825-111C6	23.70	1.21	0.73	0.00	0.00	0.97	0.24	0.00	0.00
chronic myelogenous leukemia cell line:K562 ENCODE, biol_rep3	10826-111C7	27.28	0.61	0.61	0.61	0.41	0.20	0.81	1.22	0.81
chronic myelogenous leukemia cell line:K562	10454-106G4	22.67	1.47	0.59	0.59	0.00	0.00	0.00	0.00	0.29
chronic myelogenous leukemia cell line:KU812	10409-106B4	86.27	2.35	1.56	2.87	1.04	0.78	1.56	1.04	2.35
clear cell carcinoma cell line:JHOC-5	10638-108I8	15.54	1.83	0.23	0.23	0.23	0.46	0.00	0.00	0.69
clear cell carcinoma cell line:TEN	10636-108I6	20.30	0.69	0.35	0.17	0.17	0.00	0.17	0.35	0.52
colon carcinoma cell line:CACO-2	10513-107D9	36.97	1.10	0.37	0.92	0.18	0.18	0.00	0.37	0.37
colon carcinoma cell line:COLO-320	10420-106C6	155.07	4.94	1.90	1.52	1.14	0.38	0.00	1.90	1.90
colon, adult, donor1	10082-102B1	19.04	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
colon, adult, pool1	10014-101C5	58.28	0.47	1.18	0.24	0.12	0.24	0.47	0.35	0.24
colon, fetal, donor1	10070-101I7	37.08	0.62	1.24	0.00	0.00	0.00	0.62	0.00	0.62
common myeloid progenitor CMP, donor1	12130-128D6	87.09	0.00	4.58	0.00	9.17	0.00	4.58	0.00	0.00
common myeloid progenitor CMP, donor2	12134-128E1	25.04	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
cord blood derived cell line:COBL-a 24h infection(-C)	10452-106G2	103.68	0.42	0.85	2.12	0.85	0.00	2.55	0.42	0.42
cord blood derived cell line:COBL-a 24h infection	10453-106G3	48.90	0.00	0.30	0.91	0.60	0.45	0.60	0.30	0.60
cord blood derived cell line:COBL-a untreated	10449-106F8	53.44	1.55	0.71	0.56	0.99	0.71	0.85	0.85	0.42
corpus callosum, adult, pool1	10042-101F6	99.62	1.66	2.76	1.44	1.55	0.33	1.55	0.66	0.11
cruciate ligament, donor2	10295-104G7	40.52	1.62	6.48	0.81	2.43	0.81	0.81	0.81	3.24
diaphragm, fetal, donor1	10069-101I6	47.35	1.61	0.00	0.00	0.00	0.00	0.00	0.00	0.00
diencephalon, adult	10193-103E4	82.80	4.08	3.84	2.64	2.64	1.92	0.72	2.16	1.20
diffuse large B-cell lymphoma cell line:CTB-1	10631-108I1	36.74	3.67	2.30	0.92	0.92	0.69	0.69	1.38	0.92
ductal cell carcinoma cell line:KLM-1	10438-106E6	36.93	0.26	0.00	0.77	0.00	0.00	0.26	0.26	0.26
ductal cell carcinoma cell line:MIA Paca2	10488-107B2	18.54	1.69	0.24	0.24	0.96	0.72	0.00	0.72	0.24
ductus deferens, adult	10196-103E7	57.31	1.00	1.99	2.49	1.99	1.00	0.50	0.00	0.50
duodenum, fetal, donor1, tech_rep1	10071-101I8	51.85	1.44	1.44	0.00	0.00	0.00	1.44	2.88	0.00
duodenum, fetal, donor1, tech_rep2	10071-101I8	55.91	4.41	2.21	1.47	0.74	1.47	0.74	1.47	0.00
dura mater, adult, donor1	10041-101F5	51.04	0.99	0.66	0.17	0.74	0.17	0.17	0.33	0.25
embryonic kidney cell line: HEK293/SLAM infection, 24hr	10451-106G1	52.63	0.00	0.44	0.22	0.00	0.67	0.89	0.22	0.22
embryonic kidney cell line: HEK293/SLAM untreated	10450-106F9	29.52	0.57	0.29	0.14	0.00	0.43	0.29	0.43	0.14
embryonic pancreas cell line:1B2C6	10604-108F1	51.18	0.00	3.70	0.62	3.08	0.62	0.00	0.62	0.62
embryonic pancreas cell line:1C3D3	10605-108F2	33.90	1.21	0.30	0.91	0.30	0.61	0.00	0.30	0.00
embryonic pancreas cell line:1C3IKEI	10606-108F3	57.74	1.23	2.16	0.62	0.31	0.00	0.00	0.00	0.00
embryonic pancreas cell line:2C6	10603-108E9	66.99	0.00	0.00	0.00	0.00	1.31	0.00	0.00	0.00
endometrial carcinoma cell line:OMC-2	10497-107C2	29.83	0.00	0.00	0.34	1.68	0.34	0.34	0.00	0.00
endometrial stromal sarcoma cell line:OMC-9	10448-106F7	41.87	2.36	2.36	1.63	1.45	2.17	0.00	1.81	0.36
endometrioid adenocarcinoma cell line:JHUEM-1	10643-109A4	18.33	1.61	0.80	1.13	0.16	0.32	0.16	0.32	0.64
epidermoid carcinoma cell line:A431	10426-106D3	32.57	0.56	0.44	0.44	0.33	0.56	0.11	0.00	0.11
epidermoid carcinoma cell line:Ca Ski	10431-106D8	22.99	0.88	0.55	0.33	0.44	0.11	0.11	0.55	0.00
epididymis, adult	10197-103E8	50.44	1.26	1.05	0.63	0.42	0.63	0.63	0.42	0.63
epithelioid sarcoma cell line:HS-ES-1	10443-106F2	17.74	1.60	1.06	0.35	0.71	0.35	0.00	0.00	0.53
epithelioid sarcoma cell line:HS-ES-2R	10495-107B9	13.76	0.00	0.00	0.39	0.00	0.79	0.00	0.00	0.39
epitheloid carcinoma cell line: HelaS3 ENCODE, biol_rep1	10815-111B5	22.28	2.36	0.52	0.26	0.39	1.05	0.00	0.39	0.26
epitheloid carcinoma cell line: HelaS3 ENCODE, biol_rep2	10816-111B6	29.92	1.77	0.49	0.69	0.89	0.69	0.00	0.10	0.39
epitheloid carcinoma cell line: HelaS3 ENCODE, biol_rep3	10817-111B7	21.73	1.46	0.45	0.67	0.56	0.90	0.22	0.56	0.56
esophagus, adult, pool1	10015-101C6	47.89	0.85	0.74	0.32	0.42	0.32	0.21	0.21	0.42
extraskeletal myxoid chondrosarcoma cell line:H-EMC-SS	10410-106B5	85.79	2.00	0.75	0.75	0.38	0.25	0.63	0.00	0.25
eye - muscle inferior rectus, donor1	10272-104E2	28.97	0.00	4.83	4.83	12.07	0.00	4.83	0.00	2.41
eye - muscle lateral, donor2	10298-104H1	25.25	0.00	2.10	0.00	2.10	0.00	0.00	0.00	2.10
eye - muscle medial, donor2	10299-104H2	29.76	0.00	4.46	2.98	5.95	1.49	0.00	0.00	0.00
eye - muscle superior, donor2	10297-104G9	22.93	0.00	4.59	3.44	3.44	1.15	0.00	0.00	0.00
eye - vitreous humor, donor1	10268-104D7	14.57	1.46	1.46	0.00	2.91	4.37	1.46	1.46	1.46
eye, fetal, donor1	10054-101G9	46.27	4.07	1.78	1.02	2.03	0.25	0.51	1.27	0.00
fibrosarcoma cell line:HT-1080	10758-110E2	29.11	2.18	1.03	0.90	0.51	0.38	0.26	0.77	0.13
fibrous histiocytoma cell line:GCT TIB-223	10711-109H9	21.84	1.19	0.00	0.47	0.24	0.24	0.00	0.24	0.71
frontal lobe, adult, pool1	10040-101F4	100.95	3.57	2.16	2.25	1.22	0.94	2.25	1.22	0.56
gall bladder carcinoma cell line:TGBC14TKB	10470-106I2	89.17	6.31	6.91	3.60	5.10	3.00	0.30	2.70	3.00
gall bladder carcinoma cell line:TGBC2TKB	10415-106C1	50.11	1.01	0.82	0.37	0.27	0.18	0.27	0.09	0.46
gall bladder, adult	10198-103E9	37.42	0.48	0.72	0.72	1.21	0.72	0.24	0.24	0.24
gamma delta positive T cells, donor1	11937-126A2	52.07	0.54	0.00	0.00	0.00	0.00	2.15	0.00	0.00
gamma delta positive T cells, donor2	11938-126A3	62.75	1.12	0.37	0.00	0.00	0.00	2.24	0.00	0.37
gastric adenocarcinoma cell line:MKN1	10614-108G2	32.74	3.80	0.63	1.48	0.84	0.63	0.21	0.84	1.48
gastric adenocarcinoma cell line:MKN45	10612-108F9	35.20	1.55	0.58	0.97	0.77	1.55	0.19	1.74	0.77
gastric cancer cell line:AZ521	10549-107H9	50.99	2.30	0.49	0.66	0.16	0.16	0.16	0.49	0.33
gastric cancer cell line:GSS	10560-108A2	35.69	1.83	0.00	0.00	0.00	0.00	0.00	0.92	0.00
gastrointestinal carcinoma cell line:ECC12	10615-108G3	22.62	1.14	0.91	0.23	0.23	1.14	0.00	0.91	0.69
giant cell carcinoma cell line:LU65	10487-107B1	26.28	1.38	0.57	1.15	0.57	0.80	0.11	0.34	1.03
giant cell carcinoma cell line:Lu99B	10433-106E1	33.17	1.26	0.70	0.42	0.42	0.14	0.00	0.28	0.00
glassy cell carcinoma cell line:HOKUG	10688-109F4	28.43	1.25	1.25	2.00	0.25	1.50	0.75	0.75	1.00
glioblastoma cell line:A172, tech_rep1	10444-106F3	32.09	0.95	0.63	1.06	0.74	0.11	0.11	0.32	0.42
glioblastoma cell line:A172, tech_rep2	10444-106F3	37.22	0.70	1.12	1.54	0.14	0.42	0.56	0.42	0.98
glioblastoma cell line:T98G	10485-107A8	28.81	1.99	0.77	0.77	0.55	0.88	0.22	0.33	0.77
glioma cell line:GI-1	10413-106B8	46.86	1.46	0.29	0.00	0.00	0.29	0.29	0.00	0.29
globus pallidus - adult, donor10196	10175-103C4	116.63	1.46	2.92	1.46	1.46	0.73	2.19	1.46	1.46
globus pallidus, adult, donor10252	10161-103A8	184.54	7.32	11.96	7.08	6.35	3.42	3.66	2.20	0.98
globus pallidus, adult, donor10258	10367-105F7	79.41	2.74	0.00	1.37	2.74	0.00	0.00	2.74	8.22
globus pallidus, newborn, donor10223	10364-105F4	45.83	0.53	0.00	0.00	0.00	0.53	2.13	0.00	1.07
granulocyte macrophage progenitor, donor1	12131-128D7	41.60	0.00	0.00	0.00	0.00	0.00	7.34	0.00	0.00
granulocyte macrophage progenitor, donor2	12135-128E2	21.86	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
granulocyte macrophage progenitor, donor3	12139-128E6	20.91	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
granulosa cell tumor cell line:KGN	10624-108H3	20.48	0.32	0.64	0.32	1.28	0.64	0.32	0.64	0.32
hIPS +CCl2, biol_rep1	14383-156B9	29.84	2.75	0.00	0.46	0.00	0.00	0.00	0.00	0.46
hIPS +CCl2, biol_rep2	14384-156C1	25.61	1.83	0.91	1.37	0.00	0.00	0.00	2.29	0.00
hIPS +CCl2, biol_rep3	14385-156C2	19.97	0.64	0.00	0.64	0.00	0.64	0.00	0.00	1.29
hIPS, biol_rep1	14380-156B6	12.94	0.00	1.44	0.00	0.00	1.44	0.00	0.00	0.00
hIPS, biol_rep2	14381-156B7	16.46	1.37	0.69	0.00	0.00	0.69	0.00	2.74	0.00
hIPS, biol_rep3	14382-156B8	64.00	2.21	3.31	0.00	3.31	3.31	0.00	3.31	1.10
hairy cell leukemia cell line:Mo	10712-109I1	32.76	4.31	0.29	0.57	0.86	0.86	0.57	1.15	1.72
heart - mitral valve, adult	10205-103F7	52.92	0.60	0.30	1.20	2.69	0.60	0.90	0.30	0.30
heart - pulmonic valve, adult	10206-103F8	60.40	2.61	3.66	3.14	4.97	1.83	1.57	1.31	2.88
heart - tricuspid valve, adult	10207-103F9	49.96	0.00	4.16	1.67	2.50	0.83	0.00	0.00	0.00
heart, adult, diseased post-infarction, donor1	10050-101G5	20.81	1.43	0.61	0.41	0.61	0.41	0.61	0.41	0.61
heart, adult, diseased, donor1	10051-101G6	17.88	0.43	0.00	0.00	0.85	0.00	1.28	0.00	0.00
heart, adult, pool1	10016-101C7	34.50	0.00	0.92	0.00	0.23	0.23	0.00	0.23	0.00
heart, fetal, pool1	10046-101G1	52.06	0.82	1.54	0.41	0.62	0.00	0.41	0.62	0.00
hepatic mesenchymal tumor cell line:LI90	10778-110G4	27.77	0.62	0.31	0.62	0.00	0.31	0.00	0.00	0.00
hepatoblastoma cell line:HuH-6	10633-108I3	16.65	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
hepatocellular carcinoma cell line: HepG2 ENCODE, biol_rep1	10818-111B8	34.36	1.33	1.22	0.88	0.55	0.88	0.77	0.66	0.33
hepatocellular carcinoma cell line: HepG2 ENCODE, biol_rep2	10819-111B9	40.05	0.97	0.85	1.09	0.49	0.85	0.49	0.12	0.61
hepatocellular carcinoma cell line: HepG2 ENCODE, biol_rep3	10820-111C1	46.28	2.63	1.62	1.82	0.91	0.91	0.61	0.81	0.51
hepatoma cell line:Li-7	10484-107A7	15.79	1.11	0.33	0.11	0.33	0.44	0.22	0.11	0.22
hereditary spherocytic anemia cell line:WIL2-NS	10808-111A7	35.38	2.51	0.50	0.90	0.60	0.60	0.40	1.01	0.90
hippocampus - adult, donor10196	10169-103B7	91.79	3.79	12.30	4.73	3.79	4.73	1.89	0.95	2.84
hippocampus, adult, donor10252	10153-102I9	110.21	5.71	15.31	4.49	3.88	2.25	2.65	2.86	1.22
hippocampus, adult, donor10258	10374-105G5	66.23	4.48	2.49	1.49	1.99	0.50	0.00	1.99	2.49
hippocampus, newborn, donor10223	10363-105F3	42.65	0.00	0.00	0.00	0.35	0.00	1.06	0.35	0.00
iPS differentiation to neuron, control donor C11-CRL2429, day00, rep1	13421-144D1	55.54	1.83	1.22	0.61	0.00	0.61	0.00	0.61	1.22
iPS differentiation to neuron, control donor C11-CRL2429, day00, rep2	13425-144D5	31.42	1.96	0.20	0.59	0.39	0.39	0.59	0.59	0.39
iPS differentiation to neuron, control donor C11-CRL2429, day00, rep3	13429-144D9	38.85	2.54	0.51	0.00	0.51	0.51	0.00	0.25	0.25
iPS differentiation to neuron, control donor C11-CRL2429, day06, rep1	13422-144D2	32.70	0.56	0.56	0.56	0.00	0.56	0.56	0.56	0.00
iPS differentiation to neuron, control donor C11-CRL2429, day06, rep2	13426-144D6	55.77	3.61	1.03	0.26	0.77	0.26	0.00	0.77	0.77
iPS differentiation to neuron, control donor C11-CRL2429, day06, rep3	13430-144E1	38.34	1.52	0.00	0.38	0.00	0.76	0.38	0.76	0.38
iPS differentiation to neuron, control donor C11-CRL2429, day12, rep1	13423-144D3	51.97	0.58	0.58	0.58	0.29	0.58	0.88	0.88	0.29
iPS differentiation to neuron, control donor C11-CRL2429, day12, rep2	13427-144D7	56.44	1.51	0.22	0.65	0.65	0.43	0.22	0.65	0.43
iPS differentiation to neuron, control donor C11-CRL2429, day12, rep3	13431-144E2	41.71	0.00	0.00	0.00	0.00	0.83	0.83	0.00	0.00
iPS differentiation to neuron, control donor C11-CRL2429, day18, rep1	13424-144D4	45.23	0.71	0.24	0.00	0.24	0.71	0.00	0.00	0.71
iPS differentiation to neuron, control donor C11-CRL2429, day18, rep2	13428-144D8	52.55	2.73	0.48	0.80	0.80	0.32	0.48	0.32	0.48
iPS differentiation to neuron, control donor C11-CRL2429, day18, rep3	13432-144E3	45.78	0.00	0.00	0.00	0.00	0.00	0.67	0.00	0.00
iPS differentiation to neuron, control donor C32-CRL1502, day00, rep1	13433-144E4	41.31	3.13	1.25	0.47	1.10	0.63	0.00	0.78	0.78
iPS differentiation to neuron, control donor C32-CRL1502, day00, rep2	13437-144E8	37.34	3.44	0.49	0.49	0.49	0.49	0.00	1.47	1.47
iPS differentiation to neuron, control donor C32-CRL1502, day00, rep3	13441-144F3	52.37	3.49	0.87	0.87	0.00	0.00	0.00	0.00	0.87
iPS differentiation to neuron, control donor C32-CRL1502, day06, rep1	13434-144E5	63.00	2.29	0.38	0.57	0.19	0.38	0.00	0.57	1.15
iPS differentiation to neuron, control donor C32-CRL1502, day06, rep2	13438-144E9	51.89	2.18	1.31	0.87	0.87	0.87	0.44	0.44	1.74
iPS differentiation to neuron, control donor C32-CRL1502, day06, rep3	13442-144F4	58.97	4.00	0.00	0.50	0.00	0.00	0.00	0.00	1.00
iPS differentiation to neuron, control donor C32-CRL1502, day12, rep1	13435-144E6	50.49	2.07	1.13	1.13	0.38	0.19	0.38	0.38	1.32
iPS differentiation to neuron, control donor C32-CRL1502, day12, rep2	13439-144F1	66.39	1.36	0.45	0.45	0.45	0.00	1.36	0.45	1.36
iPS differentiation to neuron, control donor C32-CRL1502, day12, rep3	13443-144F5	43.85	0.63	0.31	0.31	0.31	0.31	0.63	0.94	1.88
iPS differentiation to neuron, control donor C32-CRL1502, day18, rep1	13436-144E7	40.66	1.47	0.49	1.14	0.98	0.65	0.82	0.33	1.47
iPS differentiation to neuron, control donor C32-CRL1502, day18, rep2	13440-144F2	40.35	2.32	0.87	0.00	0.87	0.00	0.58	0.58	0.58
iPS differentiation to neuron, control donor C32-CRL1502, day18, rep3	13444-144F6	42.15	0.30	0.30	0.00	0.00	0.30	0.00	1.20	0.30
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day00, rep1	13445-144F7	37.87	2.77	0.74	0.74	0.92	0.92	0.00	0.55	0.92
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day00, rep2	13449-144G2	40.23	1.71	0.57	0.00	0.57	0.29	0.29	2.00	1.14
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day00, rep3	13453-144G6	44.10	2.04	0.82	1.63	0.41	0.82	0.41	0.41	0.82
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day06, rep1	13446-144F8	53.16	4.22	0.00	0.70	0.35	0.70	0.00	1.06	2.11
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day06, rep2	13450-144G3	43.71	2.85	0.32	0.95	0.63	0.32	0.32	1.27	1.27
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day06, rep3	13454-144G7	40.85	1.82	0.61	0.91	0.00	0.30	0.00	0.30	0.00
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day12, rep1	13447-144F9	53.78	1.55	3.10	0.52	0.00	0.00	0.00	0.00	1.03
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day12, rep2	13451-144G4	53.80	0.00	1.33	0.00	0.00	0.66	0.66	0.00	0.66
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day12, rep3	13455-144G8	43.10	0.51	0.51	0.26	1.03	0.26	0.77	0.26	0.00
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day18, rep1	13448-144G1	38.86	2.56	0.26	1.79	0.77	0.26	1.28	0.51	0.26
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day18, rep2	13452-144G5	56.03	0.00	0.00	0.00	0.76	0.00	0.00	0.76	2.27
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day18, rep3	13456-144G9	33.94	1.34	0.00	0.67	0.00	0.00	0.34	0.34	0.67
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day00, rep1	13457-144H1	45.16	2.17	0.48	0.48	0.24	0.97	0.24	0.97	1.21
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day00, rep2	13461-144H5	44.12	1.34	0.89	0.89	0.00	0.89	0.00	1.34	0.45
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day00, rep3	13465-144H9	48.29	1.46	0.49	0.00	0.49	0.49	0.49	0.49	0.49
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day06, rep1	13458-144H2	51.04	4.28	1.22	0.92	0.00	0.00	0.61	0.92	1.53
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day06, rep2	13462-144H6	348.10	6.51	6.51	3.25	3.25	0.00	0.00	0.00	6.51
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day06, rep3	13466-144I1	65.86	0.66	0.66	1.65	0.00	0.00	1.32	0.66	1.65
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day12, rep1	13459-144H3	50.35	0.00	2.19	1.09	1.09	0.55	0.55	0.00	0.55
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day12, rep2	13463-144H7	39.81	2.17	0.36	0.72	0.72	0.36	0.36	0.00	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day12, rep3	13467-144I2	42.70	0.71	1.42	0.00	0.36	0.00	0.00	0.00	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day18, rep1	13460-144H4	42.96	2.39	1.19	2.39	0.00	0.00	0.00	0.00	1.19
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day18, rep2	13464-144H8	72.99	1.22	0.27	0.68	0.27	0.14	0.14	0.68	0.68
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day18, rep3	13468-144I3	35.56	0.27	0.00	0.27	0.27	0.00	0.27	0.27	0.54
immature langerhans cells, donor1	11904-125F5	30.75	0.00	0.00	0.24	0.48	0.24	1.21	0.00	0.24
immature langerhans cells, donor2	11905-125F6	19.80	0.00	0.00	0.00	0.00	0.00	0.00	0.79	0.00
insula, adult, pool1	10039-101F3	65.01	1.14	1.80	0.85	0.28	0.76	1.04	0.19	0.47
keratoacanthoma cell line:HKA-1	10791-110H8	20.16	0.98	0.65	0.00	0.00	0.33	0.00	0.33	0.33
kidney, adult, pool1	10017-101C8	49.06	0.40	0.90	0.60	0.40	0.60	0.70	0.40	0.10
kidney, fetal, pool1	10045-101F9	41.38	0.50	0.71	0.07	0.50	0.07	0.35	0.14	0.14
large cell lung carcinoma cell line:IA-LM	10509-107D5	49.57	0.28	0.28	0.85	0.14	0.43	0.00	0.43	0.14
large cell lung carcinoma cell line:NCI-H460	10839-111E2	9.95	0.14	0.41	0.14	0.14	0.28	0.14	0.00	0.00
large cell non-keratinizing squamous carcinoma cell line:SKG-II-SF	10692-109F8	17.25	0.37	0.18	0.37	0.18	0.00	0.00	0.00	0.00
left atrium, adult, donor1	10079-102A7	27.79	0.54	1.09	1.09	0.54	0.00	1.09	0.00	0.54
left ventricle, adult, donor1	10078-102A6	28.32	0.00	0.51	1.01	1.52	0.00	0.00	0.00	0.00
leiomyoblastoma cell line:G-402	10721-110A1	28.18	0.82	1.37	0.55	0.82	0.00	0.27	0.55	0.00
leiomyoma cell line:10964C	10569-108B2	6.83	1.08	0.00	0.72	0.00	0.36	0.00	0.00	0.00
leiomyoma cell line:15242A	10570-108B3	8.70	0.00	0.54	0.00	1.09	0.54	0.00	0.00	0.00
leiomyoma cell line:15425	10571-108B4	11.41	1.46	0.24	0.24	0.73	0.00	0.00	0.24	0.49
leiomyosarcoma cell line:Hs 5.T	10722-110A2	31.75	0.00	0.00	0.00	6.35	0.00	0.00	0.00	0.00
lens epithelial cell line:SRA 01/04	10647-109A8	20.91	0.00	0.00	0.00	1.05	0.00	0.00	0.00	0.00
leukemia, chronic megakaryoblastic cell line:MEG-01	10752-110D5	20.66	2.60	0.94	1.06	0.83	1.30	1.06	1.42	0.59
liposarcoma cell line:KMLS-1	10782-110G8	22.34	0.62	0.62	0.16	0.62	0.31	0.31	0.16	0.16
liposarcoma cell line:SW 872	10726-110A6	27.29	0.61	0.24	0.24	0.24	0.12	0.37	0.24	0.37
liver, adult, pool1	10018-101C9	18.31	0.81	0.65	0.81	0.97	0.32	0.00	0.16	0.32
liver, fetal, pool1	10086-102B5	9.41	0.00	0.00	0.00	0.00	0.00	0.94	0.00	0.00
locus coeruleus - adult, donor10196	10182-103D2	116.81	3.94	10.21	2.62	3.35	3.35	2.92	1.17	1.90
locus coeruleus, adult, donor10252	10165-103B3	75.48	2.21	7.38	3.88	2.95	2.40	1.48	0.92	1.85
locus coeruleus, adult, donor10258	10375-105G6	67.43	4.23	1.13	0.28	0.28	0.85	1.13	1.13	0.56
locus coeruleus, newborn, donor10223	10362-105F2	78.24	0.84	1.26	0.84	0.42	0.84	0.84	0.84	0.84
lung adenocarcinoma cell line:A549	10499-107C4	15.64	0.14	0.00	0.00	0.00	0.14	0.00	0.14	0.14
lung adenocarcinoma cell line:PC-14	10408-106B3	59.29	0.00	1.38	0.00	0.00	0.00	0.00	0.00	0.00
lung adenocarcinoma, papillary cell line:NCI-H441	10742-110C4	23.20	0.13	0.26	0.40	0.13	0.26	0.26	0.13	0.00
lung, adult, pool1	10019-101D1	46.90	0.71	0.59	0.95	0.24	0.24	0.24	0.00	0.00
lung, fetal, donor1	10068-101I5	160.68	0.86	1.71	1.43	0.86	1.14	0.86	1.43	0.29
lung, right lower lobe, adult, donor1	10075-102A3	52.24	0.92	0.46	0.92	0.46	0.46	0.92	0.46	1.37
lymph node, adult, donor1	10077-102A5	30.77	1.42	0.00	0.95	0.00	0.00	1.42	0.00	0.00
lymphangiectasia cell line:DS-1	10727-110A7	18.41	1.32	0.66	0.66	0.22	0.44	0.44	0.22	0.00
lymphoma, malignant, hairy B-cell cell line:MLMA	10775-110G1	43.92	1.21	0.30	0.60	0.00	0.45	0.60	0.60	0.60
malignant trichilemmal cyst cell line:DJM-1	10412-106B7	97.69	1.70	3.40	0.00	0.00	1.70	2.55	0.85	0.00
mature adipocyte, donor1	12231-129F8	35.08	0.00	0.44	0.44	0.00	0.00	0.44	0.00	0.00
mature adipocyte, donor2	12232-129F9	62.05	0.42	0.00	0.42	0.42	0.21	1.25	0.00	0.21
mature adipocyte, donor3	12233-129G1	55.95	0.24	0.47	0.24	0.24	0.47	1.19	0.00	0.00
mature adipocyte, donor4	12234-129G2	56.85	0.00	0.53	0.00	0.26	0.26	0.00	0.00	0.26
maxillary sinus tumor cell line:HSQ-89	10414-106B9	72.91	0.48	0.48	0.48	0.48	0.00	0.71	0.00	0.48
medial frontal gyrus - adult, donor10196	10170-103B8	84.60	3.38	4.51	4.51	3.38	3.38	1.13	1.13	1.13
medial frontal gyrus, adult, donor10252	10150-102I6	94.34	3.49	17.47	5.70	3.68	6.07	2.02	3.49	1.10
medial frontal gyrus, adult, donor10258	10368-105F8	55.91	2.86	2.54	2.54	1.91	2.22	0.32	0.64	1.59
medial frontal gyrus, newborn, donor10223	10352-105E1	80.61	0.43	0.00	0.43	0.00	0.00	0.43	0.00	0.43
medial temporal gyrus - adult, donor10196	10183-103D3	114.58	8.94	3.71	2.53	1.86	2.87	2.70	3.04	1.69
medial temporal gyrus, adult, donor10252	10156-103A3	106.75	5.52	22.92	9.13	5.09	3.61	2.97	1.91	3.18
medial temporal gyrus, adult, donor10258, tech_rep1	10376-105G7	52.01	3.85	3.85	0.00	0.00	3.85	0.00	1.93	3.85
medial temporal gyrus, adult, donor10258, tech_rep2	10376-105G7	1550.19	157.89	57.41	100.48	43.06	57.41	0.00	28.71	301.43
medial temporal gyrus, newborn, donor10223	10353-105E2	54.92	1.08	1.44	0.36	1.08	0.36	1.79	0.36	0.00
medulla oblongata - adult, donor10196	10174-103C3	81.77	2.60	1.30	1.30	0.65	0.65	0.65	0.65	2.60
medulla oblongata, adult, donor10252	10155-103A2	89.48	3.25	6.66	3.87	3.72	2.79	0.93	1.70	1.70
medulla oblongata, adult, pool1	10038-101F2	58.77	0.82	2.45	0.65	0.65	0.65	1.31	0.41	0.08
medulla oblongata, newborn, donor10223	10361-105F1	44.79	3.12	1.74	0.35	0.35	0.35	0.35	0.35	0.69
medulloblastoma cell line:D283 Med	10838-111E1	60.45	6.86	2.21	2.88	3.32	2.44	0.22	0.89	1.77
medulloblastoma cell line:ONS-76	10759-110E3	19.69	0.37	0.37	0.37	0.98	0.61	0.12	0.24	0.12
melanoma cell line:COLO 679	10514-107E1	89.41	4.46	1.44	2.16	1.87	1.72	9.92	1.15	1.44
melanoma cell line:G-361	10465-106H6	46.69	5.16	1.90	2.17	2.44	1.36	0.54	2.17	0.81
meningioma cell line:HKBMM	10691-109F7	18.09	0.36	0.54	0.36	0.18	0.18	0.18	0.36	0.00
merkel cell carcinoma cell line:MKL-1	10843-111E6	89.00	4.41	1.76	0.88	2.64	0.88	0.00	0.88	0.88
merkel cell carcinoma cell line:MS-1	10844-111E7	64.55	0.78	1.81	1.81	1.81	0.26	0.52	0.26	0.26
mesenchymal precursor cell - adipose, donor1	11747-123G1	16.88	0.31	0.15	0.15	0.46	0.15	0.00	0.46	0.00
mesenchymal precursor cell - adipose, donor2	11748-123G2	16.54	0.36	0.18	0.55	0.18	0.55	0.18	0.18	0.55
mesenchymal precursor cell - adipose, donor3	11749-123G3	19.05	1.24	0.00	0.83	0.83	0.41	0.00	0.83	0.00
mesenchymal precursor cell - bone marrow, donor1	11750-123G4	15.31	1.12	0.56	0.14	0.14	0.28	0.00	0.42	0.00
mesenchymal precursor cell - bone marrow, donor2	11751-123G5	12.90	0.96	0.39	0.00	0.58	0.39	0.39	0.00	0.00
mesenchymal precursor cell - bone marrow, donor3	11840-124H4	15.27	0.00	0.69	0.00	0.00	0.69	1.39	0.00	0.00
mesenchymal precursor cell - cardiac, donor1	11752-123G6	13.22	0.34	0.17	0.17	0.34	0.00	0.00	0.00	0.00
mesenchymal precursor cell - cardiac, donor2	11753-123G7	14.72	0.81	0.23	0.58	0.12	0.35	0.46	0.35	0.00
mesenchymal precursor cell - cardiac, donor3	11754-123G8	17.64	0.53	0.40	0.40	0.40	0.27	0.27	0.27	0.40
mesenchymal precursor cell - cardiac, donor4	11755-123G9	17.56	1.89	0.68	0.27	0.41	0.54	0.00	0.54	0.14
mesenchymal precursor cell - ovarian cancer left ovary, donor1	11756-123H1	25.18	0.71	0.28	0.57	0.28	1.28	0.14	0.28	0.14
mesenchymal precursor cell - ovarian cancer left ovary, donor2	11833-124G6	20.42	1.98	0.00	0.33	0.66	0.99	0.00	0.00	0.33
mesenchymal precursor cell - ovarian cancer left ovary, donor3	11760-123H5	16.33	0.69	0.55	0.28	0.42	0.55	0.00	0.14	0.00
mesenchymal precursor cell - ovarian cancer left ovary, donor4	11836-124G9	22.69	3.49	0.35	0.70	0.70	0.35	0.35	0.35	0.35
mesenchymal precursor cell - ovarian cancer metastasis, donor1	11758-123H3	17.35	0.20	0.61	0.41	0.41	0.20	0.20	0.20	0.41
mesenchymal precursor cell - ovarian cancer metastasis, donor2	11835-124G8	14.02	2.16	0.72	0.36	0.00	1.08	0.00	0.36	1.08
mesenchymal precursor cell - ovarian cancer metastasis, donor3	11762-123H7	11.48	0.93	0.00	0.31	0.00	0.10	0.00	0.31	0.21
mesenchymal precursor cell - ovarian cancer metastasis, donor4	11838-124H2	13.68	0.68	0.46	0.46	0.00	0.23	0.00	0.23	0.46
mesenchymal precursor cell - ovarian cancer right ovary, donor1	11757-123H2	31.89	1.68	0.84	1.26	0.84	1.26	0.00	0.00	0.00
mesenchymal precursor cell - ovarian cancer right ovary, donor2	11759-123H4	17.78	0.60	0.60	0.30	0.60	0.00	0.15	0.15	0.60
mesenchymal precursor cell - ovarian cancer right ovary, donor3 (SOC-57-02)	11761-123H6	15.49	0.88	0.18	0.61	0.18	0.44	0.09	0.26	0.18
mesenchymal precursor cell - ovarian cancer right ovary, donor3 (SOC-57-02-G)	11842-124H6	25.40	0.74	0.37	0.37	0.74	0.37	0.00	0.37	0.00
mesenchymal precursor cell - ovarian cancer right ovary, donor4	11837-124H1	22.32	2.00	0.57	1.43	0.86	0.29	0.00	0.86	0.29
mesenchymal stem cell line:Hu5/E18	10568-108B1	21.05	1.68	0.42	0.00	0.42	0.00	0.42	1.68	0.42
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr00min, biol_rep1	13229-141I7	11.42	0.46	0.00	0.46	0.00	0.46	0.46	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr00min, biol_rep2	13230-141I8	15.09	1.28	0.26	0.00	0.00	0.00	0.26	0.51	0.51
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr00min, biol_rep3	13231-141I9	14.92	0.79	0.00	0.00	0.00	0.26	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr15min, biol_rep1	13232-142A1	12.02	2.46	0.31	0.62	0.62	0.31	0.00	0.62	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr15min, biol_rep2	13233-142A2	16.24	1.18	0.71	0.47	0.24	0.47	0.00	0.47	0.71
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr15min, biol_rep3	13234-142A3	12.86	1.02	1.02	0.00	0.00	0.00	0.34	0.00	0.34
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr30min, biol_rep1	13235-142A4	8.65	1.57	0.00	0.39	0.39	0.39	0.39	0.39	0.39
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr30min, biol_rep2	13236-142A5	13.44	0.46	0.46	0.46	0.46	0.46	0.46	0.93	0.46
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr30min, biol_rep3	13237-142A6	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr45min, biol_rep1	13238-142A7	14.71	2.31	0.29	0.29	0.00	0.29	0.29	0.58	0.87
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr45min, biol_rep2	13239-142A8	13.16	0.67	0.89	0.22	0.00	0.22	0.67	0.45	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr45min, biol_rep3	13240-142A9	12.02	0.48	0.72	0.00	0.24	0.00	0.00	0.72	0.48
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr00min, biol_rep1	13241-142B1	22.00	0.00	0.00	0.00	0.00	0.73	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr00min, biol_rep2	13242-142B2	14.77	1.01	0.00	0.34	0.00	0.34	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr00min, biol_rep3	13243-142B3	13.51	1.64	0.41	0.00	0.41	0.41	0.82	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr20min, biol_rep1	13244-142B4	13.32	0.86	0.00	0.00	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr20min, biol_rep2	13245-142B5	13.67	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr20min, biol_rep3	13246-142B6	46.48	5.16	0.00	0.00	0.00	5.16	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr40min, biol_rep1	13247-142B7	20.14	0.32	0.00	0.00	0.32	0.00	0.00	0.32	0.65
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr40min, biol_rep2	13248-142B8	16.00	0.00	0.00	0.00	0.00	2.91	1.45	2.91	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr40min, biol_rep3	13249-142B9	16.53	0.53	0.00	0.00	0.53	0.00	0.00	0.53	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr00min, biol_rep1	13250-142C1	14.72	0.00	0.82	0.00	0.00	0.00	0.82	0.82	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr00min, biol_rep2	13251-142C2	12.83	1.17	0.00	0.00	0.00	0.00	0.39	0.39	0.39
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr00min, biol_rep3	13252-142C3	2.10	2.10	0.00	0.00	0.00	2.10	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr30min, biol_rep1	13253-142C4	12.92	0.99	0.00	0.99	0.99	0.00	0.99	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr30min, biol_rep2	13254-142C5	19.07	0.00	0.00	0.00	0.00	4.77	0.00	0.00	4.77
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr30min, biol_rep3	13255-142C6	17.79	0.59	0.00	0.59	0.00	0.59	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 03hr00min, biol_rep1	13256-142C7	19.50	1.22	0.00	0.00	0.00	0.00	0.00	0.00	1.22
mesenchymal stem cells (adipose derived), adipogenic induction, 03hr00min, biol_rep2	13257-142C8	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 03hr00min, biol_rep3	13258-142C9	17.10	1.27	0.00	0.00	0.00	0.63	0.00	0.00	0.63
mesenchymal stem cells (adipose derived), adipogenic induction, 12hr00min, biol_rep1	13259-142D1	17.25	0.34	0.00	0.69	0.00	0.34	0.00	0.00	0.34
mesenchymal stem cells (adipose derived), adipogenic induction, 12hr00min, biol_rep2	13260-142D2	10.75	0.00	0.00	0.00	0.00	0.00	2.15	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 12hr00min, biol_rep3	13261-142D3	15.97	7.98	0.00	0.00	0.00	0.00	0.00	3.99	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day01, biol_rep1	13262-142D4	17.22	0.00	0.00	3.44	0.00	0.00	0.00	0.00	3.44
mesenchymal stem cells (adipose derived), adipogenic induction, day01, biol_rep2	13263-142D5	8.15	0.81	0.41	0.00	0.00	0.00	0.41	0.41	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day01, biol_rep3	13264-142D6	12.71	0.79	0.00	0.79	0.79	0.00	0.00	0.00	0.79
mesenchymal stem cells (adipose derived), adipogenic induction, day02, biol_rep1	13265-142D7	6.48	0.59	0.59	1.18	0.00	0.59	0.00	0.00	0.59
mesenchymal stem cells (adipose derived), adipogenic induction, day02, biol_rep2	13266-142D8	10.29	1.87	0.31	0.00	0.00	0.31	0.00	0.31	0.31
mesenchymal stem cells (adipose derived), adipogenic induction, day02, biol_rep3	13267-142D9	10.69	4.01	1.34	1.34	1.34	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day04, biol_rep1	13268-142E1	16.56	0.00	0.00	0.00	0.00	0.00	0.00	1.18	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day04, biol_rep2	13269-142E2	25.68	0.00	0.00	0.00	0.00	2.57	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day04, biol_rep3	13270-142E3	24.78	1.38	1.38	0.00	0.00	0.69	0.00	0.00	0.69
mesenchymal stem cells (adipose derived), adipogenic induction, day08, biol_rep1	13271-142E4	13.85	2.47	1.48	0.99	0.00	0.49	0.00	0.99	0.49
mesenchymal stem cells (adipose derived), adipogenic induction, day08, biol_rep2	13272-142E5	8.97	2.24	1.12	0.00	2.24	0.00	1.12	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day08, biol_rep3	13273-142E6	14.63	0.64	1.91	0.64	0.64	1.27	0.00	0.64	1.27
mesenchymal stem cells (adipose derived), adipogenic induction, day12, biol_rep1	13274-142E7	10.07	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day12, biol_rep2	13275-142E8	6.54	2.18	0.00	0.00	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day12, biol_rep3	13276-142E9	11.40	1.27	0.00	0.00	0.00	0.00	0.00	1.27	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day14, biol_rep1	13277-142F1	8.50	0.00	0.00	0.00	0.00	0.00	1.21	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day14, biol_rep2	13278-142F2	18.08	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day14, biol_rep3	13279-142F3	16.47	2.47	0.00	0.82	0.00	0.00	0.82	0.00	0.00
mesenchymal stem cells (adipose derived), undifferentiated control, biol_rep1	13280-142F4	19.64	0.00	0.00	0.00	0.00	0.00	0.79	0.00	0.00
mesenchymal stem cells (adipose derived), undifferentiated control, biol_rep2	13281-142F5	8.44	0.32	0.32	0.32	0.00	0.00	0.00	0.32	0.00
mesenchymal stem cells (adipose derived), undifferentiated control, biol_rep3	13282-142F6	13.24	2.04	1.02	0.00	0.00	2.04	0.00	2.04	1.02
mesodermal tumor cell line:HIRS-BM	10696-109G3	31.72	0.00	0.00	0.00	0.00	0.00	0.77	0.00	0.00
mesothelioma cell line:ACC-MESO-1	10493-107B7	39.45	0.24	0.00	0.24	0.47	0.24	0.00	0.24	0.00
mesothelioma cell line:ACC-MESO-4	10494-107B8	15.99	0.46	0.23	0.46	0.00	0.23	0.00	0.23	0.00
mesothelioma cell line:Mero-14, tech_rep1	10849-111F3	38.46	4.27	0.00	0.00	0.00	0.00	0.00	4.27	0.00
mesothelioma cell line:Mero-14, tech_rep2	10849-111F3	10.48	2.98	0.21	0.00	0.10	0.00	0.21	0.10	0.51
mesothelioma cell line:Mero-25	10850-111F4	10.67	0.45	0.00	0.45	0.68	0.68	0.00	0.23	0.23
mesothelioma cell line:Mero-41	10851-111F5	22.74	2.44	0.49	0.49	0.24	0.24	0.24	0.73	0.73
mesothelioma cell line:Mero-48a	10852-111F6	10.63	0.44	0.22	0.44	0.89	0.22	0.22	0.44	0.22
mesothelioma cell line:Mero-82	10853-111F7	22.34	3.94	0.79	0.79	0.00	1.84	0.26	2.10	0.53
mesothelioma cell line:Mero-83	10854-111F8	18.38	1.87	0.68	0.34	0.51	0.51	0.34	0.85	0.34
mesothelioma cell line:Mero-84	10855-111F9	7.84	1.26	0.00	0.00	0.00	0.25	0.00	0.51	0.00
mesothelioma cell line:Mero-95	10856-111G1	13.87	1.66	0.00	0.62	0.62	0.41	0.21	0.21	0.62
mesothelioma cell line:NCI-H2052	10847-111F1	10.44	1.33	0.50	0.50	0.66	0.33	0.00	0.33	0.17
mesothelioma cell line:NCI-H226	10846-111E9	14.48	2.53	0.00	0.18	0.36	0.18	0.18	0.36	0.54
mesothelioma cell line:NCI-H2452	10848-111F2	13.49	1.02	0.51	1.02	0.34	0.51	0.00	0.51	0.34
mesothelioma cell line:NCI-H28	10845-111E8	24.17	2.80	0.51	0.51	0.76	0.51	0.00	0.25	0.76
mesothelioma cell line:No36	10857-111G2	15.01	1.30	0.33	0.33	0.33	0.98	0.00	0.33	0.33
mesothelioma cell line:ONE58	10858-111G3	13.01	1.08	0.27	0.27	0.00	0.00	0.00	0.54	0.54
migratory langerhans cells, donor1	11901-125F2	27.06	0.38	0.38	0.00	0.19	0.00	0.19	0.00	0.00
migratory langerhans cells, donor2	11902-125F3	23.69	0.00	0.00	0.12	0.12	0.12	0.12	0.12	0.00
migratory langerhans cells, donor3	11903-125F4	37.33	1.26	0.54	0.36	0.54	0.72	0.00	0.18	0.18
mixed mullerian tumor cell line:HTMMT	10689-109F5	30.04	4.90	0.65	0.65	0.00	0.98	0.33	0.65	1.96
mucinous adenocarcinoma cell line:JHOM-1	10648-109A9	15.68	0.64	0.64	0.21	0.42	0.00	0.21	0.00	0.21
mucinous cystadenocarcinoma cell line:MCAS	10784-110H1	21.88	0.00	0.69	0.92	0.69	0.23	0.00	0.23	0.23
mycosis fungoides, T cell lymphoma cell line:HuT 102 TIB-162	10744-110C6	19.60	0.76	0.19	0.57	0.57	0.57	0.19	0.00	0.19
myelodysplastic syndrome cell line:SKM-1	10772-110F7	62.09	0.74	0.55	1.66	0.55	0.55	0.55	0.74	0.37
myeloma cell line:PCM6	10474-106I6	28.27	1.58	0.20	0.40	0.20	0.79	0.59	0.40	0.00
myxofibrosarcoma cell line:MFH-ino	10600-108E6	14.71	1.01	0.51	1.52	0.00	0.51	1.01	0.00	0.51
myxofibrosarcoma cell line:NMFH-1	10684-109E9	18.44	0.78	0.39	0.00	0.20	1.18	0.59	0.59	0.59
nasal epithelial cells, donor1, tech_rep1	12226-129F3	11.70	0.22	0.00	0.11	0.00	0.00	0.00	0.00	0.00
nasal epithelial cells, donor1, tech_rep2	12226-129F3	15.44	0.07	0.07	0.15	0.00	0.00	0.00	0.00	0.00
nasal epithelial cells, donor2	12227-129F4	13.25	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
neuroblastoma cell line:CHP-134	10508-107D4	96.17	1.15	0.46	0.92	1.15	0.23	1.38	0.23	0.00
neuroblastoma cell line:NB-1	10539-107G8	66.42	2.62	0.56	0.94	0.37	0.37	1.12	0.00	0.75
neuroblastoma cell line:NBsusSR	10607-108F4	232.40	24.25	6.33	6.12	5.69	8.86	4.43	7.38	6.54
neuroblastoma cell line:NH-12	10555-107I6	70.81	4.85	2.05	1.68	2.24	1.86	0.75	1.68	1.68
neuroectodermal tumor cell line:FU-RPNT-1	10637-108I7	114.58	9.96	5.22	5.93	5.22	3.32	4.27	5.69	5.93
neuroectodermal tumor cell line:FU-RPNT-2	10663-109C6	327.21	22.81	4.91	6.97	8.24	5.86	17.90	8.71	8.39
neuroectodermal tumor cell line:TASK1	10774-110F9	40.86	4.63	1.01	1.21	0.60	1.21	0.40	0.81	1.01
neuroepithelioma cell line:SK-N-MC	10728-110A8	50.23	0.64	0.64	0.64	1.91	0.00	1.91	0.00	0.64
neurofibroma cell line:Hs 53.T	10729-110A9	18.63	0.53	0.27	0.00	0.00	0.00	0.00	0.00	0.00
neutrophil PMN, donor1	12133-128D9	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
neutrophil PMN, donor2	12137-128E4	53.12	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
neutrophil PMN, donor3	12141-128E8	37.88	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
non T non B acute lymphoblastic leukemia (ALL) cell line:P30/OHK	10430-106D7	120.58	5.92	0.85	1.52	0.85	0.17	0.85	1.01	0.68
non-small cell lung cancer cell line:NCI-H1385	10730-110B1	33.62	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
normal embryonic palatal mesenchymal cell line:HEPM	10813-111B3	16.03	0.64	0.32	0.00	0.32	0.00	0.64	0.00	0.32
normal intestinal epithelial cell line:FHs 74 Int	10812-111B2	10.51	1.05	0.53	0.26	0.26	0.53	0.00	0.26	0.26
nucleus accumbens, adult, pool1	10037-101F1	73.96	1.69	2.16	0.94	0.75	0.66	1.22	0.47	0.19
occipital cortex - adult, donor10196	10172-103C1	148.35	2.06	4.12	2.06	2.06	2.06	4.12	0.00	0.00
occipital cortex, adult, donor10252	10163-103B1	119.42	5.90	20.66	8.05	5.90	7.78	1.07	1.61	3.22
occipital cortex, newborn, donor10223	10355-105E4	50.59	1.46	0.36	0.00	0.36	0.36	0.73	0.36	0.00
occipital lobe, adult, donor1	10076-102A4	102.86	1.57	0.79	0.52	0.52	1.05	3.15	0.26	2.62
occipital lobe, fetal, donor1	10073-102A1	128.73	2.15	0.86	0.86	0.43	2.15	6.44	2.15	1.29
occipital pole, adult, pool1	10036-101E9	43.60	0.71	0.95	0.32	0.08	0.24	0.95	0.32	0.00
olfactory region, adult	10195-103E6	87.12	4.20	15.67	3.63	4.59	3.06	1.15	4.97	1.53
optic nerve, donor1	10277-104E7	160.08	2.00	4.00	2.00	2.00	0.00	0.00	0.00	0.00
oral squamous cell carcinoma cell line:Ca9-22	10434-106E2	23.01	1.03	0.23	0.34	0.34	0.11	0.23	0.23	0.46
oral squamous cell carcinoma cell line:HO-1-u-1	10550-107I1	41.08	0.96	0.69	0.14	0.14	0.27	0.14	0.41	0.00
oral squamous cell carcinoma cell line:HSC-3	10545-107H5	39.28	3.56	1.19	0.51	2.03	1.52	0.00	1.19	1.19
oral squamous cell carcinoma cell line:SAS	10544-107H4	28.65	4.50	0.46	0.81	0.35	1.39	0.23	1.16	0.58
osteoclastoma cell line:Hs 706.T	10704-109H2	15.87	0.88	0.00	0.29	0.59	0.00	0.00	0.00	0.00
osteosarcoma cell line:143B/TK^(-)neo^(R)	10510-107D6	67.27	0.00	1.87	0.00	1.87	0.00	0.93	0.00	0.00
osteosarcoma cell line:HS-Os-1	10558-107I9	34.14	0.85	0.21	0.21	0.21	0.64	0.00	0.21	0.42
ovary, adult, pool1	10020-101D2	62.89	0.87	0.70	0.44	1.05	0.52	0.44	0.61	0.17
pagetoid sarcoma cell line:Hs 925.T	10732-110B3	19.62	0.37	0.18	0.37	0.55	0.18	0.18	0.55	0.37
pancreas, adult, donor1	10049-101G4	19.75	0.00	0.00	0.00	0.00	0.00	0.00	0.94	0.94
pancreatic carcinoma cell line:NOR-P1	10698-109G5	32.43	1.96	0.84	1.96	0.84	1.12	0.00	1.12	0.56
papillary adenocarcinoma cell line:8505C	10437-106E5	21.63	3.58	0.68	0.51	0.85	1.36	0.00	0.68	2.04
papillotubular adenocarcinoma cell line:TGBC18TKB	10417-106C3	36.10	0.83	0.50	0.33	0.00	0.33	0.00	0.17	0.17
paracentral gyrus, adult, pool1	10035-101E8	68.46	1.46	2.20	1.10	0.55	0.46	1.37	0.55	0.64
parietal cortex, adult, donor10258	10373-105G4	55.05	2.94	2.20	0.73	0.73	2.94	1.47	0.73	0.00
parietal lobe - adult, donor10196	10171-103B9	84.64	2.82	4.70	4.70	3.76	1.88	0.94	0.94	2.82
parietal lobe, adult, donor10252	10157-103A4	90.64	5.13	19.38	6.27	5.13	4.56	2.00	1.43	3.14
parietal lobe, adult, pool1	10034-101E7	54.81	0.88	2.03	1.06	0.70	0.53	0.70	0.26	0.18
parietal lobe, fetal, donor1	10072-101I9	142.57	6.79	4.85	3.88	3.88	1.94	6.79	6.79	2.91
parietal lobe, newborn, donor10223	10356-105E5	49.35	1.87	0.75	1.50	0.75	0.75	2.24	1.50	0.00
parotid gland, adult	10199-103F1	31.45	1.23	0.62	0.62	0.00	0.00	0.00	0.00	0.00
penis, adult	10200-103F2	52.10	3.76	2.69	1.61	3.22	2.15	0.00	2.15	1.07
peripheral neuroectodermal tumor cell line:KU-SN	10697-109G4	30.12	2.60	0.00	0.37	0.56	0.93	0.19	1.67	1.86
pharyngeal carcinoma cell line:Detroit 562	10723-110A3	30.30	2.77	0.58	0.87	0.58	0.73	0.15	1.46	1.17
pineal gland - adult, donor10196	10179-103C8	57.41	0.65	5.16	0.00	0.00	0.65	1.29	0.65	0.65
pineal gland, adult, donor10252	10160-103A7	137.39	4.15	6.51	2.96	4.15	4.74	0.59	0.59	2.37
pineal gland, adult, donor10258	10377-105G8	60.20	1.88	1.25	1.88	1.88	0.00	1.25	0.00	0.63
pituitary gland - adult, donor10196	10180-103C9	73.86	3.04	1.01	1.01	3.04	2.02	1.01	0.00	0.00
pituitary gland, adult, donor10252	10162-103A9	140.72	5.21	2.08	3.13	2.61	1.56	1.04	2.08	1.56
pituitary gland, adult, donor10258	10378-105G9	53.63	2.55	0.00	0.85	0.85	0.00	0.00	0.00	0.00
placenta, adult, pool1	10021-101D3	46.01	0.32	1.08	0.43	0.32	0.32	0.32	0.22	0.32
plasma cell leukemia cell line:ARH-77	10840-111E3	32.44	1.46	0.66	0.53	0.53	0.40	0.79	0.26	0.40
pleomorphic hepatocellular carcinoma cell line:SNU-387	10706-109H4	23.35	0.16	0.16	0.16	0.00	0.31	0.31	0.16	0.16
pons, adult, pool1	10033-101E6	89.25	3.10	3.36	2.15	1.12	0.77	1.81	0.60	0.95
postcentral gyrus, adult, pool1	10032-101E5	46.73	0.87	0.87	0.52	0.44	0.26	1.13	0.35	0.00
promyelocytes/myelocytes PMC, donor1	12132-128D8	20.91	0.00	0.00	0.00	2.09	0.00	0.00	0.00	0.00
promyelocytes/myelocytes PMC, donor2	12136-128E3	11.02	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
promyelocytes/myelocytes PMC, donor3	12140-128E7	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
prostate cancer cell line:DU145	10490-107B4	25.78	2.33	0.29	0.87	0.29	1.02	0.00	0.00	0.29
prostate cancer cell line:PC-3	10439-106E7	37.21	2.18	1.45	1.27	1.63	0.91	0.00	1.27	0.73
prostate, adult, pool1	10022-101D4	63.12	1.09	0.82	0.36	0.27	0.45	1.18	0.45	0.27
putamen, adult, donor10196	10176-103C5	114.96	4.96	9.91	3.78	4.01	4.49	4.25	3.07	0.94
putamen, adult, donor10252	10152-102I8	74.51	0.00	11.76	3.92	3.92	1.96	1.96	0.00	0.00
putamen, adult, donor10258, tech_rep1	10372-105G3	32.78	2.19	1.09	1.09	1.09	0.00	0.00	1.09	4.37
putamen, adult, donor10258, tech_rep2	10372-105G3	63.30	5.56	7.97	3.38	1.93	4.83	1.69	2.90	2.17
putamen, newborn, donor10223	10365-105F5	88.46	0.00	0.75	2.25	0.00	0.00	0.75	0.00	0.00
rectal cancer cell line:TT1TKB	10469-106I1	68.08	1.16	2.62	0.58	0.87	0.58	0.00	0.58	0.29
rectum, fetal, donor1	10067-101I4	93.20	1.39	1.39	0.00	1.39	1.39	1.39	0.00	4.17
renal cell carcinoma cell line:OS-RC-2	10411-106B6	31.38	1.48	0.00	0.21	0.85	0.21	0.21	0.64	0.00
renal cell carcinoma cell line:TUHR10TKB	10471-106I3	20.30	0.41	0.00	0.00	0.00	0.00	0.00	0.00	0.41
retina, adult, pool1	10030-101E3	39.16	1.59	0.50	0.30	0.40	0.30	0.20	0.10	0.00
retinoblastoma cell line:Y79	10475-106I7	73.78	2.34	3.64	3.12	2.60	2.86	0.52	1.04	1.56
rhabdomyosarcoma cell line:KYM-1	10787-110H4	30.86	1.35	1.48	1.35	0.37	0.25	0.00	1.11	0.61
rhabdomyosarcoma cell line:RMS-YM	10477-106I9	90.55	0.00	1.41	1.97	2.53	0.84	0.00	0.00	0.56
sacrococcigeal teratoma cell line:HTST	10695-109G2	34.10	0.00	0.00	1.52	1.52	0.00	0.76	0.76	0.00
salivary acinar cells, donor1	11771-123I7	22.50	1.94	1.62	0.65	0.97	1.13	0.16	0.32	0.49
salivary acinar cells, donor2	11772-123I8	23.68	2.07	0.69	1.24	1.10	1.24	0.14	0.55	0.83
salivary acinar cells, donor3	11773-123I9	30.45	0.00	2.65	0.66	1.32	1.32	0.66	0.00	0.00
salivary gland, adult, pool1	10093-102C3	21.16	0.00	0.00	0.57	0.00	0.00	0.57	0.00	0.00
schwannoma cell line:HS-PSS, tech_rep1	10442-106F1	26.73	1.26	0.51	0.59	0.67	0.84	0.00	0.42	0.42
schwannoma cell line:HS-PSS, tech_rep2	10442-106F1	29.15	2.70	0.47	0.47	0.82	1.06	0.00	0.47	0.00
seminal vesicle, adult	10201-103F3	67.72	3.70	2.65	2.12	1.06	0.53	1.06	2.12	0.53
serous adenocarcinoma cell line:JHOS-2	10639-108I9	38.38	0.73	0.24	0.24	0.97	0.49	0.24	0.24	0.49
serous adenocarcinoma cell line:SK-OV-3-R after co-culture with SOC-57-02-G, biol_rep1	11843-124H7	10.82	0.00	0.25	0.00	0.25	0.50	0.00	0.00	0.25
serous adenocarcinoma cell line:SK-OV-3-R, biol_rep1	11841-124H5	22.08	1.00	0.00	0.00	1.00	2.01	0.00	0.00	0.00
serous cystadenocarcinoma cell line:HTOA	10693-109F9	19.07	2.28	0.40	0.54	0.94	0.81	0.13	1.48	0.27
signet ring carcinoma cell line:Kato III	10436-106E4	38.68	0.66	0.66	0.88	0.11	0.55	0.11	0.11	0.44
signet ring carcinoma cell line:NUGC-4	10483-107A6	17.93	0.26	0.26	0.00	0.26	0.13	0.26	0.00	0.00
skeletal muscle - soleus muscle, donor1	10282-104F3	41.14	0.71	7.09	4.26	2.84	1.42	0.00	0.00	4.26
skeletal muscle, adult, pool1	10023-101D5	52.17	0.48	0.96	0.84	0.36	0.24	0.36	0.24	0.00
skeletal muscle, fetal, donor1	10066-101I3	40.20	1.01	1.01	1.01	1.01	0.00	0.00	1.01	2.01
skin, adult, donor1	10074-102A2	54.28	0.00	0.00	0.00	6.79	0.00	0.00	0.00	0.00
skin, fetal, donor1	10065-101I2	89.00	0.63	0.63	1.89	1.26	2.52	1.26	1.26	4.42
small cell cervical cancer cell line:HCSC-1	10800-110I8	35.69	0.67	0.67	0.33	0.33	0.33	0.33	0.67	0.33
small cell gastrointestinal carcinoma cell line:ECC10	10610-108F7	37.82	5.36	2.84	1.58	1.26	2.84	0.95	0.95	0.00
small cell lung carcinoma cell line:DMS 144	10841-111E4	21.78	0.00	0.00	0.77	0.39	0.00	0.39	0.00	0.58
small cell lung carcinoma cell line:LK-2	10541-107H1	43.51	0.99	0.16	0.33	0.49	0.16	0.16	0.00	0.33
small cell lung carcinoma cell line:NCI-H82	10842-111E5	71.58	5.15	2.41	1.61	0.80	3.06	0.16	2.41	1.93
small cell lung carcinoma cell line:WA-hT	10562-108A4	15.25	0.65	0.22	0.87	0.00	0.44	0.00	0.00	1.31
small intestine, adult, pool1	10024-101D6	50.29	0.84	0.96	0.24	0.12	0.36	0.72	0.36	0.12
small intestine, fetal, donor1	10064-101I1	49.88	3.19	0.74	2.21	0.98	1.23	0.49	1.97	1.97
small-cell gastrointestinal carcinoma cell line:ECC4	10609-108F6	23.59	2.05	0.51	0.51	0.00	1.03	0.00	1.03	1.03
smooth muscle, adult, pool1	10048-101G3	65.91	2.58	2.07	1.81	1.29	1.55	1.81	1.81	0.52
somatostatinoma cell line:QGP-1	10781-110G7	23.85	0.80	0.80	0.54	0.00	0.27	0.00	0.27	0.27
spinal cord - adult, donor10196	10181-103D1	129.16	2.98	5.74	2.75	2.75	2.29	2.75	1.15	0.46
spinal cord, adult, donor10252	10159-103A6	122.62	3.15	9.86	3.15	0.79	0.79	0.79	1.18	2.76
spinal cord, adult, donor10258	10369-105F9	92.01	2.08	3.46	2.08	2.77	0.00	0.00	2.08	0.69
spinal cord, fetal, donor1	10056-101H2	66.47	1.22	0.61	0.00	1.22	2.44	0.61	1.22	1.22
spinal cord, newborn, donor10223	10359-105E8	78.53	1.38	2.30	0.00	0.92	0.92	0.92	0.92	0.46
spindle cell sarcoma cell line:Hs 132.T	10737-110B8	14.19	0.30	0.30	0.30	0.00	0.15	0.15	0.30	0.15
spleen, adult, pool1	10025-101D7	51.87	0.99	1.32	0.77	0.55	0.22	1.10	0.22	0.55
spleen, fetal, pool1	10044-101F8	31.86	0.32	0.48	0.08	0.08	0.08	0.95	0.08	0.08
splenic lymphoma with villous lymphocytes cell line:SLVL	10424-106D1	31.05	1.45	0.93	0.21	0.31	0.21	0.62	0.10	0.21
squamous cell carcinoma cell line:EC-GI-10	10463-106H4	24.11	1.14	0.38	0.57	0.38	0.76	0.00	0.38	0.38
squamous cell carcinoma cell line:JHUS-nk1	10646-109A7	31.80	1.75	2.10	2.10	3.15	1.40	0.35	1.05	1.75
squamous cell carcinoma cell line:T3M-5	10616-108G4	25.02	0.00	0.39	0.00	0.00	0.39	0.39	0.39	0.00
squamous cell lung carcinoma cell line:EBC-1	10486-107A9	22.06	0.68	0.56	1.35	1.01	0.00	0.11	0.34	0.45
squamous cell lung carcinoma cell line:LC-1F	10457-106G7	19.91	0.85	0.00	0.00	0.42	0.85	0.00	0.42	0.00
squamous cell lung carcinoma cell line:RERF-LC-AI	10501-107C6	25.38	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
stomach, fetal, donor1	10062-101H8	43.79	0.00	0.00	1.07	0.00	0.00	0.00	0.00	0.00
submaxillary gland, adult	10202-103F4	41.02	0.57	1.14	0.57	0.00	0.57	0.00	0.00	0.57
substantia nigra - adult, donor10196	10178-103C7	1356.85	325.64	597.02	271.37	162.82	54.27	0.00	162.82	162.82
substantia nigra, adult, donor10252	10158-103A5	105.10	4.98	3.32	4.15	3.32	3.53	2.28	2.08	1.25
substantia nigra, adult, donor10258	10371-105G2	55.86	2.59	3.10	1.03	2.07	1.03	0.00	2.59	1.55
substantia nigra, newborn, donor10223	10358-105E7	47.34	0.71	0.00	0.00	0.00	0.00	0.00	1.41	0.71
synovial sarcoma cell line:HS-SY-II	10441-106E9	97.90	3.44	3.67	2.29	1.15	1.60	2.06	1.60	1.60
temporal lobe, adult, pool1	10031-101E4	41.88	0.68	1.19	0.68	0.51	0.25	0.93	0.51	0.08
temporal lobe, fetal, donor1, tech_rep1	10063-101H9	109.69	1.42	0.71	4.99	4.27	2.14	0.71	0.00	4.27
temporal lobe, fetal, donor1, tech_rep2	10063-101H9	80.44	1.32	0.44	1.76	1.76	1.32	3.52	0.88	1.76
tenocyte, donor1	11763-123H8	19.55	3.14	1.05	1.40	1.05	0.35	0.00	1.05	1.05
tenocyte, donor2	11765-123I1	14.50	0.76	0.76	0.76	0.76	0.38	0.00	0.76	0.00
tenocyte, donor3	11768-123I4	19.27	4.08	0.74	0.37	0.37	1.11	0.00	1.11	0.74
teratocarcinoma cell line:NCC-IT-A3	10790-110H7	29.06	2.55	0.85	1.02	1.02	0.85	0.00	0.68	0.34
teratocarcinoma cell line:NCR-G1	10798-110I6	31.75	0.92	0.46	0.62	1.23	0.15	0.31	0.46	0.46
teratocarcinoma cell line:PA-1	10807-111A6	40.60	2.32	0.62	0.77	0.15	0.46	0.15	1.55	0.77
testicular germ cell embryonal carcinoma cell line:ITO-II	10786-110H3	25.77	1.65	0.89	1.27	0.51	0.76	0.63	0.51	0.25
testicular germ cell embryonal carcinoma cell line:NEC14	10591-108D6	51.43	2.65	1.51	1.51	0.76	0.76	0.38	1.13	1.13
testicular germ cell embryonal carcinoma cell line:NEC15	10593-108D8	44.39	0.33	0.87	1.64	1.31	0.65	0.22	0.22	0.76
testicular germ cell embryonal carcinoma cell line:NEC8	10590-108D5	99.67	10.75	4.89	2.93	3.26	3.26	0.65	4.89	3.58
testis, adult, pool1	10026-101D8	56.37	0.75	0.54	0.75	0.32	0.11	0.54	0.32	0.11
testis, adult, pool2	10096-102C6	35.18	1.35	2.26	0.90	1.35	0.45	0.00	1.35	0.00
thalamus - adult, donor10196	10168-103B6	130.27	6.62	7.73	2.21	2.21	2.21	1.10	0.00	1.10
thalamus, adult, donor10252	10154-103A1	124.87	6.88	7.97	4.84	3.91	3.91	3.13	3.13	1.88
thalamus, adult, donor10258, tech_rep1	10370-105G1	52.35	4.62	0.00	0.00	1.54	0.00	0.00	3.08	3.08
thalamus, adult, donor10258, tech_rep2	10370-105G1	53.19	5.27	1.98	0.49	0.16	1.15	1.65	1.32	2.64
thalamus, newborn, donor10223	10366-105F6	37.40	0.58	0.58	0.00	0.00	0.58	1.15	0.58	0.58
throat, adult	10209-103G2	48.19	0.25	0.50	0.25	0.25	0.25	0.50	0.25	0.25
throat, fetal, donor1	10061-101H7	56.98	1.22	1.22	0.91	2.13	1.83	1.22	0.61	1.52
thymic carcinoma cell line:Ty-82	10803-111A2	36.37	0.79	0.99	0.79	0.40	0.20	0.40	0.99	0.40
thymus, adult, pool1	10027-101D9	98.12	2.68	1.29	0.89	0.89	0.50	2.49	0.40	0.50
thymus, fetal, pool1	10043-101F7	75.75	1.14	0.42	0.31	0.31	0.00	2.81	0.52	0.10
thyroid carcinoma cell line:KHM-5M	10776-110G2	25.26	1.06	0.13	0.13	0.40	0.13	0.13	0.53	0.66
thyroid carcinoma cell line:TCO-1	10783-110G9	23.89	1.40	1.26	0.70	0.56	0.70	0.28	0.42	0.84
thyroid, adult, pool1	10028-101E1	47.12	1.12	0.65	0.37	0.47	0.56	0.19	0.56	0.09
thyroid, fetal, donor1	10060-101H6	59.85	3.16	1.85	0.53	2.11	2.11	1.32	1.05	0.79
tongue epidermis (fungiform papillae), donor1	10288-104F9	24.64	0.00	6.16	0.00	6.16	0.00	6.16	0.00	3.08
tongue, adult	10203-103F5	36.75	3.02	1.16	0.23	1.63	0.47	0.23	0.47	1.63
tongue, fetal, donor1	10059-101H5	48.87	2.36	1.18	1.18	1.18	0.00	0.00	1.97	1.18
tonsil, adult, pool1	10047-101G2	32.76	0.10	0.00	0.30	0.30	0.00	0.60	0.10	0.00
trachea, adult, pool1	10029-101E2	41.39	0.41	0.08	0.41	0.33	0.25	0.57	0.08	0.16
trachea, fetal, donor1	10058-101H4	53.86	1.54	0.00	0.38	1.15	0.00	0.77	0.38	0.77
transitional cell carcinoma cell line:Hs 769.T	10707-109H5	21.26	2.48	0.00	0.71	0.00	0.71	0.71	0.35	0.71
transitional-cell carcinoma cell line:5637	10418-106C4	36.27	0.71	0.10	0.20	0.20	0.20	0.00	0.41	0.51
transitional-cell carcinoma cell line:JMSU1	10492-107B6	30.24	3.60	0.78	0.94	0.94	1.25	0.00	0.94	0.78
tridermal teratoma cell line:HGRT	10694-109G1	19.03	0.00	0.00	0.00	3.81	0.00	0.00	0.00	0.00
tubular adenocarcinoma cell line:SUIT-2	10797-110I5	13.71	0.76	0.25	0.51	0.51	0.42	0.08	0.25	0.17
umbilical cord, fetal, donor1	10057-101H3	56.34	0.00	2.09	0.00	2.09	0.00	0.00	0.00	2.09
uterus, adult, pool1	10100-102D1	56.14	0.51	0.68	0.17	0.17	0.51	0.17	0.51	0.51
uterus, fetal, donor1	10055-101H1	52.73	2.05	1.02	1.02	2.05	1.02	0.00	0.00	0.51
vagina, adult	10204-103F6	42.00	0.00	0.00	0.00	2.58	0.65	0.00	0.65	0.00
vein, adult	10191-103E2	45.15	0.88	0.44	1.32	0.66	0.22	0.88	0.44	0.22
xeroderma pigentosum b cell line:XPL 17	10563-108A5	21.10	1.07	0.27	1.07	0.27	0.27	0.27	0.27	0.00